{
  "meta": {
    "title": "08_Psychopharmacology",
    "url": "https://brainandscalpel.vercel.app/08-psychopharmacology-5ac0d678.html",
    "scrapedAt": "2025-11-30T07:06:49.408Z"
  },
  "questions": [
    {
      "id": 81161,
      "choices": [
        {
          "id": 236625,
          "text": "A lithium level should be taken at 4 hours post ingestion"
        },
        {
          "id": 236626,
          "text": "The first signs of toxicity are usually gastrointestinal symptoms"
        },
        {
          "id": 236627,
          "text": "The most common ECG abnormality is QRS prolongation"
        },
        {
          "id": 236628,
          "text": "Ataxia is a late sign of significant toxicity"
        }
      ],
      "text": "A 48 Years old woman has ingested an unknown amount of Lithium carbonate 2 hours ago. This had been started 3 weeks ago by her psychiatrist. Which ofthe following is True?",
      "unique_key": "Q7117417",
      "question_audio": null,
      "question_video": null,
      "map_id": 34850929,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) The first signs of toxicity are usually gastrointestinal symptoms. Lithium toxicity typically presents in three stages: mild, moderate, and severe. The earliest and most common symptoms of toxicity are gastrointestinal (GI) disturbances, such as nausea, vomiting, diarrhea, and abdominal pain. These symptoms occur because lithium directly irritates the gastrointestinal tract. If toxicity progresses, neurological symptoms such as confusion, tremors, and ataxia can develop. Given that this patient ingested lithium 2 hours ago, the GI symptoms are the earliest clinical manifestations expected before significant neurological effects occur. Explanation of Incorrect Options: (A) A lithium level should be taken at 4 hours post-ingestion – Incorrect While lithium levels are important for diagnosis and management, the timing of measurement is crucial. In cases of acute overdose, lithium levels should be checked immediately upon presentation and then repeated every 2–4 hours to assess changes over time. Lithium has a relatively long distribution phase (6–12 hours), so measuring it too early may not reflect peak serum levels. Waiting until exactly 4 hours is not necessarily the best practice, as serial monitoring is preferred to track absorption and toxicity progression. (C) The most common ECG abnormality is QRS prolongation – Incorrect Lithium can affect cardiac conduction, but the most common ECG finding is T-wave flattening or inversion, not QRS prolongation. In severe toxicity, bradycardia, sinoatrial block, or QT prolongation can occur. QRS prolongation is more typical of tricyclic antidepressant (TCA) toxicity, not lithium toxicity. (D) Ataxia is a late sign of significant toxicity – Incorrect While ataxia is a known feature of lithium toxicity, it can occur in moderate toxicity alongside tremors, dysarthria (slurred speech), and confusion. Late or severe toxicity symptoms include seizures, coma, and irreversible neurological damage. Ataxia is not exclusively a late sign; it can appear earlier as toxicity progresses, depending on the severity of lithium accumulation.",
      "correct_choice_id": 236626,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69825561699011585/69825561699011585.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69825561699011585/69825561699011585.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81162,
      "choices": [
        {
          "id": 236629,
          "text": "Divalproex sodium"
        },
        {
          "id": 236630,
          "text": "Ziprasidone"
        },
        {
          "id": 236631,
          "text": "Carbamazepine"
        },
        {
          "id": 236632,
          "text": "Clozapine"
        }
      ],
      "text": "You are treating a 32-year-old woman for bipolar I disorder with a combination of medications. She complains of hair loss. This side effect is a reversible side effect of which of the following medications?",
      "unique_key": "Q5989665",
      "question_audio": null,
      "question_video": null,
      "map_id": 34990765,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Divalproex sodium. Divalproex sodium (valproate) is a mood stabilizer commonly used to treat bipolar I disorder, particularly for acute manic episodes and maintenance therapy. One of its well-documented dose-dependent side effects is hair loss (alopecia), which occurs in some patients due to valproate-induced telogen effluvium (a temporary hair shedding process). This occurs because valproate affects hair keratin structure, leading to brittle, thinning hair. Fortunately, this side effect is reversible upon dose reduction or discontinuation of the medication. Some patients benefit from supplementing with zinc and selenium to reduce hair loss. Explanation of Incorrect Options: (B) Ziprasidone – Incorrect Ziprasidone is an atypical antipsychotic often used in bipolar disorder and schizophrenia. Its common side effects include QT prolongation, sedation, and weight gain, but it is not associated with hair loss. (C) Carbamazepine – Incorrect Carbamazepine, another mood stabilizer and anticonvulsant, is used in bipolar disorder, epilepsy, and trigeminal neuralgia. Its side effects include agranulocytosis, hyponatremia (SIADH), hepatotoxicity, and Stevens-Johnson syndrome, but hair loss is not a common side effect. (D) Clozapine – Incorrect Clozapine is an atypical antipsychotic primarily reserved for treatment-resistant schizophrenia due to its risk of agranulocytosis and myocarditis. Other side effects include hypersalivation, metabolic syndrome, and seizures, but hair loss is not associated with clozapine use.",
      "correct_choice_id": 236629,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48457511699012166/48457511699012166.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48457511699012166/48457511699012166.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81163,
      "choices": [
        {
          "id": 236633,
          "text": "Amantadine"
        },
        {
          "id": 236634,
          "text": "Methylphenidate"
        },
        {
          "id": 236635,
          "text": "SSRIs"
        },
        {
          "id": 236636,
          "text": "Antihistamines"
        }
      ],
      "text": "Ayoung man experiences erectile dysfunction and is told that the medication he is prescribed is likely to be the cause. Which of the following medications is associated with erectile dysfunction?",
      "unique_key": "Q7782668",
      "question_audio": null,
      "question_video": null,
      "map_id": 34502544,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs, such as fluoxetine, sertraline, paroxetine, and escitalopram, are widely used for treating depression, anxiety disorders, and other mood disorders. One of their most common side effects is sexual dysfunction, which includes erectile dysfunction, delayed ejaculation, anorgasmia, and decreased libido. This occurs because SSRIs increase serotonin levels, which can inhibit dopamine's role in sexual arousal and impair nitric oxide-mediated penile vasodilation. The sexual side effects can persist for weeks or months, even after discontinuation of the medication in some cases. Switching to an alternative antidepressant, such as bupropion or mirtazapine, may help alleviate these side effects. Explanation of Incorrect Options: (A) Amantadine – Incorrect Amantadine is an antiviral drug and a dopamine agonist used in Parkinson’s disease and drug-induced extrapyramidal symptoms. Unlike SSRIs, amantadine is actually associated with increased dopamine activity, which can enhance sexual function rather than impair it. It is not a common cause of erectile dysfunction. (B) Methylphenidate – Incorrect Methylphenidate is a stimulant used to treat ADHD and narcolepsy. It increases dopamine and norepinephrine levels, which can actually enhance libido and erectile function in some individuals. However, in rare cases, excessive sympathetic stimulation can cause vasoconstriction and reduce penile blood flow, leading to transient erectile issues, but this is not a primary side effect of the medication. (D) Antihistamines – Incorrect While some first-generation antihistamines (e.g., diphenhydramine, hydroxyzine) can cause sedation and reduced libido, they are not a major cause of erectile dysfunction. Second-generation antihistamines (e.g., loratadine, cetirizine) have minimal effects on sexual function. Their anticholinergic properties may contribute to sexual dysfunction, but this effect is much weaker compared to SSRIs.",
      "correct_choice_id": 236635,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2661521699012272/2661521699012272.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2661521699012272/2661521699012272.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81164,
      "choices": [
        {
          "id": 236637,
          "text": "Obtain a serum medication level"
        },
        {
          "id": 236638,
          "text": "Prescribe antidiarrheal medication."
        },
        {
          "id": 236639,
          "text": "Obtain a urine toxicology screen."
        },
        {
          "id": 236640,
          "text": "Obtain a urine pregnancy test"
        }
      ],
      "text": "A 37-year-old woman presents with severe diarrhea and a coarse tremor. The medical chart notes a history of bipolar I disorder. The most appropriate intervention aimed at establishing a diagnosis is which of the following?",
      "unique_key": "Q1887803",
      "question_audio": null,
      "question_video": null,
      "map_id": 34597588,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Obtain a serum medication level. Given the patient’s history of bipolar I disorder, the most likely cause of her severe diarrhea and coarse tremor is lithium toxicity. Lithium is a commonly used medication for bipolar disorder, and it can have serious toxicity effects, including gastrointestinal symptoms like diarrhea and neurological symptoms such as tremors. The most appropriate first step is to obtain a serum lithium level to determine if the symptoms are due to lithium toxicity, which is treatable if detected early. Serum medication levels provide a direct measurement of lithium concentration, which can guide appropriate treatment adjustments. Explanation of Incorrect Options: (B) Prescribe antidiarrheal medication – Incorrect Although diarrhea is one of the symptoms of lithium toxicity, prescribing antidiarrheal medication without first identifying the underlying cause would be inappropriate. It is essential to diagnose the cause of the diarrhea (e.g., lithium toxicity) rather than just treating the symptom. Symptomatic treatment like antidiarrheals would not address the root cause and could delay necessary interventions. (C) Obtain a urine toxicology screen – Incorrect A urine toxicology screen is typically used to identify illicit drug use or substance abuse, but it is not the most appropriate test for lithium toxicity or for diagnosing conditions related to psychiatric medications like lithium. While drug abuse could be a concern in some cases, the patient's history suggests medication-related toxicity rather than illicit drug use. (D) Obtain a urine pregnancy test – Incorrect While it is important to rule out pregnancy in women of reproductive age when evaluating any illness, pregnancy is unlikely to explain severe diarrhea and coarse tremor in this context. The patient’s history of bipolar disorder and her symptoms are more consistent with lithium toxicity, making a serum lithium level more relevant to her current presentation. A urine pregnancy test would be indicated only if pregnancy-related complications (e.g., hyperemesis gravidarum) were suspected.",
      "correct_choice_id": 236637,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22700581699012809/22700581699012809.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22700581699012809/22700581699012809.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81165,
      "choices": [
        {
          "id": 236641,
          "text": "Depressed mood"
        },
        {
          "id": 236642,
          "text": "Muscle cramping"
        },
        {
          "id": 236643,
          "text": "Headache"
        },
        {
          "id": 236644,
          "text": "Irritability"
        }
      ],
      "text": "A 34-year-old executive reports drinking up to six cups of caffeinated coffee per day. He boards a plane scheduled for an 18-hour flight on which only decaffeinated beverages are served. Which of the following symptoms is the executive most likely to experience?",
      "unique_key": "Q4156143",
      "question_audio": null,
      "question_video": null,
      "map_id": 34554113,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Headache. The executive, who typically consumes six cups of caffeinated coffee per day, is likely to experience withdrawal symptoms after the abrupt cessation of caffeine. Caffeine withdrawal commonly causes headaches, which are one of the most frequent and distressing symptoms. Since the flight offers only decaffeinated beverages, which contain little to no caffeine, the executive may experience withdrawal due to the lack of his usual caffeine intake, leading to a headache. Explanation of Incorrect Options: (A) Depressed mood – Incorrect While depressed mood can be a symptom of caffeine withdrawal, it is generally less common compared to physical symptoms like headaches. Withdrawal symptoms typically start with headaches, followed by irritability or fatigue, but depression is less likely to be the initial symptom of caffeine cessation. (B) Muscle cramping – Incorrect Muscle cramping is not a typical symptom of caffeine withdrawal. While dehydration or electrolyte imbalances can cause muscle cramping, caffeine withdrawal generally manifests more through headaches, fatigue, irritability, and difficulty concentrating, rather than physical symptoms like muscle cramps. (D) Irritability – Incorrect Irritability is indeed a possible symptom of caffeine withdrawal, but headache is usually the most prominent and immediate symptom in people who consume large amounts of caffeine daily. Irritability tends to occur alongside other symptoms, such as fatigue or difficulty concentrating, but it is not as likely to occur as quickly or as intensely as a headache.",
      "correct_choice_id": 236643,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58729021699012863/58729021699012863.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58729021699012863/58729021699012863.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81166,
      "choices": [
        {
          "id": 236645,
          "text": "Sertraline"
        },
        {
          "id": 236646,
          "text": "Clonazepam"
        },
        {
          "id": 236647,
          "text": "Haloperidol"
        },
        {
          "id": 236648,
          "text": "Lithium"
        }
      ],
      "text": "Soon after admission, the 36 yrs old male begins experiencing hallucinations due to alcohol withdrawal and becomes agitated. Which of the following medications should be prescribed to treat these symptoms?",
      "unique_key": "Q2246044",
      "question_audio": null,
      "question_video": null,
      "map_id": 34255432,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Clonazepam. In the case of alcohol withdrawal, benzodiazepines, such as clonazepam, are the first-line treatment to manage symptoms like agitation, hallucinations, and tremors. Clonazepam works by enhancing the activity of GABA, the brain's primary inhibitory neurotransmitter, which helps calm the central nervous system during withdrawal. This action can prevent more serious withdrawal symptoms, such as seizures and delirium tremens (DTs). It is specifically effective in managing the agitation and hallucinations associated with alcohol withdrawal. Explanation of Incorrect Options: (A) Sertraline – Incorrect Sertraline is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression, anxiety, and obsessive-compulsive disorder (OCD). While it is effective for managing mood and anxiety disorders, it is not suitable for treating alcohol withdrawal symptoms like hallucinations and agitation, which are more appropriately managed with benzodiazepines. (C) Haloperidol – Incorrect Haloperidol is an antipsychotic medication that can be used to treat delirium and psychotic disorders, including agitation. However, it is generally not the first-line treatment for alcohol withdrawal symptoms, especially hallucinations. Using antipsychotics like haloperidol can increase the risk of seizures in alcohol withdrawal and is typically avoided unless the patient is showing severe psychiatric symptoms that do not respond to benzodiazepines. (D) Lithium – Incorrect Lithium is a mood stabilizer primarily used for bipolar disorder. It is not effective in managing the symptoms of alcohol withdrawal, and its use in an acute withdrawal setting could be dangerous due to its potential for toxicity, especially when the patient may have dehydration or electrolyte imbalances, which are common in alcohol withdrawal.",
      "correct_choice_id": 236646,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54077681699012892/54077681699012892.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54077681699012892/54077681699012892.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81167,
      "choices": [
        {
          "id": 236649,
          "text": "Restless shuffling and pacing"
        },
        {
          "id": 236650,
          "text": "Muscle spasm in neck"
        },
        {
          "id": 236651,
          "text": "Writhing movement in fingers and hands"
        },
        {
          "id": 236652,
          "text": "“Rabbit” syndrome"
        }
      ],
      "text": "A 20-year-old man is started on haloperidol,20 mg, each day for psychotic symptoms. Which of the following side effects would most likely be seen in the first 5 days of treatment?",
      "unique_key": "Q5746844",
      "question_audio": null,
      "question_video": null,
      "map_id": 34025617,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Muscle spasm in neck. Haloperidol is a first-generation (typical) antipsychotic that works by blocking dopamine receptors, which can lead to a variety of side effects, particularly in the early stages of treatment. The most common side effects during the first few days of therapy are extrapyramidal symptoms (EPS), which include dystonic reactions, such as muscle spasms. A muscle spasm in the neck, also known as cervical dystonia or torticollis, is a classic sign of acute dystonic reactions. These reactions typically occur within the first few days of starting haloperidol and can be distressing but are generally reversible with treatment. Explanation of Incorrect Options: (A) Restless shuffling and pacing – Incorrect This symptom is more suggestive of akathisia, another extrapyramidal side effect of antipsychotic medications. Akathisia presents as a sense of restlessness and an inability to remain still, leading to pacing or fidgeting. However, akathisia usually develops within a few weeks of starting antipsychotic treatment, rather than within the first 5 days. It is not the most common side effect in the first 5 days. (C) Writhing movement in fingers and hands – Incorrect This symptom is more indicative of tardive dyskinesia, a movement disorder that results in repetitive, involuntary movements such as writhing or twisting of the hands, fingers, and other body parts. Tardive dyskinesia typically develops after prolonged use of antipsychotic medications (months to years) and is unlikely to appear in the first few days of treatment. (D) \"Rabbit\" syndrome – Incorrect \"Rabbit syndrome\" refers to a specific type of tardive dyskinesia characterized by repetitive, involuntary lip movements resembling the movement of a rabbit's mouth. Like tardive dyskinesia, this side effect develops over time with prolonged use of antipsychotic medications. It would not be expected within the first 5 days of treatment.",
      "correct_choice_id": 236650,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55675461699013392/55675461699013392.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55675461699013392/55675461699013392.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81168,
      "choices": [
        {
          "id": 236653,
          "text": "Buspirone"
        },
        {
          "id": 236654,
          "text": "Clomipramine"
        },
        {
          "id": 236655,
          "text": "Doxepin"
        },
        {
          "id": 236656,
          "text": "Fluvoxamine"
        }
      ],
      "text": "A 40-year-old woman suffers from depression and obsessive ritualistic behavior. The physician decides to prescribe an SSRI. Which of the following medications might the physician consider?",
      "unique_key": "Q8187656",
      "question_audio": null,
      "question_video": null,
      "map_id": 34458200,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Fluvoxamine The patient’s symptoms suggest a combination of depression and obsessive-compulsive disorder (OCD). Fluvoxamine is an SSRI that is specifically approved for the treatment of OCD in addition to depression. SSRIs like fluvoxamine are commonly prescribed for both conditions because they help increase serotonin levels in the brain, which can alleviate symptoms of depression and reduce obsessive-compulsive behaviors. Since this patient has both depression and OCD, fluvoxamine is an appropriate choice, as it effectively treats both conditions and has a favorable side effect profile. Explanation of Incorrect Responses: (A) Buspirone – Incorrect Buspirone is an anxiolytic medication used primarily for generalized anxiety disorder (GAD). While it can be helpful for anxiety symptoms, it is not effective for treating depression or obsessive-compulsive behaviors. It does not have the same efficacy as SSRIs like fluvoxamine in managing both depression and OCD, so it would not be the first choice for this patient. (B) Clomipramine – Incorrect Clomipramine is a tricyclic antidepressant (TCA) that is effective for treating OCD but is not as commonly used as SSRIs due to its side effect profile. While clomipramine can be effective in treating OCD, it is often considered a second-line treatment due to its anticholinergic side effects (e.g., dry mouth, constipation) and cardiotoxicity risks. Therefore, fluvoxamine, an SSRI with fewer side effects, is generally preferred. (C) Doxepin – Incorrect Doxepin is another tricyclic antidepressant (TCA) that is primarily used to treat depression and anxiety. While it can also be helpful for sleep disorders and some other conditions, it is not typically prescribed for OCD. Like clomipramine, doxepin carries a higher risk of side effects compared to SSRIs, which makes it less ideal for treating depression with obsessive-compulsive symptoms.",
      "correct_choice_id": 236656,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15435351699013463/15435351699013463.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15435351699013463/15435351699013463.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81169,
      "choices": [
        {
          "id": 236657,
          "text": "Alcohol"
        },
        {
          "id": 236658,
          "text": "Amphetamines"
        },
        {
          "id": 236659,
          "text": "Benzodiazepines"
        },
        {
          "id": 236660,
          "text": "Heroin"
        }
      ],
      "text": "A 24-year-old patient is experiencingintense hunger as well as tiredness and headache. This patient is most likely to be withdrawing from which of the following substances?",
      "unique_key": "Q9479835",
      "question_audio": null,
      "question_video": null,
      "map_id": 34044813,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Amphetamines The patient’s symptoms—intense hunger, tiredness, and headache—are commonly seen in amphetamine withdrawal. Amphetamines, such as methamphetamine or ecstasy, increase levels of dopamine and norepinephrine in the brain, leading to feelings of euphoria and increased energy. Upon withdrawal, individuals often experience a crash, which includes increased appetite (due to the return of normal food intake after the stimulant effect wears off), fatigue, and headaches. These symptoms are indicative of the body readjusting after the cessation of stimulant use. Explanation of Incorrect Responses: (A) Alcohol – Incorrect While alcohol withdrawal can lead to tremors, anxiety, insomnia, and severe cases of delirium tremens, the specific symptoms of hunger, tiredness, and headache are less characteristic of alcohol withdrawal. Alcohol withdrawal usually involves more autonomic symptoms, such as sweating, elevated heart rate, and nausea, which are not highlighted in this case. (C) Benzodiazepines – Incorrect Benzodiazepine withdrawal can cause anxiety, irritability, tremors, and seizures in severe cases, but it does not typically present with hunger, tiredness, and headache as prominent features. Withdrawal from benzodiazepines usually manifests with physical agitation, insomnia, and muscle stiffness, which are not the main symptoms here. (D) Heroin – Incorrect Heroin withdrawal typically involves symptoms such as muscle aches, nausea, vomiting, diarrhea, irritability, and sweating, but it is less likely to cause intense hunger. While opioid withdrawal symptoms can involve headaches and fatigue, these symptoms are more often accompanied by physical discomfort rather than the food cravings seen with amphetamine withdrawal.",
      "correct_choice_id": 236658,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40919791699013475/40919791699013475.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40919791699013475/40919791699013475.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81170,
      "choices": [
        {
          "id": 236661,
          "text": "Anhedonia"
        },
        {
          "id": 236662,
          "text": "Dystonia"
        },
        {
          "id": 236663,
          "text": "Restless leg syndrome"
        },
        {
          "id": 236664,
          "text": "Akathisia"
        }
      ],
      "text": "A 30 year old manic patient was prescribed haloperidol one week back. For the last two days he has become restless and kept pacing in the room for a day. On examination he was found to have tremors of hand. He is most likely suffering from –",
      "unique_key": "Q2105709",
      "question_audio": null,
      "question_video": null,
      "map_id": 34766479,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Akathisia The most likely diagnosis in this case is akathisia, which is a side effect of antipsychotic medications such as haloperidol. Akathisia is characterized by restlessness, an inner sense of agitation, and the urge to move, which often leads to pacing or constant movement. The patient exhibits restlessness (pacing) and tremors, which are consistent with akathisia. The symptoms are usually seen within the first few days to weeks of starting an antipsychotic like haloperidol. Akathisia can occur in manic patients who are prescribed antipsychotics as part of their treatment. It is generally managed with beta-blockers, benzodiazepines, or anticholinergic medications. Explanation of Incorrect Responses: (A) Anhedonia – Incorrect Anhedonia refers to the inability to experience pleasure or interest in activities that were previously enjoyable. It is a symptom commonly seen in depression rather than being a side effect of medications like haloperidol. The patient's symptoms of restlessness, pacing, and tremors do not align with anhedonia, which is related to emotional blunting rather than physical restlessness. (B) Dystonia – Incorrect Dystonia involves muscle spasms and abnormal postures that often affect the neck, face, or limbs. The patient in this case does not exhibit these types of sustained abnormal postures or muscle spasms but instead demonstrates restlessness and pacing, which are more indicative of akathisia. Dystonia usually appears early in treatment (within the first few days) but typically presents with rigid postures or muscle spasms, which are not seen here. (C) Restless leg syndrome – Incorrect Restless leg syndrome (RLS) is characterized by uncomfortable sensations in the legs, accompanied by an irresistible urge to move them, particularly at rest or during sleep. It typically occurs in the evening or night, leading to sleep disturbances. In contrast, this patient has been pacing during the day and is experiencing tremors in the hands, which are more suggestive of akathisia rather than RLS, which primarily affects the legs and occurs during rest.",
      "correct_choice_id": 236664,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75191351699013552/75191351699013552.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75191351699013552/75191351699013552.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81171,
      "choices": [
        {
          "id": 236665,
          "text": "Increase in the dose of haloperidol"
        },
        {
          "id": 236666,
          "text": "Addition of anticholinergic drug"
        },
        {
          "id": 236667,
          "text": "Addition of beta blocker"
        },
        {
          "id": 236668,
          "text": "Adding another antipsychotic drug"
        }
      ],
      "text": "A 19 year old BOY suffering from chronic schizophrenia is put on haloperidol in the dose of 20 mg/day. A week after the initiation of medication the patient shows restlessness, fidgety, irritability and cannot sit still at one place. The most appropriate treatment strategy is -",
      "unique_key": "Q3632646",
      "question_audio": null,
      "question_video": null,
      "map_id": 34203985,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Addition of beta blocker The patient's symptoms of restlessness, fidgetiness, and irritability are indicative of akathisia, a common side effect of antipsychotic medications like haloperidol. Akathisia is characterized by motor restlessness and an inner sense of agitation, often leading to the inability to sit still. The most appropriate treatment for akathisia is the addition of a beta blocker, such as propranolol. Beta blockers help to alleviate the restlessness and agitation associated with akathisia. They are effective in treating this condition without causing significant sedation or other adverse effects. Beta blockers work by blocking the beta-adrenergic receptors, which are involved in the sympathetic nervous system, helping to reduce the symptoms of akathisia. Explanation of Incorrect Responses: (A) Increase in the dose of haloperidol – Incorrect Increasing the dose of haloperidol would not be appropriate in this scenario. In fact, higher doses of antipsychotics can exacerbate akathisia, as it is a dopamine-related side effect. Increasing the dose of haloperidol would likely worsen the restlessness and agitation associated with akathisia. Instead, the dose of haloperidol should be reduced or an alternative treatment for akathisia should be implemented. (B) Addition of anticholinergic drug – Incorrect Anticholinergic drugs such as benztropine or trihexyphenidyl are commonly used to treat extrapyramidal symptoms (EPS), such as dystonia and Parkinsonism, which can occur with antipsychotic medications. However, anticholinergics are not the best choice for treating akathisia, as they are more effective for rigidity and tremor rather than for relieving the restlessness characteristic of akathisia. In fact, anticholinergics can have side effects such as dry mouth, constipation, and blurred vision, and should not be used for akathisia when beta blockers are more effective. (D) Adding another antipsychotic drug – Incorrect Adding another antipsychotic medication is not the most appropriate approach for treating akathisia. This would only increase the risk of further side effects and would likely worsen the symptoms of akathisia. Instead of adding another antipsychotic, it is better to manage the side effect by adjusting the current treatment (such as adding a beta blocker) rather than introducing additional medications.",
      "correct_choice_id": 236667,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2234971699013563/2234971699013563.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2234971699013563/2234971699013563.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81172,
      "choices": [
        {
          "id": 236669,
          "text": "Haloperidol"
        },
        {
          "id": 236670,
          "text": "Clozapine"
        },
        {
          "id": 236671,
          "text": "Fluphenazine"
        },
        {
          "id": 236672,
          "text": "Loxapine"
        }
      ],
      "text": "An elderly woman suffering from schizophrenia is on antipsychotic medication. She developed purposeless involuntary facial and limb movements, constant chewing and puffing of cheeks. Which of the following drugs is least likely to be involved in this side effect?",
      "unique_key": "Q2634025",
      "question_audio": null,
      "question_video": null,
      "map_id": 34593936,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer: (B) Clozapine The symptoms described—purposeless involuntary facial and limb movements, as well as constant chewing and puffing of cheeks—are indicative of tardive dyskinesia (TD). Tardive dyskinesia is a movement disorder characterized by involuntary, repetitive movements, often occurring after prolonged use of antipsychotic medications, particularly dopamine antagonists. Clozapine is the least likely antipsychotic drug to cause tardive dyskinesia. Clozapine is an atypical antipsychotic with a lower risk of inducing movement disorders like tardive dyskinesia compared to typical antipsychotics (first-generation antipsychotics) due to its stronger serotonin receptor antagonism and weaker dopamine receptor antagonism. Clozapine is often used in patients who do not respond well to other antipsychotics and has the advantage of having a lower incidence of TD. Explanation of Incorrect Responses: (A) Haloperidol – Incorrect Haloperidol is a typical antipsychotic (first-generation), and one of the most common side effects of typical antipsychotics is tardive dyskinesia. This medication has potent dopamine antagonism, which increases the risk of extrapyramidal symptoms (EPS), including tardive dyskinesia. In this patient, haloperidol is likely involved in the development of the described side effects. (C) Fluphenazine – Incorrect Fluphenazine is another typical antipsychotic with strong dopamine antagonism. Like haloperidol, it carries a high risk for movement disorders, including tardive dyskinesia. Therefore, fluphenazine is also likely to be associated with the side effects described in the patient. (D) Loxapine – Incorrect Loxapine is a typical antipsychotic, and like other medications in this class, it has a significant risk of causing tardive dyskinesia with long-term use. Its dopamine receptor antagonism contributes to this risk, making it more likely than clozapine to cause the described movement abnormalities.",
      "correct_choice_id": 236670,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4360201699013573/4360201699013573.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4360201699013573/4360201699013573.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81173,
      "choices": [
        {
          "id": 236673,
          "text": "Drug overdose"
        },
        {
          "id": 236674,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236675,
          "text": "Drug induce Parkinsonism"
        },
        {
          "id": 236676,
          "text": "Tardive dyskinesia"
        }
      ],
      "text": "A 30 year old man who was recently started on haloperidol 30mg/day developed hyperpyrexia, muscle rigidity, akinesia, mutism, sweating, tachycardia and increased blood pressure. The investigations showed increased WBC count, increased creatinine phosphokinase. There is no history of any other drug intake or any signs of infection. The most likely diagnosis -",
      "unique_key": "Q7788488",
      "question_audio": null,
      "question_video": null,
      "map_id": 34195005,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer: (B) Neuroleptic Malignant Syndrome (NMS) The most likely diagnosis in this case is Neuroleptic Malignant Syndrome (NMS). NMS is a life-threatening condition that can occur after the administration of antipsychotic medications like haloperidol. It is characterized by hyperpyrexia (high fever), muscle rigidity, autonomic dysregulation (e.g., sweating, tachycardia, increased blood pressure), and altered mental status (akinesia, mutism). In this patient, the elevated white blood cell count (WBC) and creatine phosphokinase (CPK) levels are consistent with NMS, as these are commonly elevated due to muscle breakdown and systemic stress. The lack of infection and absence of other drug intake also support the diagnosis of NMS rather than an infectious process or drug overdose. Explanation of Incorrect Responses: (A) Drug overdose – Incorrect A drug overdose can present with similar symptoms, including altered mental status, muscle rigidity, and autonomic dysfunction. However, in this case, there is no history of other drug intake, and the patient's symptoms align more with NMS, which is specifically related to antipsychotic drugs like haloperidol. Moreover, drug overdoses often present with other signs like respiratory depression or severe hypotension, which were not described here. (C) Drug-induced Parkinsonism – Incorrect Drug-induced Parkinsonism refers to extrapyramidal symptoms (EPS) such as resting tremor, bradykinesia, and rigidity due to dopamine antagonism by antipsychotic drugs. However, the presence of hyperpyrexia, autonomic dysregulation, and altered mental status (e.g., mutism and akinesia) indicates a much more severe syndrome, which is characteristic of NMS, not simple drug-induced Parkinsonism. Additionally, drug-induced Parkinsonism does not typically cause the significant autonomic instability or elevated laboratory values seen in this patient. (D) Tardive dyskinesia – Incorrect Tardive dyskinesia (TD) is a movement disorder that results from long-term use of antipsychotic medications. It is characterized by involuntary, repetitive movements such as lip smacking, tongue protrusion, and facial grimacing, and typically occurs after months to years of medication use. In contrast, this patient has developed symptoms rapidly (within a week of starting haloperidol) and exhibits signs of severe systemic distress, which are not consistent with TD. TD does not cause the hyperpyrexia, muscle rigidity, and autonomic instability seen in this case.",
      "correct_choice_id": 236674,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60866991699013599/60866991699013599.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60866991699013599/60866991699013599.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81174,
      "choices": [
        {
          "id": 236677,
          "text": "Lithium toxicity"
        },
        {
          "id": 236678,
          "text": "Tardive dyskinesia"
        },
        {
          "id": 236679,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236680,
          "text": "Hypertensive encephalopathy"
        }
      ],
      "text": "A 31 year old male, with mood disorder, on 30 mg of haloperidol and 1000 mg of lithium, is brought to the hospital emergency room with history of acute onset of fever, excessive sweating, confusion, rigidity of limbs and decreased communication for a day. Examination reveals tachycardia and labile blood pressure and investigations reveal increased CPK enzyme levels and leucocytosis. He is likely to havedeveloped-",
      "unique_key": "Q2118269",
      "question_audio": null,
      "question_video": null,
      "map_id": 34038409,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Neuroleptic Malignant Syndrome (NMS) The most likely diagnosis for this patient is Neuroleptic Malignant Syndrome (NMS). This condition is a life-threatening emergency most commonly caused by antipsychotic medications such as haloperidol. The patient presents with fever, rigidity of limbs, altered mental status (confusion, decreased communication), tachycardia, labile blood pressure, and elevated creatine phosphokinase (CPK) and leukocytosis—all characteristic features of NMS. NMS results from dopamine receptor antagonism and can develop rapidly after initiating or increasing the dose of an antipsychotic medication. Given that this patient has been on haloperidol (an antipsychotic) and presents with the hallmark features of NMS, this diagnosis is most appropriate. Explanation of Incorrect Responses: (A) Lithium toxicity – Incorrect Lithium toxicity can present with neurological symptoms such as confusion, rigidity, and tremors, but it is generally characterized by elevated lithium levels in the blood, which are not mentioned here. Additionally, fever, tachycardia, labile blood pressure, and elevated CPK are more characteristic of NMS rather than lithium toxicity, which primarily causes renal dysfunction, tremors, and altered mental status. This patient's presentation aligns better with NMS, especially in the context of the antipsychotic use. (B) Tardive dyskinesia – Incorrect Tardive dyskinesia (TD) is a chronic condition that typically develops after months or years of antipsychotic medication use. It is characterized by involuntary movements (e.g., lip smacking, tongue protrusion, grimacing) and does not cause the acute fever, confusion, rigidity, or autonomic instability seen in this patient. TD is a long-term side effect and is not associated with the acute systemic symptoms presented here. (D) Hypertensive encephalopathy – Incorrect Hypertensive encephalopathy is a rare and severe complication of uncontrolled hypertension, causing symptoms such as headache, confusion, and visual disturbances, but it does not typically present with fever, rigidity, or elevated CPK. This patient's fever, muscle rigidity, and increased CPK are more suggestive of NMS. Furthermore, labile blood pressure can occur in NMS but is not a primary feature of hypertensive encephalopathy.",
      "correct_choice_id": 236679,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67549351699013626/67549351699013626.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67549351699013626/67549351699013626.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81175,
      "choices": [
        {
          "id": 236681,
          "text": "Lithium toxicity"
        },
        {
          "id": 236682,
          "text": "Dehydration"
        },
        {
          "id": 236683,
          "text": "Manic episode"
        },
        {
          "id": 236684,
          "text": "Depressive stupor"
        }
      ],
      "text": "A patient is brought to the casualty in the state of altered sensorium. He was on lithium treatment for affective fits. On examination he has tremors, increased DTR's and incontinence of urine. He has also undergone an episode of severe gastroenteritis 2 days ago. The serum lithium was found to be 1.95 meq/Lit. The probable cause for his present state is-",
      "unique_key": "Q6772496",
      "question_audio": null,
      "question_video": null,
      "map_id": 34596370,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Lithium Toxicity The most likely cause of this patient's symptoms is lithium toxicity. The patient is on lithium treatment for affective disorder, and his serum lithium level is elevated at 1.95 meq/L, which is above the therapeutic range (0.6–1.2 meq/L). This elevated level, combined with his symptoms of altered sensorium, tremors, increased deep tendon reflexes (DTRs), and urinary incontinence, is highly suggestive of lithium toxicity. Lithium toxicity can occur due to increased serum levels, often exacerbated by factors like dehydration, renal impairment, or gastrointestinal losses (as seen with his recent gastroenteritis). The symptoms of lithium toxicity can range from mild (tremors) to severe (confusion, ataxia, seizures), and elevated lithium levels are the primary factor in diagnosing it. Explanation of Incorrect Responses: (B) Dehydration – Incorrect Dehydration could contribute to elevated lithium levels because lithium is excreted by the kidneys, and fluid loss (as from gastroenteritis) can impair its clearance. However, while dehydration can raise lithium levels, it is not the primary diagnosis in this case. The serum lithium level of 1.95 meq/L is already suggestive of toxic levels, and the patient’s clinical signs and symptoms (tremors, altered sensorium, increased DTRs) directly align with lithium toxicity, not just dehydration. Dehydration alone would not typically cause the neurologic and systemic signs seen here. (C) Manic Episode – Incorrect A manic episode in bipolar disorder might present with elevated mood, hyperactivity, impulsivity, and irritability, but it would not explain the patient’s tremors, increased DTRs, altered sensorium, or urinary incontinence. These physical symptoms are not characteristic of a manic episode and are more consistent with neurological toxicity from lithium. Furthermore, the recent history of gastroenteritis and elevated serum lithium level point toward lithium toxicity as the more likely cause. (D) Depressive Stupor – Incorrect Depressive stupor is typically characterized by lethargy, mutism, immobility, and low energy. The patient’s symptoms—tremors, increased DTRs, and incontinence—are not consistent with depressive stupor. Additionally, the elevated lithium level and history of recent gastroenteritis suggest lithium toxicity rather than a primary mood disorder episode, making this diagnosis unlikely.",
      "correct_choice_id": 236681,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63432251699013651/63432251699013651.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63432251699013651/63432251699013651.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81176,
      "choices": [
        {
          "id": 236685,
          "text": "Start the patient on benztropine"
        },
        {
          "id": 236686,
          "text": "Start the patient on amantadine"
        },
        {
          "id": 236687,
          "text": "Start the patient on propranolol"
        },
        {
          "id": 236688,
          "text": "Start the patient on diphenhydramine"
        },
        {
          "id": 236689,
          "text": "Switch the patient to clozapine"
        }
      ],
      "text": "A 56-year-old woman who was diagnosed with paranoid schizophreniain her early twenties has received daily doses of various typical neuroleptics for many years. For the past 2 years, she has had symptoms of tardive dyskinesia. Discontinuation of the neuroleptic is not possible because she becomes aggressive and violent in response to command hallucinations when she is not medicated. Which of the following actions should be taken next?",
      "unique_key": "Q7563462",
      "question_audio": null,
      "question_video": null,
      "map_id": 34563062,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (E) Switch the patient to clozapine The patient in this case has developed tardive dyskinesia (TD), a movement disorder caused by long-term use of antipsychotic medications (typically typical antipsychotics). Clozapine, an atypical antipsychotic, has been shown to be most effective in treating patients with tardive dyskinesia, especially when the patient cannot discontinue antipsychotic treatment due to severe psychiatric symptoms (like aggression and violence). Clozapine is less likely to cause tardive dyskinesia compared to typical antipsychotics and may improve the motor symptoms associated with this disorder. Switching to clozapine is considered the best next step in managing a patient with tardive dyskinesia while still requiring antipsychotic therapy. Explanation of Incorrect Responses: (A) Start the patient on benztropine – Incorrect Benztropine is an anticholinergic medication that is used to treat extrapyramidal side effects (EPS) caused by antipsychotics, such as dystonia, parkinsonism, and akathisia. However, benztropine is not effective for tardive dyskinesia, which is a chronic movement disorder and is often resistant to anticholinergic treatment. Therefore, benztropine would not be helpful in managing this patient’s tardive dyskinesia. (B) Start the patient on amantadine – Incorrect Amantadine has been used in some cases to treat drug-induced parkinsonism and tardive dyskinesia, particularly when the dyskinesia is mild. However, the effectiveness of amantadine in managing severe tardive dyskinesia is limited and not as reliable as switching to clozapine. Therefore, amantadine is not the best next step in this case. (C) Start the patient on propranolol – Incorrect Propranolol, a beta-blocker, is primarily used to treat tremors, and is sometimes considered for managing symptoms of tremor-related movement disorders. However, tardive dyskinesia is primarily characterized by involuntary movements (such as facial grimacing, tongue protrusion, and lip smacking) rather than tremors. Propranolol is not an appropriate treatment for tardive dyskinesia, and would not address the underlying movement disorder effectively. (D) Start the patient on diphenhydramine – Incorrect Diphenhydramine is an antihistamine with anticholinergic properties that can be used to treat acute extrapyramidal symptoms (EPS) like dystonia and parkinsonism that can be caused by antipsychotic medications. However, diphenhydramine is not effective for tardive dyskinesia, which is a chronic and more complex side effect of long-term antipsychotic use. It would not improve this patient's tardive dyskinesia and could potentially worsen other side effects.",
      "correct_choice_id": 236689,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55413741699013680/55413741699013680.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55413741699013680/55413741699013680.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81177,
      "choices": [
        {
          "id": 236690,
          "text": "CT scan brain and hemogram"
        },
        {
          "id": 236691,
          "text": "Hemogram, electrolyte levels and creatinine"
        },
        {
          "id": 236692,
          "text": "ECG, chest X ray and hemogram"
        },
        {
          "id": 236693,
          "text": "Hemogram, CPK and Renal function test"
        }
      ],
      "text": "A patient was on treatment with trifluperazine for some time. He presents with complaint of hyperthermia, lethargy and sweating. Needed investigations are:",
      "unique_key": "Q5457829",
      "question_audio": null,
      "question_video": null,
      "map_id": 34516911,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hemogram, CPK, and Renal function test The patient’s symptoms of hyperthermia, lethargy, and sweating while on trifluoperazine, an antipsychotic medication, strongly suggest the possibility of neuroleptic malignant syndrome (NMS). NMS is a rare but potentially life-threatening reaction to antipsychotic medications, which is characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic dysregulation (e.g., sweating, tachycardia, labile blood pressure). The following investigations are crucial in managing a suspected case of NMS: Hemogram: To assess for any signs of leukocytosis, which can be elevated in NMS. Creatine phosphokinase (CPK): A key marker for muscle breakdown, which is often elevated in NMS due to muscle rigidity and rhabdomyolysis. Renal function tests: To check for renal impairment, which can occur if rhabdomyolysis leads to acute kidney injury due to the release of muscle breakdown products like myoglobin. These investigations are essential in both diagnosing NMS and assessing the potential complications associated with this condition. Explanation of Incorrect Responses: (A) CT scan brain and hemogram – Incorrect A CT scan of the brain is not helpful in diagnosing NMS. The primary clinical suspicion should be based on symptoms and drug history, rather than imaging studies. The hemogram could be helpful to check for leukocytosis, but the CT scan is not needed unless there is concern about a neurological issue that might explain the symptoms, which is unlikely in this case. (B) Hemogram, electrolyte levels, and creatinine – Incorrect While a hemogram is useful for monitoring for leukocytosis, electrolyte levels are not specifically required for diagnosing NMS, though they can help assess hydration status and electrolyte imbalances in severe cases. Creatinine can be part of the renal function tests, but it’s not as comprehensive on its own compared to full renal function tests (including creatinine, BUN, and electrolytes). This response lacks the essential CPK measurement, which is the most relevant test for muscle injury in NMS. (C) ECG, chest X-ray, and hemogram – Incorrect An ECG and chest X-ray are generally not required for the diagnosis of NMS unless the patient has specific cardiac symptoms (e.g., arrhythmias). The ECG might show tachycardia or labile blood pressure changes due to autonomic instability, but these findings are not diagnostic of NMS. Similarly, a chest X-ray would not help in diagnosing NMS and would typically be reserved for assessing respiratory issues or pneumonia, which are not the primary concern in this case.",
      "correct_choice_id": 236693,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67257491699013694/67257491699013694.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67257491699013694/67257491699013694.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81178,
      "choices": [
        {
          "id": 236694,
          "text": "Fluphenazine"
        },
        {
          "id": 236695,
          "text": "Haloperidol"
        },
        {
          "id": 236696,
          "text": "Paliperidone"
        },
        {
          "id": 236697,
          "text": "Aripiprazole"
        }
      ],
      "text": "A 34-year-old woman complains that she is gaining weight since she started taking chlorpromazine for chronic undifferentiated schizophrenia. A complete review of systems and history shows evidence of breast enlargement and lactation. However, a serum pregnancy test is negative. Which of the following antipsychotics would be a good choice for a treatment change?",
      "unique_key": "Q6253642",
      "question_audio": null,
      "question_video": null,
      "map_id": 34130452,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Aripiprazole The patient's symptoms, including weight gain, breast enlargement, and lactation (without pregnancy), suggest hyperprolactinemia. This is a common side effect of many antipsychotic medications, particularly those that block dopamine D2 receptors. Dopamine inhibits prolactin release, so when dopamine is blocked (as with chlorpromazine, a typical antipsychotic), prolactin levels increase, leading to symptoms like galactorrhea (lactation) and gynecomastia (breast enlargement). Aripiprazole is a atypical antipsychotic that has a partial agonist effect on dopamine D2 receptors, meaning it can help modulate dopamine activity and reduce prolactin levels. Because of its unique mechanism of action, aripiprazole is less likely to cause hyperprolactinemia compared to other antipsychotics, making it a good choice for patients experiencing these side effects. Explanation of Incorrect Responses: (A) Fluphenazine – Incorrect Fluphenazine is a typical antipsychotic that, like chlorpromazine, blocks dopamine D2 receptors. This action can lead to hyperprolactinemia, which could worsen the patient's current symptoms of lactation and breast enlargement. Switching to fluphenazine would not address the side effect of hyperprolactinemia and could actually exacerbate it. (B) Haloperidol – Incorrect Like fluphenazine, haloperidol is also a typical antipsychotic that blocks dopamine D2 receptors. This results in a high risk of hyperprolactinemia, which could continue to cause or worsen the patient's breast enlargement and lactation symptoms. Therefore, haloperidol is not a good option for patients with these side effects. (C) Paliperidone – Incorrect Paliperidone is an atypical antipsychotic that also has a tendency to increase prolactin levels, though to a lesser degree than typical antipsychotics like chlorpromazine. However, paliperidone can still cause hyperprolactinemia, which might not resolve the patient's symptoms of breast enlargement and lactation. Therefore, paliperidone would not be the best choice for this patient.",
      "correct_choice_id": 236697,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12734931699013706/12734931699013706.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12734931699013706/12734931699013706.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81179,
      "choices": [
        {
          "id": 236698,
          "text": "Give i.m. Haloperidol"
        },
        {
          "id": 236699,
          "text": "Give i.m. olanzapine"
        },
        {
          "id": 236700,
          "text": "Give i.v. promethazine"
        },
        {
          "id": 236701,
          "text": "Reassure the attendants that the patient has nothing serious and is just a dissociative symptoms"
        }
      ],
      "text": "A young boy earlier diagnosed as schizophrenia was taking some antipsychotic medication. He presented to casualty with sudden twisting of neck muscles, tremulousness of hands, stiffening of fingers, protrusion of tongue, he is frightened and restless. You are in the casualty, how will you manage the patient",
      "unique_key": "Q2490587",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334080,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Give i.v. promethazine The symptoms described in the question — twisting of neck muscles, tremulousness of hands, stiffening of fingers, protrusion of tongue, and restlessness — are characteristic of acute dystonia, a type of extrapyramidal side effect (EPS) often seen with the use of antipsychotic medications. Acute dystonia is typically caused by dopamine D2 receptor antagonism, which is a common side effect of first-generation antipsychotics (such as haloperidol) and some second-generation antipsychotics (such as olanzapine). To treat acute dystonia, the best approach is to administer an anticholinergic medication, such as promethazine, which is an antihistamine with anticholinergic properties. Promethazine can help reverse the dystonic symptoms by blocking acetylcholine receptors, which helps in relieving muscle stiffness and reducing involuntary movements. I.V. promethazine is a suitable and effective choice in an acute emergency situation like this. Explanation of Incorrect Responses: (A) Give i.m. Haloperidol – Incorrect Although haloperidol is an antipsychotic used to treat schizophrenia, it is not appropriate in this case. The patient is already exhibiting symptoms of acute dystonia, which is a side effect of antipsychotic medications like haloperidol. Administering more haloperidol could exacerbate the dystonic reaction, worsening the patient's condition. This approach would be dangerous and inappropriate. (B) Give i.m. Olanzapine – Incorrect Like haloperidol, olanzapine is an antipsychotic that can also cause extrapyramidal symptoms, including acute dystonia. Administering olanzapine to a patient already showing signs of acute dystonia would not only fail to relieve the symptoms but could potentially make them worse. Olanzapine is not a treatment for acute dystonia and is contraindicated in this case. (D) Reassure the attendants that the patient has nothing serious and is just a dissociative symptom – Incorrect This option is incorrect because the patient’s symptoms are serious and suggest acute dystonia, not dissociative symptoms. Dissociative symptoms would typically involve disconnection from reality, but the physical signs in this patient (e.g., muscle rigidity, tremors, and tongue protrusion) are indicative of neurological effects, specifically extrapyramidal side effects from antipsychotic medications. Reassurance alone would not address the underlying cause or provide appropriate medical treatment.",
      "correct_choice_id": 236700,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29810811699013719/29810811699013719.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29810811699013719/29810811699013719.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81180,
      "choices": [
        {
          "id": 236702,
          "text": "Retinitis pigmentosa"
        },
        {
          "id": 236703,
          "text": "Macular degeneration"
        },
        {
          "id": 236704,
          "text": "Glaucoma"
        },
        {
          "id": 236705,
          "text": "Corneal deposits"
        }
      ],
      "text": "A 58-year-old male presents to his primary care doctor with the complaint of vision changes over the last several months. The patient's past medical history is notable for schizophrenia which has been well-controlled for the last 25 years on chlorpromazine. Which of the following is likely to be seen on ophthalmoscopy?",
      "unique_key": "Q2730108",
      "question_audio": null,
      "question_video": null,
      "map_id": 34720739,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Corneal deposits The patient has been on chlorpromazine, a first-generation antipsychotic, for 25 years. A well-known side effect of chlorpromazine is the development of corneal deposits. These deposits are typically yellow-brown or grey and can accumulate in the corneal epithelium, leading to visual disturbances. Chlorpromazine can also cause lens opacities, and the side effects are dose-related. The presence of these corneal deposits on ophthalmoscopy is a classic sign of long-term use of chlorpromazine, and it is the most likely cause of the patient's vision changes. Explanation of Incorrect Responses: (A) Retinitis pigmentosa – Incorrect Retinitis pigmentosa is a genetic condition that leads to progressive vision loss due to degeneration of the retina. It is characterized by the presence of retinal pigmentary changes, particularly pigment deposits in the peripheral retina. This is not associated with chlorpromazine use. While retinitis pigmentosa can cause vision changes, it would not be expected in this patient without a family history or other risk factors for genetic retinal disease. (B) Macular degeneration – Incorrect Macular degeneration, specifically age-related macular degeneration (AMD), typically affects individuals over the age of 50 and leads to central vision loss due to degeneration of the macula, the central part of the retina. However, this condition is not related to antipsychotic use. In this case, the patient's vision changes are more likely to be associated with long-term chlorpromazine use, which is known for causing corneal deposits rather than macular degeneration. (C) Glaucoma – Incorrect Glaucoma is a condition in which increased intraocular pressure damages the optic nerve, potentially leading to vision loss. While certain medications, including some antipsychotics, can affect intraocular pressure, chlorpromazine is not typically associated with glaucoma. The more common visual changes associated with chlorpromazine are corneal deposits and lens opacities, not glaucoma. Therefore, glaucoma is unlikely to be the cause of the patient's symptoms in this case.",
      "correct_choice_id": 236705,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1995711699013731/1995711699013731.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1995711699013731/1995711699013731.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81181,
      "choices": [
        {
          "id": 236706,
          "text": "A combination of two typical antipsychotics"
        },
        {
          "id": 236707,
          "text": "A combination of typical and atypical antipsychotics"
        },
        {
          "id": 236708,
          "text": "Electroconvulsive therapy"
        },
        {
          "id": 236709,
          "text": "Clozapine therapy"
        }
      ],
      "text": "A 22 y/o male with the diagnosis of schizophrenia was started on Risperidone 8 mg/d. Despite 6 weeks of continuous therapy patient did not show any improvement and his medications were changed to Haloperidol which was gradually increased to 20 mg/d. The patient did not show any response and continues to be symptomatic. What is the next best course of action:",
      "unique_key": "Q7646018",
      "question_audio": null,
      "question_video": null,
      "map_id": 34677593,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Clozapine therapy In this case, the patient has been diagnosed with schizophrenia and has not responded to two different antipsychotics (Risperidone and Haloperidol) despite adequate treatment duration and dosage. Clozapine is considered the next best course of action for patients with treatment-resistant schizophrenia. It is the most effective medication for individuals who do not respond to other antipsychotic drugs, particularly typical and atypical antipsychotics. Clozapine has been shown to significantly reduce symptoms in patients with resistant schizophrenia, and is often used when other treatment options fail. However, it requires careful monitoring for potential adverse effects, including agranulocytosis (a potentially serious reduction in white blood cells). Explanation of Incorrect Responses: (A) A combination of two typical antipsychotics – Incorrect Using two typical antipsychotics together is generally not recommended due to the increased risk of side effects, such as extrapyramidal symptoms and tardive dyskinesia, without providing any significant additional therapeutic benefit. Furthermore, combining typical antipsychotics for treatment-resistant schizophrenia is not supported by evidence and does not address the underlying issue of non-response to initial therapy. Clozapine is the preferred choice in this scenario rather than a combination of typical antipsychotics. (B) A combination of typical and atypical antipsychotics – Incorrect While combining a typical and atypical antipsychotic might be considered in some cases of partial response to treatment, it is not the first-line approach for treatment-resistant schizophrenia. The combination therapy may result in an increased risk of side effects, such as sedation, metabolic changes, and movement disorders, without significant added benefit. Given the patient's non-responsiveness to both risperidone (atypical) and haloperidol (typical), the next appropriate step would be clozapine therapy, not a combination of antipsychotics. (C) Electroconvulsive therapy – Incorrect While electroconvulsive therapy (ECT) can be an option in patients with treatment-resistant schizophrenia who are severely ill or have specific indications (such as catatonia or suicidal ideation), it is generally not the first line of treatment for schizophrenia. Clozapine therapy is the most well-established treatment for patients who fail to respond to antipsychotic medications. ECT is typically reserved for cases where pharmacological treatments have not been effective or in severe instances of the disorder.",
      "correct_choice_id": 236709,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53776021699014603/53776021699014603.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53776021699014603/53776021699014603.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81182,
      "choices": [
        {
          "id": 236710,
          "text": "Haloperidol"
        },
        {
          "id": 236711,
          "text": "Lithium"
        },
        {
          "id": 236712,
          "text": "Promethazine"
        },
        {
          "id": 236713,
          "text": "Clonazepam"
        }
      ],
      "text": "A 30 – years old pregnant woman comes to your clinic with decreased sleep, increased appetite and hyperactivity for 2 weeks. A diagnosis of mania is made. Further probing reveals four episodes of major depression in the past two years. What drug will you prescribe to the patients?",
      "unique_key": "Q1674461",
      "question_audio": null,
      "question_video": null,
      "map_id": 34620290,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Haloperidol In this case, the patient presents with symptoms of mania along with a history of major depressive episodes, which suggests the diagnosis of bipolar disorder. Haloperidol is an antipsychotic medication that can be effective for acute manic episodes. It is commonly used in the acute management of mania and works by blocking dopamine receptors to help reduce symptoms such as hyperactivity, agitation, and racing thoughts. However, caution is needed in pregnancy, as haloperidol is classified as a Category C drug, meaning it should only be used if the potential benefit outweighs the potential risks. Explanation of Incorrect Responses: (B) Lithium – Incorrect While lithium is commonly used for long-term management of bipolar disorder and is effective for preventing both mania and depression, it is generally not the first choice during pregnancy, particularly in the first trimester. Lithium has been associated with an increased risk of congenital malformations, such as cardiac defects, and is contraindicated during pregnancy unless absolutely necessary. Therefore, lithium would not be the first choice for this patient during pregnancy. (C) Promethazine – Incorrect Promethazine is an antihistamine used primarily for nausea and vomiting, motion sickness, and as a sedative. While it may help with sleep, it is not indicated for the treatment of mania or bipolar disorder. It does not have any therapeutic benefit in managing the symptoms of mania, and it is not a recommended treatment option for this patient. (D) Clonazepam – Incorrect Clonazepam is a benzodiazepine that can be used to treat anxiety and agitation but is generally not effective for treating the core symptoms of mania. While it might help with anxiety or insomnia, benzodiazepines are not appropriate for managing mania or bipolar disorder in the long term, particularly in a pregnant patient due to the potential risks of sedation and respiratory depression in the fetus. Furthermore, clonazepam is not indicated for treating mania.",
      "correct_choice_id": 236710,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57843891699014615/57843891699014615.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57843891699014615/57843891699014615.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81183,
      "choices": [
        {
          "id": 236714,
          "text": "Anti-psychotics"
        },
        {
          "id": 236715,
          "text": "Anti-depressants"
        },
        {
          "id": 236716,
          "text": "Anxiolytics"
        },
        {
          "id": 236717,
          "text": "Hypno-sedatives"
        }
      ],
      "text": "A 34 year old housewife reports a three month history of feeling low, lack of interest in activities, lethargy, multiple body-aches, ideas of worthlessness, decreased appetite and disturbed sleep with early morning awakening. She is likely to benefit form",
      "unique_key": "Q1260431",
      "question_audio": null,
      "question_video": null,
      "map_id": 34500717,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Anti-depressants The patient is presenting with symptoms consistent with major depressive disorder (MDD), including low mood, lack of interest in activities, lethargy, feelings of worthlessness, decreased appetite, and early morning awakening. These symptoms are indicative of a depressive episode, and antidepressants are the primary treatment for this condition. Antidepressants, such as SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), or other classes, are used to help regulate mood, alleviate the emotional and physical symptoms of depression, and improve the patient's overall functioning. Explanation of Incorrect Responses: (A) Anti-psychotics – Incorrect Antipsychotic medications are primarily used for treating psychotic disorders such as schizophrenia, bipolar disorder (during manic or mixed episodes), or other conditions with significant psychotic symptoms. The patient described here does not show signs of psychosis, such as hallucinations or delusions, which would typically warrant the use of antipsychotics. Therefore, this treatment is not appropriate in this case. (C) Anxiolytics – Incorrect Anxiolytic medications, such as benzodiazepines, are often used for acute anxiety and short-term relief of anxiety symptoms. Although the patient might experience some anxiety due to depression, the primary issue here is the depressive symptoms (e.g., low mood, anhedonia, sleep disturbance), which are better addressed with antidepressants rather than anxiolytics. Overuse of anxiolytics may also pose a risk for dependency and does not address the core symptoms of depression. (D) Hypno-sedatives – Incorrect Hypno-sedatives (such as benzodiazepines or sleeping pills) are often used for short-term management of insomnia or acute anxiety but are not suitable for the treatment of depression. The patient's early morning awakening and other depressive symptoms suggest that the primary issue is depression, not simply sleep disturbance. Long-term use of hypno-sedatives can be problematic, especially since they do not treat the underlying depressive disorder.",
      "correct_choice_id": 236715,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49320921699014637/49320921699014637.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49320921699014637/49320921699014637.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81184,
      "choices": [
        {
          "id": 236718,
          "text": "Haloperidol"
        },
        {
          "id": 236719,
          "text": "Sertraline"
        },
        {
          "id": 236720,
          "text": "Alprazolam"
        },
        {
          "id": 236721,
          "text": "Olanzapine"
        }
      ],
      "text": "A middle aged man presented with pain in back, lack of interest in recreational activities, low mood, lethargy, decreased sleep and appetite for two months. There was no history suggestive of delusions or hallucinations. He did not suffer from any chronic medical illness. There was no family history of psychiatric illness. Routine investigations including hemogram, renal function tests, liver function tests electrocardiogram did not reveal any abnormality. This patient should be treated with",
      "unique_key": "Q9024616",
      "question_audio": null,
      "question_video": null,
      "map_id": 34651028,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Sertraline This patient presents with symptoms consistent with major depressive disorder (MDD), including low mood, lack of interest, lethargy, decreased sleep and appetite, and back pain. These are classic signs of a depressive episode, which should be treated with antidepressants. Sertraline, an SSRI (selective serotonin reuptake inhibitor), is a first-line treatment for MDD. SSRIs like sertraline are effective at modulating serotonin levels in the brain and are generally well-tolerated, with fewer side effects than older antidepressants. Since the patient does not show any signs of psychosis or specific anxiety symptoms, sertraline is the best choice. Explanation of Incorrect Responses: (A) Haloperidol – Incorrect Haloperidol is a typical antipsychotic used primarily for treating psychosis (e.g., schizophrenia) or severe agitation. This patient does not show any psychotic symptoms (such as delusions or hallucinations), which are the typical indications for antipsychotics like haloperidol. The patient's symptoms are consistent with depression, not a psychotic disorder, making haloperidol an inappropriate choice. (C) Alprazolam – Incorrect Alprazolam is a benzodiazepine used primarily for anxiety and panic disorders. While benzodiazepines can provide short-term relief for anxiety, they are not the treatment of choice for major depressive disorder. This patient is presenting with clear signs of depression (not anxiety), and benzodiazepines do not address the core symptoms of depression. Long-term use of alprazolam may also lead to dependence, making it an inappropriate long-term solution. (D) Olanzapine – Incorrect Olanzapine is an atypical antipsychotic that is used primarily for schizophrenia, bipolar disorder (during manic episodes), or severe agitation. While it may also have mood-stabilizing effects, it is not the first-line treatment for major depressive disorder unless the patient has treatment-resistant depression or coexisting psychotic features. This patient's presentation does not suggest psychosis, making olanzapine an inappropriate first-line treatment.",
      "correct_choice_id": 236719,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49512851699014647/49512851699014647.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49512851699014647/49512851699014647.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81185,
      "choices": [
        {
          "id": 236722,
          "text": "Gastic lavage to be done"
        },
        {
          "id": 236723,
          "text": "Sodium bicarbonate should be administered to treat acidosis"
        },
        {
          "id": 236724,
          "text": "Atropine sulphate should be administered as an antidote"
        },
        {
          "id": 236725,
          "text": "Diazepam should be injected to control seizures"
        }
      ],
      "text": "A female patient on treatment for depression took a massive dose of amitryptiline for suicide. Which of the following statement regarding her management is wrong?",
      "unique_key": "Q2708326",
      "question_audio": null,
      "question_video": null,
      "map_id": 34250158,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Atropine sulphate should be administered as an antidote In the case of an amitryptyline overdose, which is a tricyclic antidepressant (TCA), atropine is not used as an antidote. Atropine is an anticholinergic agent and may worsen the symptoms of TCA overdose because it can increase the anticholinergic toxicity of the drug, leading to delirium, urinary retention, tachycardia, and increased risk of seizures. Therefore, the use of atropine is not recommended in this scenario. Instead, other treatments such as sodium bicarbonate are used to correct acidosis and treat TCA-induced arrhythmias. Explanation of Incorrect Responses: (A) Gastric lavage to be done – Correct Gastric lavage can be performed within 1 hour of ingestion in cases of TCA overdose, as it may help to remove the drug from the stomach and reduce the risk of further absorption. However, this procedure should not be done in cases of cardiac arrest or if the patient is unconscious or unprotected from aspiration. In this case, gastric lavage is appropriate in the initial management as it can decrease the toxic load. (B) Sodium bicarbonate should be administered to treat acidosis – Correct Sodium bicarbonate is a key treatment for TCA overdose because it helps to alkalinize the blood and reverse the life-threatening cardiac effects, including prolonged QT interval and arrhythmias. The alkalization helps to improve the protein binding of the drug and prevents further cardiac toxicity. It also helps correct metabolic acidosis, which is a common complication in TCA toxicity. (D) Diazepam should be injected to control seizures – Correct Diazepam is a benzodiazepine used for the management of seizures associated with TCA overdose. TCAs can lower the seizure threshold, and benzodiazepines like diazepam can be used to control any seizures that may occur. Therefore, diazepam is an important part of the management of this overdose.",
      "correct_choice_id": 236724,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32863811699014703/32863811699014703.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32863811699014703/32863811699014703.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81186,
      "choices": [
        {
          "id": 236726,
          "text": "Aripiprazole"
        },
        {
          "id": 236727,
          "text": "Lamotrigine"
        },
        {
          "id": 236728,
          "text": "Lithium"
        },
        {
          "id": 236729,
          "text": "Olanzepine"
        }
      ],
      "text": "A 28-year-old woman is diagnosed with bipolar disorder, manic type, when she was hospitalized after becoming psychotic, hypersexual, severely agitated, and unable to sleep. She is started on a medication in the acute phase of her illness. Which of the following medications, recommended for acute use in manic patients, is recommended to be continued on into maintenance therapy?",
      "unique_key": "Q6051170",
      "question_audio": null,
      "question_video": null,
      "map_id": 34483687,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Lithium Lithium is considered a first-line treatment for bipolar disorder, both in the acute and maintenance phases. It is effective for treating mania and has a strong proven track record in preventing future manic and depressive episodes, which makes it the preferred choice for long-term maintenance therapy. After stabilizing the acute episode, lithium is often continued as part of the long-term management plan to prevent relapse. It is well-suited for bipolar disorder maintenance due to its mood-stabilizing properties and is especially effective in reducing the risk of manic recurrences. Explanation of Incorrect Responses: (A) Aripiprazole – Incorrect Aripiprazole is an atypical antipsychotic that can be used in the acute treatment of manic episodes in bipolar disorder. It is effective in managing acute mania and psychosis but is generally not the first choice for maintenance therapy. While it can be used long-term in some patients, it does not have the same long-term mood-stabilizing effects as lithium. For chronic management and to reduce the frequency of future episodes, mood stabilizers like lithium are typically preferred. (B) Lamotrigine – Incorrect Lamotrigine is an antiepileptic drug that is effective for preventing depressive episodes in bipolar disorder, but it is not as effective for preventing or treating mania. While it is a valuable treatment for the maintenance phase, especially for bipolar II disorder, it is not as effective as lithium in preventing mania. Lamotrigine is generally used for long-term maintenance in patients who predominantly experience depressive episodes, not those with mania as the primary issue. (D) Olanzapine – Incorrect Olanzapine is another atypical antipsychotic that can be used in the acute phase of bipolar disorder, particularly for manic episodes. However, like aripiprazole, it is not typically used as a first-line maintenance medication. Olanzapine can be part of the long-term treatment plan, particularly in patients who have poor response to other treatments or have co-occurring psychiatric conditions, but lithium is generally preferred for long-term mood stabilization.",
      "correct_choice_id": 236728,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39761431699015050/39761431699015050.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39761431699015050/39761431699015050.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81187,
      "choices": [
        {
          "id": 236730,
          "text": "Vertigo"
        },
        {
          "id": 236731,
          "text": "Steven Johnson syndrome"
        },
        {
          "id": 236732,
          "text": "Hyponatremia"
        },
        {
          "id": 236733,
          "text": "Hepatitis"
        }
      ],
      "text": "A patient with rapid cycling bipolar disorder was well maintained on carbamazepine, developed skin rash. Psychiatrist tapered the doses, and gradually cross-titrated to oxcarbazepine (newer congener of carbamazepine) but even on oxcarbazepine, the following problem is what the psychiatrist has to be careful about:",
      "unique_key": "Q5598338",
      "question_audio": null,
      "question_video": null,
      "map_id": 34405820,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hyponatremia When switching from carbamazepine to oxcarbazepine, the psychiatrist must be especially cautious about hyponatremia, a known risk associated with oxcarbazepine use. Oxcarbazepine can lead to SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion), where the body retains excess water, diluting the sodium levels in the blood and causing hyponatremia. This can be particularly dangerous, as symptoms can range from mild (headache, nausea) to severe (seizures, coma). Monitoring sodium levels, especially during the early phases of therapy, is crucial. Hyponatremia is considered the most important issue to monitor for in this case. Explanation of Incorrect Responses: (A) Vertigo – Incorrect While oxcarbazepine can cause dizziness as a side effect, vertigo is not a common or primary concern when switching from carbamazepine to oxcarbazepine. Dizziness may occur due to CNS effects of the medication, but it is not as significant or urgent to manage compared to hyponatremia. (B) Stevens-Johnson syndrome – Incorrect Stevens-Johnson syndrome (SJS) is a severe skin reaction that can occur with carbamazepine, but it is less common with oxcarbazepine. Cross-sensitivity may exist, but the risk of SJS is not significantly higher with oxcarbazepine compared to carbamazepine. Hence, it is not the primary concern when switching medications in this patient. (D) Hepatitis – Incorrect Hepatitis is a rare side effect of carbamazepine, and while it can occur with oxcarbazepine, it is not as common. Oxcarbazepine tends to be safer in terms of liver toxicity compared to carbamazepine. Hepatitis would not be the most critical issue to monitor for when switching between these medications.",
      "correct_choice_id": 236732,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10178371699015097/10178371699015097.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10178371699015097/10178371699015097.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81188,
      "choices": [
        {
          "id": 236734,
          "text": "Akathisia"
        },
        {
          "id": 236735,
          "text": "Pseudo-parkinsonism"
        },
        {
          "id": 236736,
          "text": "Dystonia"
        },
        {
          "id": 236737,
          "text": "Tardive dyskinesia"
        }
      ],
      "text": "Most common extrapyramidal side effect?",
      "unique_key": "Q8357605",
      "question_audio": null,
      "question_video": null,
      "map_id": 34835518,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Akathisia. Akathisia is one of the most common extrapyramidal side effects (EPS) associated with the use of antipsychotic medications, especially the first-generation (typical) antipsychotics. It is characterized by an inner restlessness and the inability to sit still, often leading to constant movement such as pacing or shifting in one’s seat. This side effect is particularly common early in treatment and can be distressing for patients, requiring adjustments to their medication or additional treatment for management. B. Pseudo-parkinsonism is another common extrapyramidal side effect, but it is typically less frequent than akathisia. It manifests as symptoms resembling Parkinson’s disease, such as tremor, rigidity, bradykinesia (slowness of movement), and a shuffling gait. While it can occur with antipsychotic medications, especially those with stronger dopamine receptor antagonism, it does not occur as frequently as akathisia. C. Dystonia is a less common but serious extrapyramidal side effect. It involves sudden, sustained muscle contractions that can result in abnormal postures, twisting, or spasms, often affecting the neck, face, or tongue. Dystonia usually occurs early in the course of antipsychotic treatment, and though it is significant, it is not as prevalent as akathisia in the broader population of patients receiving antipsychotics. D. Tardive dyskinesia is a chronic side effect that develops after long-term use of antipsychotics, often after several months or years of treatment. It manifests as involuntary, repetitive movements, typically involving the face, such as lip smacking, tongue thrusting, or grimacing. Although it is a significant and often irreversible side effect, it is less common in the early stages of treatment compared to akathisia.",
      "correct_choice_id": 236734,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61582371698996369/61582371698996369.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61582371698996369/61582371698996369.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81189,
      "choices": [
        {
          "id": 236738,
          "text": "Aripiprazole"
        },
        {
          "id": 236739,
          "text": "Injectable neuroleptics"
        },
        {
          "id": 236740,
          "text": "ECT"
        },
        {
          "id": 236741,
          "text": "Clozapine"
        }
      ],
      "text": "Drug of choice in treatment resistant schizophrenia?",
      "unique_key": "Q1447941",
      "question_audio": null,
      "question_video": null,
      "map_id": 34451864,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Clozapine. Clozapine is the drug of choice for treatment-resistant schizophrenia, which refers to cases where patients do not respond adequately to two or more antipsychotic medications, typically including at least one second-generation antipsychotic. Clozapine is a unique atypical antipsychotic that has been shown to be significantly more effective than other antipsychotics for patients who fail to respond to conventional treatments. It is particularly effective in reducing both positive and negative symptoms of schizophrenia, but its use requires regular monitoring due to potential side effects like agranulocytosis, which is a life-threatening condition. A. Aripiprazole is an atypical antipsychotic that is commonly used to treat schizophrenia, but it is not typically considered a first-line option for treatment-resistant cases. While aripiprazole can be effective for many individuals, it does not have the same level of evidence supporting its use specifically in treatment-resistant schizophrenia as clozapine does. B. Injectable neuroleptics (antipsychotics) are often used for patients who have difficulty adhering to oral medications, especially in cases where treatment compliance is a concern. While injectable forms of antipsychotics can be helpful for managing symptoms, they are not specifically indicated for treatment-resistant schizophrenia, as they don’t address the underlying resistance to treatment that clozapine is known to target. C. ECT (Electroconvulsive therapy) is sometimes considered for patients with treatment-resistant schizophrenia, particularly when other treatments have failed or in cases of severe, life-threatening symptoms. However, ECT is typically reserved for patients who have not responded to pharmacological treatments, and it is not the first-line approach. Clozapine remains the preferred pharmacological treatment for this condition.",
      "correct_choice_id": 236741,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23484711698996393/23484711698996393.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23484711698996393/23484711698996393.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81190,
      "choices": [
        {
          "id": 236742,
          "text": "Chlorpromazine"
        },
        {
          "id": 236743,
          "text": "Risperidone"
        },
        {
          "id": 236744,
          "text": "Olanzapine"
        },
        {
          "id": 236745,
          "text": "Quetiapine"
        }
      ],
      "text": "Best drug therapy for paranoid schizophrenia in a thin built 21 years old young male would be",
      "unique_key": "Q4404823",
      "question_audio": null,
      "question_video": null,
      "map_id": 34997997,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Olanzapine. Olanzapine is an atypical antipsychotic that is generally preferred for treating paranoid schizophrenia in younger patients due to its efficacy and relatively favorable side-effect profile when compared to first-generation antipsychotics. It is known for its ability to effectively treat both positive and negative symptoms of schizophrenia. While olanzapine can lead to weight gain and metabolic changes, it is often chosen for its strong antipsychotic effects, and in a thin-built 21-year-old patient, its benefits in symptom control may outweigh these risks, especially with regular monitoring. A. Chlorpromazine is a first-generation (typical) antipsychotic that has been used for many years in the treatment of schizophrenia. However, it is associated with a higher incidence of extrapyramidal side effects (EPS), which can be particularly troublesome for younger patients. Given the availability of newer antipsychotics with a better side-effect profile, chlorpromazine is not typically the drug of choice for paranoid schizophrenia, especially in younger individuals. B. Risperidone is another atypical antipsychotic that is effective for treating paranoid schizophrenia, and it is generally well-tolerated. However, risperidone carries a risk of extrapyramidal symptoms, particularly at higher doses, and it is also associated with increased prolactin levels. In comparison to olanzapine, risperidone might not be the first choice in this case due to its side-effect profile, although it could still be a viable option. D. Quetiapine is also an atypical antipsychotic and can be effective in treating schizophrenia. However, it is often considered less potent than olanzapine in controlling the full spectrum of schizophrenia symptoms, particularly the positive symptoms. Additionally, quetiapine tends to cause sedation and has a lower affinity for the dopamine receptors, which may make it less ideal for patients with prominent paranoid symptoms. It is more commonly used for patients with co-occurring mood disorders or those who have difficulty with sedation caused by other medications.",
      "correct_choice_id": 236744,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76860931698996408/76860931698996408.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76860931698996408/76860931698996408.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81191,
      "choices": [
        {
          "id": 236746,
          "text": "Middle aged females"
        },
        {
          "id": 236747,
          "text": "Elderly females"
        },
        {
          "id": 236748,
          "text": "Young females"
        },
        {
          "id": 236749,
          "text": "Middle aged males"
        }
      ],
      "text": "Pseudo-parkinsonism is most commonly seen in",
      "unique_key": "Q8750955",
      "question_audio": null,
      "question_video": null,
      "map_id": 34467376,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Elderly females. Pseudo-parkinsonism, a common extrapyramidal side effect of antipsychotic medications, is most commonly seen in elderly females. This demographic is particularly vulnerable due to age-related changes in the central nervous system and the fact that elderly patients often take multiple medications, including antipsychotics, which can increase the risk of developing movement disorders like pseudo-parkinsonism. The symptoms resemble Parkinson's disease, including tremors, rigidity, and bradykinesia, and tend to occur more frequently in older adults due to their increased sensitivity to medications. A. Middle-aged females can also develop pseudo-parkinsonism, but they are less likely to be affected than elderly females. While middle-aged individuals may experience this side effect, the risk is lower compared to older patients, who are more sensitive to drug-induced movement disorders. C. Young females are the least likely group to experience pseudo-parkinsonism. Although young females can develop extrapyramidal side effects, they are typically less prone to pseudo-parkinsonism than older patients. Younger individuals may be more likely to experience other side effects such as akathisia or dystonia rather than the classic features of pseudo-parkinsonism. D. Middle-aged males are not particularly more prone to pseudo-parkinsonism than females. While they can experience this side effect, the incidence is generally lower compared to elderly females. Men, particularly middle-aged men, are less likely to develop movement disorders induced by antipsychotics when compared to older females.",
      "correct_choice_id": 236747,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56069951698996419/56069951698996419.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56069951698996419/56069951698996419.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81192,
      "choices": [
        {
          "id": 236750,
          "text": "Risperidone"
        },
        {
          "id": 236751,
          "text": "Amisulpiride"
        },
        {
          "id": 236752,
          "text": "Haloperidol"
        },
        {
          "id": 236753,
          "text": "Aripiprazole"
        }
      ],
      "text": "Antipsychotic least likely to cause “prolactin elevation” as side effect",
      "unique_key": "Q3510296",
      "question_audio": null,
      "question_video": null,
      "map_id": 34124266,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Aripiprazole. Aripiprazole is an atypical antipsychotic that has a unique mechanism of action as a partial dopamine agonist. It binds to dopamine receptors and works to stabilize dopamine activity in the brain, which reduces the risk of prolactin elevation. This characteristic makes it the least likely among the listed antipsychotics to cause increased prolactin levels. In fact, aripiprazole is often preferred in patients where prolactin elevation is a concern due to its minimal impact on prolactin. A. Risperidone is an atypical antipsychotic that has a higher likelihood of causing prolactin elevation compared to aripiprazole. Risperidone strongly blocks dopamine receptors in the mesolimbic and tuberoinfundibular pathways, the latter of which is involved in regulating prolactin release from the pituitary. As a result, risperidone can significantly increase prolactin levels, leading to side effects such as galactorrhea, amenorrhea, or sexual dysfunction. B. Amisulpiride is another antipsychotic that can increase prolactin levels. It is a selective dopamine D2 receptor antagonist, which inhibits dopamine's action in the tuberoinfundibular pathway, resulting in elevated prolactin levels. Like risperidone, amisulpiride is associated with a higher risk of hyperprolactinemia. C. Haloperidol is a first-generation (typical) antipsychotic known for its strong dopamine receptor antagonism, particularly at D2 receptors. This blockade in the tuberoinfundibular pathway increases prolactin secretion, making haloperidol a common cause of prolactin elevation and related side effects. It has a much higher tendency to cause hyperprolactinemia compared to aripiprazole.",
      "correct_choice_id": 236753,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52685771698996430/52685771698996430.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52685771698996430/52685771698996430.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81193,
      "choices": [
        {
          "id": 236754,
          "text": "Sedation"
        },
        {
          "id": 236755,
          "text": "Agranulocytosis"
        },
        {
          "id": 236756,
          "text": "Hypersalivation"
        },
        {
          "id": 236757,
          "text": "Hypotension"
        }
      ],
      "text": "Most common side effect of clozapine?",
      "unique_key": "Q2030168",
      "question_audio": null,
      "question_video": null,
      "map_id": 34446367,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Sedation. Sedation is the most common side effect of clozapine, especially during the initial phase of treatment. This occurs due to its potent antagonistic effects on histamine H1 receptors, which leads to drowsiness and fatigue. While sedation can be bothersome, it typically improves over time as the body adjusts to the medication. Although sedation is common, it is often considered manageable and may even be beneficial for patients with severe agitation or insomnia. B. Agranulocytosis is a serious and potentially life-threatening side effect of clozapine, but it is much less common than sedation. Agranulocytosis involves a severe drop in white blood cells, making the patient highly susceptible to infections. Due to this risk, clozapine treatment requires regular blood monitoring. Despite its seriousness, it occurs in a minority of patients, which is why sedation is the most common side effect. C. Hypersalivation (excessive salivation) is another known side effect of clozapine, particularly in the early stages of treatment. It can be uncomfortable and socially embarrassing for patients, but it is not as common as sedation. The exact mechanism behind hypersalivation is not fully understood, but it is typically manageable with medications or adjustments to the clozapine dose. D. Hypotension is a potential side effect of clozapine, particularly in the initial stages of treatment. It is related to clozapine's ability to block alpha-1 adrenergic receptors, which can lead to orthostatic hypotension (a drop in blood pressure when standing up). However, hypotension is not as frequent as sedation and tends to be more of a concern during the initial titration phase of the drug.",
      "correct_choice_id": 236754,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81194,
      "choices": [
        {
          "id": 236758,
          "text": "Risperidone"
        },
        {
          "id": 236759,
          "text": "Haloperidol"
        },
        {
          "id": 236760,
          "text": "Clozapine"
        },
        {
          "id": 236761,
          "text": "Olanzapine"
        }
      ],
      "text": "Antipsychotic drug causing maximum “weight gain”?",
      "unique_key": "Q4468134",
      "question_audio": null,
      "question_video": null,
      "map_id": 34596845,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Clozapine. Clozapine is an atypical antipsychotic that is well-known for causing significant weight gain. This is due to its strong antagonistic effects on serotonin and histamine receptors, which can increase appetite and reduce energy expenditure. The weight gain associated with clozapine is often more pronounced compared to other antipsychotics, and it can be challenging to manage. This side effect is one of the reasons why clozapine is typically reserved for treatment-resistant schizophrenia, as the benefits of the drug outweigh the risks in those cases. A. Risperidone can also cause weight gain, but it is generally less pronounced than with clozapine. Risperidone has moderate effects on serotonin and histamine receptors, contributing to some increase in appetite and weight gain, but the extent is not as severe as with clozapine or other medications like olanzapine. B. Haloperidol is a first-generation (typical) antipsychotic that tends to cause fewer metabolic side effects, including weight gain, compared to second-generation (atypical) antipsychotics like clozapine or olanzapine. While haloperidol can cause other side effects like extrapyramidal symptoms (EPS), weight gain is generally less significant with this drug. D. Olanzapine is another atypical antipsychotic that is known for causing weight gain. However, clozapine typically causes more significant weight gain than olanzapine. Both medications have a similar risk profile in terms of metabolic effects, but clozapine is considered to have a more severe impact on weight gain.",
      "correct_choice_id": 236760,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16823621698996529/16823621698996529.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16823621698996529/16823621698996529.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81195,
      "choices": [
        {
          "id": 236762,
          "text": "Amisulpiride"
        },
        {
          "id": 236763,
          "text": "Olanzapine"
        },
        {
          "id": 236764,
          "text": "Aripiprazole"
        },
        {
          "id": 236765,
          "text": "Risperidone"
        }
      ],
      "text": "Atypical antipsychotic which is itself a dopaminergic partial agonist?",
      "unique_key": "Q1747744",
      "question_audio": null,
      "question_video": null,
      "map_id": 34524548,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Aripiprazole. Aripiprazole is an atypical antipsychotic that functions as a dopaminergic partial agonist. Unlike most antipsychotics that primarily block dopamine receptors, aripiprazole works by partially activating dopamine receptors, specifically the D2 receptor, while also blocking excess dopamine in certain areas of the brain. This unique mechanism of action allows it to stabilize dopamine activity, which is particularly beneficial in treating symptoms of schizophrenia and bipolar disorder with a lower risk of side effects such as extrapyramidal symptoms (EPS) and prolactin elevation. A. Amisulpiride is an atypical antipsychotic that primarily acts as a dopamine D2 receptor antagonist. It works by blocking dopamine receptors, which can help reduce psychotic symptoms. However, unlike aripiprazole, it does not function as a partial agonist but instead as a full antagonist at the D2 receptor, leading to a more straightforward reduction in dopamine activity. B. Olanzapine is another atypical antipsychotic that primarily works as a dopamine receptor antagonist. It has broad effects on both dopamine and serotonin receptors, which contribute to its antipsychotic properties. However, it does not function as a partial agonist. Olanzapine is effective in managing schizophrenia and bipolar disorder but carries a higher risk of metabolic side effects like weight gain. D. Risperidone is an atypical antipsychotic that acts primarily as a dopamine D2 receptor antagonist, similar to amisulpiride. While it is effective in treating psychotic disorders, it does not act as a partial agonist. Risperidone is associated with a higher risk of extrapyramidal symptoms (EPS) and prolactin elevation compared to aripiprazole, due to its stronger dopamine antagonism.",
      "correct_choice_id": 236764,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69518121698997939/69518121698997939.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69518121698997939/69518121698997939.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81196,
      "choices": [
        {
          "id": 236766,
          "text": "5HT3"
        },
        {
          "id": 236767,
          "text": "5HT2a"
        },
        {
          "id": 236768,
          "text": "5HT2c"
        },
        {
          "id": 236769,
          "text": "5HT1a"
        }
      ],
      "text": "Weight gain due to antipsychotics is due to its action on which receptors?",
      "unique_key": "Q6541885",
      "question_audio": null,
      "question_video": null,
      "map_id": 34859129,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 5HT2c. Weight gain associated with many atypical antipsychotics is primarily due to their antagonistic effects on the 5HT2c serotonin receptors. The 5HT2c receptors are involved in regulating appetite and food intake, and blocking these receptors can lead to an increase in appetite and, consequently, weight gain. This action is seen in several antipsychotics, such as olanzapine and clozapine, which are known to cause significant weight gain as a side effect. A. 5HT3 receptors are involved in the regulation of nausea and vomiting, not appetite or weight gain. Antagonism of these receptors is typically linked to antiemetic effects, such as the use of certain medications in chemotherapy-induced nausea. However, 5HT3 antagonism does not play a significant role in the weight gain observed with antipsychotic drugs. B. 5HT2a receptors are primarily involved in mood regulation and the mechanism of action of many antipsychotics. While their antagonism can contribute to some of the therapeutic effects of atypical antipsychotics, they are not directly responsible for the weight gain seen with these medications. The 5HT2a receptors are more related to antipsychotic efficacy and reducing positive symptoms of schizophrenia. D. 5HT1a receptors are involved in anxiety and mood regulation, and antagonism of these receptors can contribute to anxiolytic and antidepressant effects. However, they are not associated with weight gain caused by antipsychotics. Their effects are more related to mood stabilization and reducing anxiety symptoms, not appetite regulation.",
      "correct_choice_id": 236768,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74709661698997961/74709661698997961.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74709661698997961/74709661698997961.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81197,
      "choices": [
        {
          "id": 236770,
          "text": "Benzodiazepines"
        },
        {
          "id": 236771,
          "text": "Tricyclic antidepressants"
        },
        {
          "id": 236772,
          "text": "Progesterone"
        },
        {
          "id": 236773,
          "text": "SSRI"
        }
      ],
      "text": "Drug of choice for “pre-menstrual dysphoric disorder”?",
      "unique_key": "Q6090760",
      "question_audio": null,
      "question_video": null,
      "map_id": 34170270,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) SSRI. Selective serotonin reuptake inhibitors (SSRIs) are considered the first-line treatment for pre-menstrual dysphoric disorder (PMDD). SSRIs help alleviate mood symptoms such as irritability, depression, and anxiety, which are the hallmark symptoms of PMDD. They are effective in improving emotional regulation during the luteal phase of the menstrual cycle, making them the preferred pharmacological treatment. SSRIs like fluoxetine and sertraline have shown significant benefit in managing PMDD symptoms and are well-tolerated by most patients. A. Benzodiazepines are sometimes used to manage anxiety or sleep disturbances associated with PMDD, but they are not considered a first-line treatment. Benzodiazepines may have a sedative effect and could potentially lead to dependency if used long-term, making them less ideal for treating PMDD compared to SSRIs, which specifically target mood regulation and the underlying pathophysiology. B. Tricyclic antidepressants (TCAs) are another class of antidepressants that can be used in PMDD, particularly for patients who do not respond to SSRIs. However, TCAs are generally considered second-line treatments due to their higher risk of side effects, such as dry mouth, constipation, and sedation, which make them less tolerable than SSRIs. C. Progesterone is sometimes used in the treatment of PMDD, especially in patients with hormonal imbalances. However, progesterone alone is not considered the drug of choice. It is often used in combination with other treatments or as part of hormonal therapy, but SSRIs are generally more effective for managing the mood-related symptoms of PMDD.",
      "correct_choice_id": 236773,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2398301698997992/2398301698997992.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2398301698997992/2398301698997992.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81198,
      "choices": [
        {
          "id": 236774,
          "text": "Imipramine"
        },
        {
          "id": 236775,
          "text": "Fluvoxamine"
        },
        {
          "id": 236776,
          "text": "Phenelzine"
        },
        {
          "id": 236777,
          "text": "Bupropion"
        }
      ],
      "text": "Antidepressant drug that can be used in nocturnal enuresis?",
      "unique_key": "Q5879988",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334220,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Imipramine. Imipramine, a tricyclic antidepressant (TCA), is the drug of choice for treating nocturnal enuresis (bedwetting), particularly in children. It works by increasing the levels of norepinephrine and serotonin in the brain, which in turn helps to improve bladder control. Imipramine is thought to have both its central and peripheral effects on the bladder, which reduce nighttime urination. Due to its anticholinergic properties, it can also help in reducing involuntary bladder contractions, thus preventing enuresis. B. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that is primarily used to treat obsessive-compulsive disorder (OCD) and anxiety disorders. It is not effective for nocturnal enuresis, as SSRIs do not have the same anticholinergic or bladder-modifying effects as TCAs like imipramine. Therefore, fluvoxamine is not a treatment option for bedwetting. C. Phenelzine is a monoamine oxidase inhibitor (MAOI) used primarily in the treatment of depression and anxiety disorders. However, it is not recommended for nocturnal enuresis. MAOIs like phenelzine work by inhibiting the breakdown of neurotransmitters, but they do not have any specific effect on bladder control or enuresis. Furthermore, MAOIs are associated with significant dietary restrictions and side effects, making them unsuitable for treating nocturnal enuresis. D. Bupropion is an atypical antidepressant primarily used for depression and smoking cessation. While it has some effects on norepinephrine and dopamine, it does not have the necessary properties to address the specific mechanisms involved in nocturnal enuresis. Bupropion is not effective for controlling bedwetting and is not used for this purpose.",
      "correct_choice_id": 236774,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65463851698998003/65463851698998003.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65463851698998003/65463851698998003.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81199,
      "choices": [
        {
          "id": 236778,
          "text": "Citalopram"
        },
        {
          "id": 236779,
          "text": "Vortioxetine"
        },
        {
          "id": 236780,
          "text": "Duloxetine"
        },
        {
          "id": 236781,
          "text": "Paroxetine"
        }
      ],
      "text": "Which is not an SSRI?",
      "unique_key": "Q4600591",
      "question_audio": null,
      "question_video": null,
      "map_id": 34015501,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Duloxetine. Duloxetine is not a selective serotonin reuptake inhibitor (SSRI). It is a serotonin-norepinephrine reuptake inhibitor (SNRI), which works by inhibiting the reuptake of both serotonin and norepinephrine. This dual action differentiates it from SSRIs, which primarily target serotonin reuptake alone. Duloxetine is used to treat conditions like depression, generalized anxiety disorder, and neuropathic pain, but it is not classified as an SSRI. A. Citalopram is an SSRI. It works by selectively inhibiting the reuptake of serotonin in the brain, increasing serotonin levels and improving mood. Citalopram is commonly prescribed for depression and anxiety disorders and is classified as an SSRI. B. Vortioxetine is also an SSRI, although it has additional properties that involve the modulation of other serotonin receptors. While it has a more complex mechanism of action, vortioxetine primarily functions as a serotonin reuptake inhibitor, making it an SSRI. D. Paroxetine is an SSRI as well. It selectively inhibits the reuptake of serotonin in the brain, which helps improve mood in individuals with depression or anxiety disorders. Paroxetine is commonly used to treat conditions such as generalized anxiety disorder, panic disorder, and depression.",
      "correct_choice_id": 236780,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49684211698998016/49684211698998016.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49684211698998016/49684211698998016.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81200,
      "choices": [
        {
          "id": 236782,
          "text": "Progesterone"
        },
        {
          "id": 236783,
          "text": "Cortisol"
        },
        {
          "id": 236784,
          "text": "ACTH"
        },
        {
          "id": 236785,
          "text": "Levothyroxine"
        }
      ],
      "text": "Which of the following hormones is most commonly used in the adjuvant treatment of depression?",
      "unique_key": "Q7862833",
      "question_audio": null,
      "question_video": null,
      "map_id": 34616019,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Levothyroxine. Levothyroxine, a synthetic form of the thyroid hormone thyroxine (T4), is commonly used in the adjuvant treatment of depression, particularly in cases where there is a co-existing hypothyroidism or treatment-resistant depression. Thyroid hormones play an important role in regulating mood, and levothyroxine can enhance the effects of antidepressants in patients with low thyroid function. Even in euthyroid patients (those with normal thyroid function), adding levothyroxine may sometimes improve the response to antidepressants, especially when patients are not fully responsive to standard depression treatment. A. Progesterone is a hormone involved in the menstrual cycle and pregnancy. While some studies have explored its potential role in mood regulation, progesterone is not a commonly used adjuvant treatment for depression. It can have some mood-stabilizing effects, but it is not considered a standard treatment option for depression. B. Cortisol is a hormone produced by the adrenal glands in response to stress. Although cortisol levels are often dysregulated in individuals with depression, increasing cortisol through treatment is not part of the therapeutic approach. In fact, treatments aimed at normalizing cortisol levels, such as certain antidepressants and other interventions, are more common. C. ACTH (Adrenocorticotropic hormone) stimulates the adrenal glands to produce cortisol. However, ACTH is not used in the treatment of depression. Although some research has explored the use of ACTH in various psychiatric conditions, it is not a standard or commonly used adjuvant therapy for depression.",
      "correct_choice_id": 236785,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40861051698998026/40861051698998026.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40861051698998026/40861051698998026.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81201,
      "choices": [
        {
          "id": 236786,
          "text": "Lithium"
        },
        {
          "id": 236787,
          "text": "Valproate"
        },
        {
          "id": 236788,
          "text": "Atypical antipsychotics"
        },
        {
          "id": 236789,
          "text": "Benzodiazepines"
        }
      ],
      "text": "Drug of choice for acute mania in pregnancy?",
      "unique_key": "Q4147625",
      "question_audio": null,
      "question_video": null,
      "map_id": 34128820,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Atypical antipsychotics. Atypical antipsychotics, such as olanzapine or risperidone, are generally considered the first-line treatment for acute mania during pregnancy. These medications are preferred because they have a more favorable safety profile compared to mood stabilizers like lithium or valproate during pregnancy. Atypical antipsychotics are effective in managing manic symptoms, and while they may carry some risks during pregnancy, the risks are generally lower compared to other options, making them the safest choice in managing acute mania during this period. A. Lithium is a well-established treatment for bipolar disorder, but it is contraindicated during pregnancy, particularly during the first trimester due to the risk of cardiac malformations in the fetus, specifically Ebstein's anomaly. While lithium may be used in pregnancy under careful monitoring during the second and third trimesters, it is not considered the drug of choice for acute mania in pregnancy. B. Valproate is another mood stabilizer used to treat acute mania, but it is contraindicated during pregnancy due to its teratogenic effects, which include a higher risk of neural tube defects and developmental abnormalities in the fetus. Valproate is avoided during pregnancy, especially in the first trimester, due to these significant risks. D. Benzodiazepines can be used for short-term management of anxiety or insomnia in pregnant women but are not effective in treating acute mania. Additionally, benzodiazepines are not typically recommended in pregnancy, particularly during the first trimester, due to the potential for sedation and withdrawal symptoms in the newborn. They may also have a risk of teratogenicity when used in high doses over prolonged periods.",
      "correct_choice_id": 236788,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52689561698998035/52689561698998035.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52689561698998035/52689561698998035.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81202,
      "choices": [
        {
          "id": 236790,
          "text": "Carbamazepine"
        },
        {
          "id": 236791,
          "text": "Valproate"
        },
        {
          "id": 236792,
          "text": "Phenytoin"
        },
        {
          "id": 236793,
          "text": "Lithium"
        }
      ],
      "text": "Drug of choice for rapid cyclers in manic depressive psychosis?",
      "unique_key": "Q3481710",
      "question_audio": null,
      "question_video": null,
      "map_id": 34845099,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Valproate. Valproate is the drug of choice for rapid cycling in manic depressive psychosis (also known as bipolar disorder). Rapid cycling refers to the occurrence of four or more mood episodes (mania, hypomania, or depression) within a year. Valproate, a mood stabilizer and anticonvulsant, is effective in managing both the manic and depressive episodes in individuals with rapid cycling bipolar disorder. It is particularly preferred in this population because it tends to be more effective than other treatments in preventing mood swings and stabilizing mood, and it is generally well-tolerated. A. Carbamazepine is another mood stabilizer that can be used to treat bipolar disorder, but it is typically considered second-line treatment for rapid cycling. While carbamazepine can be effective in preventing mania, it is generally not as preferred as valproate due to its potential for drug interactions, side effects (such as rash or blood dyscrasias), and less robust evidence for its effectiveness in rapid cycling. C. Phenytoin is an anticonvulsant used to manage seizures, but it is not indicated for the treatment of bipolar disorder or rapid cycling. Phenytoin does not have mood-stabilizing properties and is not effective for treating the manic or depressive episodes associated with bipolar disorder. D. Lithium is a first-line treatment for bipolar disorder, but it is less effective for individuals with rapid cycling mania. Lithium is more effective in individuals with non-rapid cycling bipolar disorder and may not be as effective in preventing mood episodes in those with rapid cycling. Additionally, lithium has a narrow therapeutic range, which requires close monitoring and may pose a higher risk of toxicity in some patients, making it less ideal for rapid cyclers.",
      "correct_choice_id": 236791,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36051811698998046/36051811698998046.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36051811698998046/36051811698998046.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81203,
      "choices": [
        {
          "id": 236794,
          "text": "Neutropenia"
        },
        {
          "id": 236795,
          "text": "Major depression"
        },
        {
          "id": 236796,
          "text": "Vasculogenic headache"
        },
        {
          "id": 236797,
          "text": "Generalised anxiety disorder"
        }
      ],
      "text": "All are indications of lithium except?",
      "unique_key": "Q8403435",
      "question_audio": null,
      "question_video": null,
      "map_id": 34966412,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Generalized anxiety disorder. Lithium is not indicated for the treatment of generalized anxiety disorder (GAD). It is primarily used as a mood stabilizer in conditions like bipolar disorder (for both manic and depressive episodes) and major depression when there is a mood component. While lithium has some mood-stabilizing properties, it is not effective in treating anxiety disorders, including GAD. First-line treatments for GAD typically include SSRIs (such as sertraline or escitalopram) or SNRIs (such as venlafaxine), and sometimes benzodiazepines for short-term management. A. Neutropenia is a known side effect of lithium, especially at higher doses or with long-term use. Lithium can cause neutropenia (a decrease in white blood cell count) and leukocytosis. It is one of the reasons why regular blood monitoring is required during lithium therapy. Therefore, neutropenia is something that can occur in patients taking lithium. B. Major depression is an indication for lithium use. Lithium is used as an adjuvant treatment for major depressive disorder, especially in patients who are not responding to traditional antidepressant therapy alone or who have a history of bipolar disorder. Lithium can help prevent depressive episodes and manic switches, especially in bipolar depression. C. Vasculogenic headache is another condition where lithium has been used. While not a first-line treatment, there is some evidence suggesting lithium's potential effectiveness in treating certain types of headaches, particularly cluster headaches and possibly vasculogenic headaches (which involve vascular changes in the brain). Thus, lithium may be used in select cases to help manage these headaches.",
      "correct_choice_id": 236797,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21596821698998060/21596821698998060.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21596821698998060/21596821698998060.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81204,
      "choices": [
        {
          "id": 236798,
          "text": "Therapeutic drug monitoring is not required"
        },
        {
          "id": 236799,
          "text": "Carbamazepine does not cause agranulocytosis"
        },
        {
          "id": 236800,
          "text": "It is associated with Steven Johnson syndrome"
        },
        {
          "id": 236801,
          "text": "It causes severe nephrotoxicity"
        }
      ],
      "text": "Which of the following is true about carbamazepine?",
      "unique_key": "Q9447405",
      "question_audio": null,
      "question_video": null,
      "map_id": 34562200,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) It is associated with Steven Johnson syndrome. Carbamazepine is known to be associated with Stevens-Johnson syndrome (SJS), a rare but serious skin reaction that involves blistering and peeling of the skin, often with mucous membrane involvement. SJS can be life-threatening and is considered a major adverse effect of carbamazepine, especially in certain populations with genetic predispositions (such as those with the HLA-B*1502 allele, more commonly seen in people of Asian descent). Due to this risk, genetic testing is often recommended before starting carbamazepine in high-risk populations. A. Therapeutic drug monitoring is not required is incorrect. Carbamazepine requires therapeutic drug monitoring due to its narrow therapeutic index. Monitoring blood levels helps ensure that the drug remains within a therapeutic range to avoid toxicity (such as ataxia, drowsiness, or coma) while ensuring its efficacy in treating conditions like epilepsy and bipolar disorder. B. Carbamazepine does not cause agranulocytosis is incorrect. Carbamazepine can cause agranulocytosis, a severe drop in white blood cells, leading to an increased risk of infection. This is another important reason for regular monitoring of blood counts in patients taking carbamazepine. Agranulocytosis is a rare but serious side effect that can occur during treatment. D. It causes severe nephrotoxicity is incorrect. While nephrotoxicity can occur with many drugs, carbamazepine is not typically associated with severe nephrotoxicity. Its primary adverse effects are more related to the hematologic system (such as agranulocytosis) and skin reactions (such as SJS), rather than significant kidney damage. Nephrotoxicity is not a major concern with carbamazepine use.",
      "correct_choice_id": 236800,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37608711698998071/37608711698998071.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37608711698998071/37608711698998071.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81205,
      "choices": [
        {
          "id": 236802,
          "text": "Venlafaxine"
        },
        {
          "id": 236803,
          "text": "Desipramine"
        },
        {
          "id": 236804,
          "text": "Amitryptiline"
        },
        {
          "id": 236805,
          "text": "Imipramine"
        }
      ],
      "text": "Which of the following antidepressant causes sedation & pain relief?",
      "unique_key": "Q4880107",
      "question_audio": null,
      "question_video": null,
      "map_id": 34467192,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Amitriptyline. Amitriptyline is a tricyclic antidepressant (TCA) that is known for its sedative effects due to its strong antihistamine activity. It is often prescribed for conditions involving chronic pain (such as neuropathic pain and fibromyalgia) due to its analgesic properties. Amitriptyline also helps with sleep disturbances, making it beneficial for patients with both depression and insomnia. Its sedative effect is one of the reasons it is sometimes used off-label for pain relief, especially in conditions like post-herpetic neuralgia or chronic headaches. A. Venlafaxine is an SSNRI (serotonin-norepinephrine reuptake inhibitor) that primarily treats depression and anxiety. While venlafaxine can have some mild effects on pain, it is not typically associated with sedation. In fact, at higher doses, venlafaxine may be more stimulating due to its effects on norepinephrine. Therefore, it is not known for its sedative or significant pain-relieving effects. B. Desipramine is another tricyclic antidepressant (TCA), but it is generally more stimulating compared to other TCAs like amitriptyline. Desipramine has a lower sedative effect and is not typically used for pain relief as it has less anticholinergic and antihistaminic activity compared to amitriptyline. Therefore, it is not the drug of choice for sedation or pain management. D. Imipramine is also a TCA, and while it has some sedative effects, it is generally less sedating than amitriptyline. Imipramine is more commonly used for depression and panic disorder and does not have as strong of an analgesic effect as amitriptyline. While it can help with some pain conditions, it is not as frequently used for this purpose as amitriptyline.",
      "correct_choice_id": 236804,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6127721698998082/6127721698998082.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6127721698998082/6127721698998082.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81206,
      "choices": [
        {
          "id": 236806,
          "text": "Excessive yawning"
        },
        {
          "id": 236807,
          "text": "Sexual dysfunction"
        },
        {
          "id": 236808,
          "text": "Emotional blunting"
        },
        {
          "id": 236809,
          "text": "Gastrointestinal side effects"
        }
      ],
      "text": "Most common adverse effect of SSRI associated with long term use?",
      "unique_key": "Q5161823",
      "question_audio": null,
      "question_video": null,
      "map_id": 34915495,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Sexual dysfunction. Sexual dysfunction is the most common adverse effect associated with long-term use of SSRIs (selective serotonin reuptake inhibitors). It can include symptoms such as reduced libido, difficulty achieving orgasm, and erectile dysfunction. These side effects are well-documented and occur in a significant proportion of patients using SSRIs. They are particularly common with drugs like fluoxetine, sertraline, and paroxetine. For many patients, these effects persist throughout treatment, and they can sometimes lead to discontinuation of the medication. Adjusting the dose, switching medications, or adding other treatments can help mitigate these side effects. A. Excessive yawning is a less common side effect of SSRIs, though it can occur in some individuals. It is more often associated with dopamine-related effects and is not a hallmark issue with SSRIs. It is generally a transient effect that can be managed by adjusting the medication. C. Emotional blunting refers to a reduction in emotional responsiveness and is sometimes reported by patients taking SSRIs. While it can occur, especially with higher doses, it is not as common or as prominent as sexual dysfunction. Emotional blunting tends to be a less frequent complaint and is generally considered a more subtle or variable side effect that may not significantly impact every patient. D. Gastrointestinal side effects like nausea, diarrhea, and weight loss are common during the initial phase of SSRI treatment, particularly in the first few weeks as the body adjusts. However, these side effects usually subside over time and are not as persistent or long-lasting as sexual dysfunction, which can occur consistently throughout long-term use.",
      "correct_choice_id": 236807,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34825191698998093/34825191698998093.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34825191698998093/34825191698998093.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81207,
      "choices": [
        {
          "id": 236810,
          "text": "Amitryptiline"
        },
        {
          "id": 236811,
          "text": "SSRI"
        },
        {
          "id": 236812,
          "text": "Buspirone"
        },
        {
          "id": 236813,
          "text": "Nootropic drugs"
        }
      ],
      "text": "Which of the following drug should be used to treat depression in a patient of “acute hemiplegic stroke” with mild hypertension?",
      "unique_key": "Q4487066",
      "question_audio": null,
      "question_video": null,
      "map_id": 34336154,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) SSRI. SSRIs (Selective Serotonin Reuptake Inhibitors), such as sertraline, fluoxetine, or escitalopram, are the drug of choice for treating depression in a patient with acute hemiplegic stroke, especially when the patient has mild hypertension. SSRIs are generally well-tolerated, have a favorable safety profile, and are effective in treating post-stroke depression, which is a common complication after a stroke. Additionally, SSRIs have minimal cardiovascular side effects, making them appropriate for patients with mild hypertension. They also do not have the sedative or anticholinergic side effects that some older antidepressants like TCAs (e.g., amitriptyline) may have. A. Amitriptyline is a tricyclic antidepressant (TCA), which has several side effects, including anticholinergic effects (e.g., dry mouth, constipation), sedation, and orthostatic hypotension. These can be dangerous for patients with a history of stroke, as these side effects can exacerbate other symptoms or cause complications. Furthermore, TCAs can increase the risk of cardiac arrhythmias and may worsen hypertension, which makes them less ideal in a patient with a mild hypertensive state. C. Buspirone is an anxiolytic used primarily to treat generalized anxiety disorder (GAD), but it is not effective for depression. While it has a good safety profile, especially in patients with hypertension, it is not indicated for the treatment of depression, especially in the setting of acute hemiplegic stroke, where mood disorders are typically treated with antidepressants rather than anxiolytics. D. Nootropic drugs, which are used to improve cognitive function, are not appropriate for treating depression. These drugs have limited evidence in managing mood disorders and are not considered a primary treatment for depression following a stroke. While they may have benefits for cognitive recovery in some stroke patients, they are not recommended for addressing the underlying depressive symptoms, which require antidepressants like SSRIs.",
      "correct_choice_id": 236811,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71218501698998141/71218501698998141.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71218501698998141/71218501698998141.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81208,
      "choices": [
        {
          "id": 236814,
          "text": "AIDS related behavioural disturbances"
        },
        {
          "id": 236815,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236816,
          "text": "Serotonin syndrome"
        },
        {
          "id": 236817,
          "text": "Protease inhibitor related disturbances"
        }
      ],
      "text": "A 30-year-old man comes to the emergency room with symptoms of tachycardia, diaphoresis, mydriasis, and hyperthermia. He also shows muscle twitching and clonus. His medications include a protease in- hibitor and fluoxetine 20 mg daily which was started 1 week ago. Diag- nosis?",
      "unique_key": "Q1277733",
      "question_audio": null,
      "question_video": null,
      "map_id": 34270901,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Serotonin syndrome. Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the central nervous system. The patient's symptoms of tachycardia, diaphoresis (sweating), mydriasis (dilated pupils), hyperthermia, muscle twitching, and clonus (involuntary muscle contractions) are all hallmark signs of serotonin syndrome. The patient recently started fluoxetine, an SSRI (Selective Serotonin Reuptake Inhibitor), which increases serotonin levels. When combined with other serotonergic drugs, such as protease inhibitors, the risk of serotonin syndrome increases. This condition typically manifests within hours of starting or increasing the dose of a serotonergic medication and requires immediate treatment to prevent complications. A. AIDS-related behavioral disturbances refers to changes in mood, cognition, or behavior associated with HIV/AIDS. Although protease inhibitors are commonly prescribed to HIV patients, the symptoms in this case (tachycardia, hyperthermia, muscle twitching, etc.) are not indicative of behavioral changes associated with HIV/AIDS. AIDS-related behavioral disturbances would not present with the physical signs seen here, such as muscle hyperactivity and autonomic instability. B. Neuroleptic malignant syndrome (NMS) is a life-threatening condition caused by the use of antipsychotic drugs. NMS is characterized by fever, muscle rigidity, autonomic dysregulation (such as tachycardia and labile blood pressure), and altered mental status. However, NMS typically develops after the administration of antipsychotic medications, which is not the case here. The patient’s recent use of fluoxetine and protease inhibitors makes serotonin syndrome more likely than NMS, particularly in the absence of antipsychotic use. D. Protease inhibitor-related disturbances could include a range of side effects such as gastrointestinal issues, lipid abnormalities, or liver toxicity, but protease inhibitors are not typically associated with the autonomic and neuromuscular symptoms seen here (tachycardia, diaphoresis, clonus). While protease inhibitors can interact with serotonergic drugs, leading to serotonin syndrome, they are not independently responsible for this set of symptoms.",
      "correct_choice_id": 236816,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50685521698998194/50685521698998194.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50685521698998194/50685521698998194.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81209,
      "choices": [
        {
          "id": 236818,
          "text": "Administration of normal saline IV"
        },
        {
          "id": 236819,
          "text": "Emergency dialysis"
        },
        {
          "id": 236820,
          "text": "Administration of benztropine IM"
        },
        {
          "id": 236821,
          "text": "Cardiac monitoring"
        }
      ],
      "text": "A 36-year-old man is admitted to the hospital after a suicide attempt, in which he swallowed his entire bottle of lithium pills. In the emergency room, he is noted to be stuporous, with a lithium level of 4.5 meq/L. His urine output is noted to be less than one-half what would normally beexpected for a patient of his age. Which of the following procedures should be performed next?",
      "unique_key": "Q7966526",
      "question_audio": null,
      "question_video": null,
      "map_id": 34860979,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Emergency dialysis. The patient has a lithium level of 4.5 meq/L, which is severely elevated (normal therapeutic range is 0.6-1.2 meq/L). The symptoms of stupor, along with reduced urine output, suggest lithium toxicity, which can be life-threatening. Lithium toxicity can cause renal impairment, making it difficult for the kidneys to clear the drug from the system. In severe cases, such as in this patient, emergency dialysis is required to rapidly lower the lithium level, as it is the most effective way to eliminate the drug when the renal function is compromised. Dialysis is particularly indicated when the lithium level exceeds 4.0 meq/L, there is acute kidney injury, or when the patient is symptomatic with severe toxicity. A. Administration of normal saline IV may be used as part of supportive care for lithium toxicity, as it helps maintain hydration and promote renal excretion of lithium. However, in this case, the patient’s lithium level is critically high, and there is evidence of renal dysfunction (low urine output). IV fluids alone are unlikely to lower the lithium level sufficiently, making dialysis the more appropriate intervention. C. Administration of benztropine IM is used to treat extrapyramidal side effects caused by antipsychotic medications, such as dystonia or parkinsonism. However, this drug is not relevant to lithium toxicity, as the patient is experiencing symptoms directly related to an overdose of lithium, not antipsychotic-induced movement disorders. D. Cardiac monitoring is important in cases of lithium toxicity, as arrhythmias can occur, especially at high lithium levels. However, cardiac monitoring alone will not treat the underlying issue of elevated lithium levels. Dialysis is the most effective way to address the life-threatening high lithium levels in this patient.",
      "correct_choice_id": 236819,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26825211698998204/26825211698998204.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26825211698998204/26825211698998204.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81210,
      "choices": [
        {
          "id": 236822,
          "text": "Anticholinergic syndrome"
        },
        {
          "id": 236823,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236824,
          "text": "Extrapyramidal side effect"
        },
        {
          "id": 236825,
          "text": "Akathisia"
        }
      ],
      "text": "A 42-year-old man is diagnosed with a psychotic depression and is started on imipramine and perphenazine. When he develops a dystonia, he is begun on benztropine 2 mg/day. One week later, his wife reports that the patient has become unusually forgetful and seems disoriented at night. On physical examination, the man appears slightly flushed, his skin and palms are dry, and he is tachycardic. He is oriented to name and place only. He showed none of these symptoms during his last appointment. Which of the following is the most likely diagnosis?",
      "unique_key": "Q3955819",
      "question_audio": null,
      "question_video": null,
      "map_id": 34403873,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Anticholinergic syndrome. The patient is taking imipramine (a tricyclic antidepressant), perphenazine (an antipsychotic), and benztropine (an anticholinergic used to treat extrapyramidal symptoms). The symptoms of flushed skin, dry mouth, tachycardia, and delirium (disorientation at night) are classic signs of anticholinergic toxicity, which can result from the combination of benztropine and imipramine. Both benztropine and imipramine have anticholinergic properties, and their combination can lead to excessive anticholinergic effects. Anticholinergic syndrome is characterized by delirium, dry skin, tachycardia, flushed appearance, and mydriasis (dilated pupils), which fits this patient's presentation. B. Neuroleptic malignant syndrome (NMS) is a serious condition typically caused by the use of antipsychotic medications, such as perphenazine. NMS is characterized by hyperthermia, muscle rigidity, autonomic dysregulation (such as labile blood pressure), and altered mental status. Although this patient has mental confusion, he does not show the hallmark signs of muscle rigidity or fever that are typically seen in NMS. Therefore, this is not the most likely diagnosis in this case. C. Extrapyramidal side effect (EPS) refers to movement disorders caused by antipsychotic medications, including dystonia, akathisia, and parkinsonism. While the patient initially developed dystonia (a type of EPS) and was started on benztropine to treat it, the current symptoms (delirium, flushed skin, dry mouth) are not typical of EPS. In fact, these symptoms are more consistent with anticholinergic toxicity, not extrapyramidal side effects. D. Akathisia is a movement disorder characterized by an inner restlessness, often associated with antipsychotic use. While akathisia can cause significant discomfort, it does not cause the anticholinergic symptoms seen in this patient, such as delirium, tachycardia, or flushed skin. Akathisia is more commonly associated with motor restlessness rather than confusion and autonomic dysregulation.",
      "correct_choice_id": 236822,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24440791698998214/24440791698998214.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24440791698998214/24440791698998214.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81211,
      "choices": [
        {
          "id": 236826,
          "text": "Change in neurotransmitter receptor sensitivity"
        },
        {
          "id": 236827,
          "text": "Decreased levels of neurotransmitters"
        },
        {
          "id": 236828,
          "text": "Change in efficacy of neurotransmit- ters"
        },
        {
          "id": 236829,
          "text": "None of the above"
        }
      ],
      "text": "The clinical effects of the antidepressant drugs is mainly based on:",
      "unique_key": "Q8702574",
      "question_audio": null,
      "question_video": null,
      "map_id": 34740023,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Change in neurotransmitter receptor sensitivity. The clinical effects of antidepressant drugs primarily result from their ability to modulate neurotransmitter systems, leading to changes in receptor sensitivity over time. For instance, most antidepressants, such as SSRIs, SNRIs, and TCAs, increase the availability of neurotransmitters like serotonin, norepinephrine, or dopamine in the synaptic cleft. However, the therapeutic effects do not occur immediately. Instead, they develop as the neurotransmitter receptors become more sensitive or undergo adaptive changes. Over time, this receptor sensitivity change helps restore the balance in neurotransmitter systems, which is crucial in alleviating symptoms of depression. B. Decreased levels of neurotransmitters is not correct because antidepressants typically increase the availability of neurotransmitters, rather than decreasing their levels. Medications like SSRIs increase serotonin levels, and SNRIs increase both serotonin and norepinephrine levels. The goal is to enhance neurotransmission, not reduce neurotransmitter levels. C. Change in efficacy of neurotransmitters is also incorrect. While antidepressants increase neurotransmitter levels, the key mechanism behind their clinical effects is not about directly altering the efficacy of neurotransmitters themselves. Instead, it is primarily through altering receptor sensitivity and the neuroplastic changes that occur with prolonged exposure to the medication. The efficacy of neurotransmitters in synaptic transmission is influenced indirectly by changes in receptor responsiveness. D. None of the above is incorrect because, as explained earlier, the clinical effects of antidepressant drugs are indeed based on changes in neurotransmitter receptor sensitivity, making option A the correct answer.",
      "correct_choice_id": 236826,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58433951698998227/58433951698998227.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58433951698998227/58433951698998227.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81212,
      "choices": [
        {
          "id": 236830,
          "text": "Thiazide diuretic"
        },
        {
          "id": 236831,
          "text": "Diazepam"
        },
        {
          "id": 236832,
          "text": "Amiloride"
        },
        {
          "id": 236833,
          "text": "None"
        }
      ],
      "text": "Drug of choice for Lithium induced Diabetes Insipidus?",
      "unique_key": "Q3226038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34978277,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Amiloride. Lithium-induced diabetes insipidus (DI) is a common side effect of long-term lithium therapy, where lithium interferes with the kidney's ability to concentrate urine, resulting in excessive urination and thirst. Amiloride, a potassium-sparing diuretic, is considered the drug of choice for lithium-induced DI because it inhibits the renal epithelial sodium channel (ENaC), which is thought to be involved in lithium's effect on the kidney. Amiloride can reduce lithium’s impact on the kidneys and improve the symptoms of diabetes insipidus without causing further electrolyte imbalances. A. Thiazide diuretic is incorrect because while thiazides may be used in idiopathic nephrogenic diabetes insipidus, they are not effective in lithium-induced diabetes insipidus. In fact, thiazide diuretics may worsen lithium toxicity and electrolyte imbalances, so they are not recommended for managing lithium-induced DI. B. Diazepam is incorrect because diazepam is a benzodiazepine used primarily for anxiety, seizures, and muscle spasms, but it has no role in treating diabetes insipidus, whether it is caused by lithium or other factors. There is no evidence supporting the use of diazepam for lithium-induced DI. D. None is incorrect because amiloride is indeed an appropriate treatment option for lithium-induced diabetes insipidus, so the answer cannot be \"none.\"",
      "correct_choice_id": 236832,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66310451698998238/66310451698998238.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66310451698998238/66310451698998238.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81213,
      "choices": [
        {
          "id": 236834,
          "text": "Hypertension, hyperthermia and hyper-reflexia are seen"
        },
        {
          "id": 236835,
          "text": "I/V Dantrolene is the treatment of choice"
        },
        {
          "id": 236836,
          "text": "SSRI and MAOIs causes it"
        },
        {
          "id": 236837,
          "text": "It is predictable and not idiosyncratic"
        }
      ],
      "text": "Not true regarding serotonin syndrome is",
      "unique_key": "Q8991715",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067766,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) I/V Dantrolene is the treatment of choice. Serotonin syndrome is a life-threatening condition caused by excessive serotonergic activity in the central nervous system, typically due to the use of serotonergic medications, such as SSRIs and MAOIs. The treatment of serotonin syndrome is primarily supportive, and benzodiazepines (such as lorazepam) are often used to control agitation and muscle rigidity. While dantrolene (a muscle relaxant) can be used to treat neuroleptic malignant syndrome (NMS), it is not considered the treatment of choice for serotonin syndrome. Serotonin syndrome is typically managed with benzodiazepines, cooling measures, and serotonin antagonists like cyproheptadine if necessary. A. Hypertension, hyperthermia, and hyper-reflexia are seen is correct. These are classic symptoms of serotonin syndrome. Patients may present with autonomic instability (e.g., hypertension, tachycardia), neuromuscular hyperactivity (e.g., hyper-reflexia, tremors, muscle rigidity), and altered mental status (e.g., agitation, confusion, or delirium). Hyperthermia is also a common finding and can lead to multi-organ failure if untreated. C. SSRI and MAOIs cause it is correct. Both SSRIs (selective serotonin reuptake inhibitors) and MAOIs (monoamine oxidase inhibitors) are known to increase serotonin levels in the brain. SSRIs increase serotonin availability by inhibiting its reuptake, while MAOIs prevent the breakdown of serotonin. When these drugs are taken together, or when overdosed, they can lead to serotonin syndrome due to the excessive serotonergic activity. D. It is predictable and not idiosyncratic is correct. Serotonin syndrome is considered a predictable reaction resulting from excess serotonergic activity, rather than being an idiosyncratic reaction. It occurs when the dose of serotonergic medications exceeds the body’s ability to maintain normal serotonin levels, and it can be anticipated based on drug interactions or overdose. Therefore, it is not a rare, unpredictable reaction but rather a known adverse effect that can be managed if recognized early.",
      "correct_choice_id": 236835,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11944181698998249/11944181698998249.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11944181698998249/11944181698998249.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81214,
      "choices": [
        {
          "id": 236838,
          "text": "Met-enkephalins"
        },
        {
          "id": 236839,
          "text": "Epinephrine"
        },
        {
          "id": 236840,
          "text": "Leu-enkephalin"
        },
        {
          "id": 236841,
          "text": "Endorphins"
        }
      ],
      "text": "Which of the following is not an opioid peptide?",
      "unique_key": "Q9388760",
      "question_audio": null,
      "question_video": null,
      "map_id": 34054485,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Epinephrine. Epinephrine (also known as adrenaline) is a catecholamine hormone and neurotransmitter, not an opioid peptide. It is primarily involved in the body's fight-or-flight response and has no role in the opioid system. Epinephrine functions by increasing heart rate, blood pressure, and blood flow to muscles, but it does not act on opioid receptors. A. Met-enkephalins is incorrect because met-enkephalins are opioid peptides. These peptides are part of the body's natural pain-relieving system and bind to opioid receptors, producing effects similar to those of opiates. They are derived from the proenkephalin precursor and play a role in modulating pain. C. Leu-enkephalin is incorrect because leu-enkephalin is also an opioid peptide. Like met-enkephalins, leu-enkephalin is derived from the proenkephalin precursor and binds to opioid receptors, providing pain relief and regulating other physiological processes. D. Endorphins is incorrect because endorphins are also opioid peptides. They are produced by the pituitary gland and hypothalamus during activities like exercise or stress. Endorphins act on the opioid receptors to reduce pain and enhance feelings of pleasure, similar to the effects of opioids like morphine.",
      "correct_choice_id": 236839,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31277411698998263/31277411698998263.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31277411698998263/31277411698998263.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81215,
      "choices": [
        {
          "id": 236842,
          "text": "Lysergic acid diethylamide"
        },
        {
          "id": 236843,
          "text": "Phencyclidine"
        },
        {
          "id": 236844,
          "text": "Cocaine"
        },
        {
          "id": 236845,
          "text": "Mescaline"
        }
      ],
      "text": "All of the following are psychedelic drugs except:",
      "unique_key": "Q2275004",
      "question_audio": null,
      "question_video": null,
      "map_id": 34322473,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cocaine. Cocaine is a stimulant drug that primarily affects the dopamine system by inhibiting its reuptake, leading to increased dopamine levels in the brain. Unlike psychedelic drugs, which primarily alter perception, mood, and cognition through serotonin and other neurotransmitter systems, cocaine has a stimulant effect, causing increased alertness, energy, and euphoria, along with the potential for addiction and adverse cardiovascular effects. Cocaine does not typically produce the hallucinatory or perceptual distortions that are characteristic of psychedelics. A. Lysergic acid diethylamide (LSD) is incorrect because LSD is a classic psychedelic drug. It is a potent serotonergic compound that alters perception, mood, and thought processes, producing hallucinations and altered sensory experiences, which are hallmark effects of psychedelics. B. Phencyclidine (PCP) is incorrect because PCP is a dissociative anesthetic that, at higher doses, can produce hallucinations and a distorted sense of reality, effects that overlap with psychedelics. Though PCP acts on the NMDA receptor, which is distinct from the typical serotonergic activity of classical psychedelics, it still produces psychedelic-like effects such as delirium and dissociation. D. Mescaline is incorrect because mescaline is a naturally occurring psychedelic found in certain cactus species (e.g., peyote). It primarily acts on serotonin receptors, producing hallucinations, altered perception, and changes in mood and thought, which are characteristic effects of psychedelics.",
      "correct_choice_id": 236844,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70408191698999973/70408191698999973.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70408191698999973/70408191698999973.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81216,
      "choices": [
        {
          "id": 236846,
          "text": "Opium"
        },
        {
          "id": 236847,
          "text": "Cannabis"
        },
        {
          "id": 236848,
          "text": "Alcohol"
        },
        {
          "id": 236849,
          "text": "Amphetamine"
        }
      ],
      "text": "Widmark formula is used for",
      "unique_key": "Q5929118",
      "question_audio": null,
      "question_video": null,
      "map_id": 34982221,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Alcohol. The Widmark formula is used to estimate blood alcohol concentration (BAC), which helps determine the level of alcohol in a person's bloodstream after consumption. This formula considers factors such as the amount of alcohol consumed, the individual's body weight, and the volume of distribution to estimate the BAC. It is specifically designed for alcohol and helps in forensic and clinical settings to assess intoxication levels or alcohol overdose. A. Opium is incorrect because the Widmark formula does not apply to opium. Opium is derived from the poppy plant and contains various alkaloids such as morphine, codeine, and thebaine, but the formula is not used to assess the concentration of these substances in the body. B. Cannabis is incorrect because the Widmark formula is not used for cannabis. Cannabis is a psychoactive drug that contains compounds like THC (tetrahydrocannabinol), which affects the brain differently from alcohol. The pharmacokinetics of cannabis are more complex and do not follow the same principles as alcohol for calculating concentrations in the blood. D. Amphetamine is incorrect because the Widmark formula is not applicable to amphetamines. Amphetamines are stimulants that affect the dopamine and norepinephrine systems, and their blood concentration is determined differently, usually through urine tests or specific blood tests designed for these substances.",
      "correct_choice_id": 236848,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70240191698999996/70240191698999996.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70240191698999996/70240191698999996.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81217,
      "choices": [
        {
          "id": 236850,
          "text": "Morphine"
        },
        {
          "id": 236851,
          "text": "Diacetylmorphine"
        },
        {
          "id": 236852,
          "text": "Oxycodine"
        },
        {
          "id": 236853,
          "text": "Buprenorphine"
        }
      ],
      "text": "Most commonly abused opioid",
      "unique_key": "Q1085643",
      "question_audio": null,
      "question_video": null,
      "map_id": 34934217,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Diacetylmorphine (commonly known as heroin). Heroin is the most commonly abused opioid worldwide. It is a highly addictive drug that is derived from morphine, but it crosses the blood-brain barrier more quickly, leading to rapid euphoria. This makes it extremely popular among individuals who misuse opioids, contributing to the opioid epidemic. Heroin is often injected, smoked, or snorted, and its high potential for abuse, dependence, and overdose makes it a significant public health concern. A. Morphine is incorrect because while morphine is a powerful opioid and widely used for pain management, it is not as commonly abused as heroin. Morphine is generally prescribed in medical settings for pain relief, particularly in severe pain, such as post-surgery or cancer-related pain, and is less likely to be abused compared to heroin. C. Oxycodone is incorrect because although oxycodone (found in medications like OxyContin and Percocet) is frequently abused, it is still less commonly abused than heroin. Oxycodone is a prescription opioid used to treat moderate to severe pain, but its abuse is typically associated with individuals misusing prescription drugs, leading to issues like the opioid crisis. Despite this, heroin remains the more widely abused opioid overall. D. Buprenorphine is incorrect because buprenorphine is a partial agonist opioid used primarily for the treatment of opioid addiction (as part of medication-assisted treatment or MAT). While it has some abuse potential, it is much less commonly abused than heroin. Buprenorphine has a ceiling effect, meaning that beyond a certain dose, its effects plateau, reducing its potential for abuse and overdose.",
      "correct_choice_id": 236851,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16522831699000030/16522831699000030.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16522831699000030/16522831699000030.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81218,
      "choices": [
        {
          "id": 236854,
          "text": "Nihilism ideation"
        },
        {
          "id": 236855,
          "text": "Guilt ideation"
        },
        {
          "id": 236856,
          "text": "Suicidal ideation"
        },
        {
          "id": 236857,
          "text": "Envious ideation"
        }
      ],
      "text": "SSRIs should be carefully used in the young for the management of depression due to increase in",
      "unique_key": "Q4548038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34411023,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Suicidal ideation. SSRIs (Selective Serotonin Reuptake Inhibitors) are commonly prescribed to manage depression in both adults and young individuals. However, there is a well-established risk that SSRIs can increase the incidence of suicidal ideation (thoughts of suicide) and behaviors, particularly in children, adolescents, and young adults under the age of 25. This is a serious concern, and the FDA has issued a black box warning about the risk of suicidal thoughts and actions when starting treatment with SSRIs in this age group. Close monitoring is essential during the first few weeks of treatment to detect any worsening of depressive symptoms or emergence of suicidal thoughts. A. Nihilism ideation is incorrect because nihilism refers to the belief that life is meaningless or without purpose. While nihilistic thoughts may occur in severe depression, they are not specifically associated with SSRIs. The primary concern with SSRIs in the young is the increase in suicidal ideation, not nihilism. B. Guilt ideation is incorrect because guilt ideation refers to thoughts involving excessive feelings of guilt, often seen in depression. SSRIs can help reduce feelings of guilt in depressed patients, but they are not specifically associated with an increase in guilt ideation. The major concern with SSRIs in the young is the potential for suicidal ideation, not guilt. D. Envious ideation is incorrect because envious ideation is not a commonly discussed or recognized symptom in depression. SSRIs are not typically associated with an increase in envy, and this is not a recognized side effect or risk associated with their use in young individuals. The primary concern is suicidal ideation, not envy.",
      "correct_choice_id": 236856,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28924691699000089/28924691699000089.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28924691699000089/28924691699000089.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81219,
      "choices": [
        {
          "id": 236858,
          "text": "Lithium"
        },
        {
          "id": 236859,
          "text": "SSRI"
        },
        {
          "id": 236860,
          "text": "Valproate"
        },
        {
          "id": 236861,
          "text": "Antispsychotics"
        }
      ],
      "text": "Which of the following drugs is most commonly used to control “impulsivity” in a case of emotionally unstable personality disorder?",
      "unique_key": "Q2961094",
      "question_audio": null,
      "question_video": null,
      "map_id": 34077020,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Suicidal ideation. SSRIs (Selective Serotonin Reuptake Inhibitors) are commonly prescribed to manage depression in both adults and young individuals. However, there is a well-established risk that SSRIs can increase the incidence of suicidal ideation (thoughts of suicide) and behaviors, particularly in children, adolescents, and young adults under the age of 25. This is a serious concern, and the FDA has issued a black box warning about the risk of suicidal thoughts and actions when starting treatment with SSRIs in this age group. Close monitoring is essential during the first few weeks of treatment to detect any worsening of depressive symptoms or emergence of suicidal thoughts. A. Nihilism ideation is incorrect because nihilism refers to the belief that life is meaningless or without purpose. While nihilistic thoughts may occur in severe depression, they are not specifically associated with SSRIs. The primary concern with SSRIs in the young is the increase in suicidal ideation, not nihilism. B. Guilt ideation is incorrect because guilt ideation refers to thoughts involving excessive feelings of guilt, often seen in depression. SSRIs can help reduce feelings of guilt in depressed patients, but they are not specifically associated with an increase in guilt ideation. The major concern with SSRIs in the young is the potential for suicidal ideation, not guilt. D. Envious ideation is incorrect because envious ideation is not a commonly discussed or recognized symptom in depression. SSRIs are not typically associated with an increase in envy, and this is not a recognized side effect or risk associated with their use in young individuals. The primary concern is suicidal ideation, not envy.",
      "correct_choice_id": 236859,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54636881699000183/54636881699000183.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54636881699000183/54636881699000183.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81220,
      "choices": [
        {
          "id": 236862,
          "text": "Weight gain"
        },
        {
          "id": 236863,
          "text": "Weight loss"
        },
        {
          "id": 236864,
          "text": "Sedation"
        },
        {
          "id": 236865,
          "text": "Blurred vision"
        }
      ],
      "text": "Which of the following are side effects of mirtazapine?",
      "unique_key": "Q5432645",
      "question_audio": null,
      "question_video": null,
      "map_id": 34160909,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Sedation Mirtazapine causes sedation > weight gain.",
      "correct_choice_id": 236864,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11438871699003499/11438871699003499.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11438871699003499/11438871699003499.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81221,
      "choices": [
        {
          "id": 236866,
          "text": "Anticholinergic action"
        },
        {
          "id": 236867,
          "text": "Anti MAO (monoamine acid oxidasa) action"
        },
        {
          "id": 236868,
          "text": "Blocks 5 HT (serotonin) or NE (norepinephrine) reuptake"
        },
        {
          "id": 236869,
          "text": "Causes sedation"
        }
      ],
      "text": "Tricyclic antidepressants have all of the following actions except:",
      "unique_key": "Q2257548",
      "question_audio": null,
      "question_video": null,
      "map_id": 34037139,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Anti MAO (monoamine oxidase) action. Tricyclic antidepressants (TCAs) primarily work by blocking the reuptake of serotonin (5-HT) and norepinephrine (NE), thus increasing the levels of these neurotransmitters in the synaptic cleft. However, TCAs do not inhibit monoamine oxidase (MAO), which is the action of a different class of antidepressants called MAO inhibitors. Therefore, the anti-MAO action is not a characteristic of TCAs. A. Anticholinergic action is incorrect because TCAs are well-known for their anticholinergic effects, which include dry mouth, blurred vision, constipation, urinary retention, and cognitive disturbances. These side effects arise from the TCA’s ability to block muscarinic acetylcholine receptors. C. Blocks 5 HT (serotonin) or NE (norepinephrine) reuptake is incorrect because this is the primary action of tricyclic antidepressants. By blocking the reuptake of serotonin and norepinephrine, TCAs increase the levels of these neurotransmitters in the synaptic cleft, which helps alleviate symptoms of depression. D. Causes sedation is incorrect because TCAs often cause sedation, especially at higher doses. This occurs due to the blockade of histamine receptors, which leads to drowsiness or sleepiness as a common side effect of the medication.",
      "correct_choice_id": 236867,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23563871699003516/23563871699003516.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23563871699003516/23563871699003516.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81222,
      "choices": [
        {
          "id": 236870,
          "text": "Glaucoma"
        },
        {
          "id": 236871,
          "text": "Brain tumor"
        },
        {
          "id": 236872,
          "text": "Bronchial asthma"
        },
        {
          "id": 236873,
          "text": "Hypertension"
        }
      ],
      "text": "Tricyclic antidepressant are contraindicated in",
      "unique_key": "Q7553077",
      "question_audio": null,
      "question_video": null,
      "map_id": 34896556,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Glaucoma. Tricyclic antidepressants (TCAs) are contraindicated in patients with glaucoma, particularly narrow-angle glaucoma, due to their anticholinergic effects. TCAs block muscarinic receptors, which can reduce the outflow of aqueous humor from the eye, leading to an increase in intraocular pressure. This can exacerbate glaucoma and potentially lead to acute angle-closure glaucoma, which is a medical emergency. Therefore, TCAs should be avoided in patients with this condition. B. Brain tumor is incorrect because TCAs are not specifically contraindicated in brain tumor. However, caution should be exercised in any patient with a central nervous system (CNS) condition, as TCAs can cause sedation and confusion, which may complicate the clinical picture. Still, brain tumor is not an absolute contraindication. C. Bronchial asthma is incorrect because TCAs are not strictly contraindicated in bronchial asthma. While TCAs do have anticholinergic effects that may cause mild bronchoconstriction in sensitive individuals, this is not a common contraindication. However, caution is warranted in asthmatic patients, especially those with poorly controlled symptoms, due to the potential for respiratory side effects. D. Hypertension is incorrect because TCAs are not directly contraindicated in hypertension. In fact, some TCAs can cause orthostatic hypotension (low blood pressure upon standing), which can be beneficial in hypertensive patients. However, TCAs should still be used with caution in individuals with pre-existing cardiovascular issues, as they can affect heart rate and conduction.",
      "correct_choice_id": 236870,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77949291699003736/77949291699003736.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77949291699003736/77949291699003736.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81223,
      "choices": [
        {
          "id": 236874,
          "text": "Fluoxetine"
        },
        {
          "id": 236875,
          "text": "Mirtazapine"
        },
        {
          "id": 236876,
          "text": "Bupropion"
        },
        {
          "id": 236877,
          "text": "None"
        }
      ],
      "text": "Which of the following medicines are associated with side effect of sexual dysfunction?",
      "unique_key": "Q9928581",
      "question_audio": null,
      "question_video": null,
      "map_id": 34930828,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Fluoxetine. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is known to be associated with sexual dysfunction as a common side effect. This can include decreased libido, delayed ejaculation, anorgasmia (inability to orgasm), and other sexual issues. SSRIs, including fluoxetine, increase serotonin levels in the brain, and while this can be beneficial for mood regulation, it can interfere with sexual arousal and function, making sexual side effects one of the major concerns for patients on SSRIs. B. Mirtazapine is incorrect because, while it has various side effects, sexual dysfunction is not one of the most common ones. Mirtazapine is an atypical antidepressant that works by increasing both serotonin and norepinephrine. It is more commonly associated with sedation, weight gain, and increased appetite, but sexual dysfunction is not a major issue with mirtazapine. C. Bupropion is incorrect because it is less likely to cause sexual dysfunction compared to other antidepressants. In fact, bupropion is often prescribed when sexual dysfunction is a concern with other antidepressants like SSRIs. Bupropion primarily affects dopamine and norepinephrine and does not have significant serotonergic effects, which is why it has a lower incidence of sexual side effects. D. None is incorrect because, as explained above, fluoxetine (an SSRI) is associated with sexual dysfunction as a side effect, making this option incorrect.",
      "correct_choice_id": 236874,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78342331699003816/78342331699003816.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78342331699003816/78342331699003816.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81224,
      "choices": [
        {
          "id": 236878,
          "text": "Completely reversible after stopping the drug"
        },
        {
          "id": 236879,
          "text": "Partially reversible"
        },
        {
          "id": 236880,
          "text": "Irreversible"
        },
        {
          "id": 236881,
          "text": "None of the above"
        }
      ],
      "text": "Sexual side effects caused by SSRI are?",
      "unique_key": "Q5458990",
      "question_audio": null,
      "question_video": null,
      "map_id": 34810803,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Completely reversible after stopping the drug. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression and anxiety, but they can have sexual side effects, such as reduced libido, delayed orgasm, and erectile dysfunction. Fortunately, these side effects are generally completely reversible after discontinuing the medication. Once the SSRI is stopped, serotonin levels return to normal, and sexual function typically returns to baseline over time, though this process may vary between individuals. Most patients experience improvement once the drug is cleared from the system. Now, for the incorrect answers: B. Partially reversible: This option is incorrect because, in most cases, sexual side effects caused by SSRIs are fully reversible. While some individuals may experience a prolonged recovery period, complete reversibility is the norm once the medication is stopped. Therefore, \"partially reversible\" is not a correct description of the typical outcomes. C. Irreversible: This option is also incorrect because SSRIs do not cause permanent sexual dysfunction. Although the side effects can be bothersome, they are not permanent and generally resolve after discontinuation of the drug. Cases of irreversible sexual dysfunction are exceedingly rare and typically involve other underlying health factors. D. None of the above: This is incorrect because option A, \"completely reversible,\" is the correct answer. Since SSRIs’ sexual side effects are generally reversible after stopping the drug, this option does not apply.",
      "correct_choice_id": 236878,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38229331699003839/38229331699003839.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38229331699003839/38229331699003839.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81225,
      "choices": [
        {
          "id": 236882,
          "text": "Lithium"
        },
        {
          "id": 236883,
          "text": "Lamotrigine"
        },
        {
          "id": 236884,
          "text": "Valproate"
        },
        {
          "id": 236885,
          "text": "Carbamazepine"
        }
      ],
      "text": "What is the mood stabilizer of choice in a case of bipolar with predominant depressed polarity?",
      "unique_key": "Q9284870",
      "question_audio": null,
      "question_video": null,
      "map_id": 34007650,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Lamotrigine. In cases of bipolar disorder with a predominant depressive polarity, lamotrigine is often considered the mood stabilizer of choice. Lamotrigine has been shown to be particularly effective in preventing depressive episodes in bipolar disorder, making it an ideal option for individuals with a depressive predominant polarity. It works by modulating glutamate release and stabilizing mood without the risk of inducing mania, which can sometimes occur with other mood stabilizers. Now, for the incorrect answers: A. Lithium: Lithium is one of the classic mood stabilizers and is very effective in treating manic episodes and preventing both manic and depressive relapses in bipolar disorder. However, in cases where depression is the predominant polarity, lithium can sometimes worsen depressive symptoms or be less effective at managing depressive episodes specifically. While it can still be used, it's not the first choice when depressive symptoms dominate. C. Valproate: Valproate (or valproic acid) is effective in treating acute mania and preventing manic episodes, but it is not typically preferred for bipolar depression. It may have a sedative effect and can be effective in mixed states or manic episodes but is less effective for long-term prevention of depressive episodes compared to lamotrigine. D. Carbamazepine: Carbamazepine is used in the treatment of bipolar disorder, especially for mania, but like valproate, it is not as effective for bipolar depression. It has a more significant role in managing manic and mixed episodes, and its use in bipolar depression is limited, making it a less appropriate option for predominant depressive polarity.",
      "correct_choice_id": 236883,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68224611699003851/68224611699003851.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68224611699003851/68224611699003851.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81226,
      "choices": [
        {
          "id": 236886,
          "text": "Epoprostrenol"
        },
        {
          "id": 236887,
          "text": "Alprostadil"
        },
        {
          "id": 236888,
          "text": "Sildenafil"
        },
        {
          "id": 236889,
          "text": "Tadalafil"
        }
      ],
      "text": "Which drug is used in intracavernous injection for erectile dysfunction?",
      "unique_key": "Q7606143",
      "question_audio": null,
      "question_video": null,
      "map_id": 34272973,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Alprostadil. Alprostadil is the drug commonly used in intracavernous injections for erectile dysfunction. It is a prostaglandin E1 (PGE1) analog that works by increasing blood flow to the penis, which helps to induce and maintain an erection. When injected directly into the cavernous tissue of the penis, alprostadil causes smooth muscle relaxation and vasodilation, which is particularly useful for individuals who do not respond to oral medications like sildenafil. Now, for the incorrect answers: A. Epoprostenol: Epoprostenol is another prostacyclin analogue, but it is primarily used in the treatment of pulmonary hypertension, not erectile dysfunction. While it has vasodilatory effects, it is not typically used for erectile dysfunction and is not indicated for intracavernous injections for this purpose. C. Sildenafil: Sildenafil is an oral medication (commonly known as Viagra) used to treat erectile dysfunction, but it is not used for intracavernous injections. Sildenafil works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which increases the effects of nitric oxide and helps to relax the smooth muscles and increase blood flow to the penis. However, it is taken orally and not through injection. D. Tadalafil: Tadalafil (known as Cialis) is also an oral medication used to treat erectile dysfunction. It works similarly to sildenafil by inhibiting PDE5 to enhance erectile function. Like sildenafil, it is not used in intracavernous injections but is taken orally for erectile dysfunction management.",
      "correct_choice_id": 236887,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28756891699003861/28756891699003861.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28756891699003861/28756891699003861.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81227,
      "choices": [
        {
          "id": 236890,
          "text": "Clonidine"
        },
        {
          "id": 236891,
          "text": "Methylphenidate"
        },
        {
          "id": 236892,
          "text": "Atomoxetine"
        },
        {
          "id": 236893,
          "text": "Phenobarbitone"
        }
      ],
      "text": "Which of the following drug is not given in ADHD?",
      "unique_key": "Q8008936",
      "question_audio": null,
      "question_video": null,
      "map_id": 34707352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Phenobarbitone. Phenobarbitone (also known as phenobarbital) is not used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). It is a barbiturate primarily used as an anticonvulsant and for managing seizures. While it has sedative properties, it is not effective for managing the core symptoms of ADHD, such as inattention, hyperactivity, and impulsivity. Therefore, phenobarbitone is not a medication used in ADHD treatment. Now, for the incorrect answers: A. Clonidine: Clonidine is an alpha-2 adrenergic agonist that is used as an adjunctive treatment for ADHD, especially for managing symptoms like hyperactivity and impulsivity. It can be particularly helpful for children who do not respond to first-line stimulants or have associated problems like tics or sleep disturbances. B. Methylphenidate: Methylphenidate is one of the most commonly prescribed stimulant medications for ADHD. It works by increasing the levels of dopamine and norepinephrine in the brain, which helps improve attention, focus, and impulse control in individuals with ADHD. It is a first-line treatment for ADHD. C. Atomoxetine: Atomoxetine is a non-stimulant medication used to treat ADHD. It works by selectively inhibiting the reuptake of norepinephrine, improving attention and impulse control. Atomoxetine is often used when stimulant medications are ineffective or cause unacceptable side effects.",
      "correct_choice_id": 236893,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74584311699003933/74584311699003933.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74584311699003933/74584311699003933.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81228,
      "choices": [
        {
          "id": 236894,
          "text": "Dyskinesia"
        },
        {
          "id": 236895,
          "text": "Hyperphagia"
        },
        {
          "id": 236896,
          "text": "Hyperpathia"
        },
        {
          "id": 236897,
          "text": "Hypomania"
        }
      ],
      "text": "What is produced by the supersensitivity of dopamine receptors?",
      "unique_key": "Q2609599",
      "question_audio": null,
      "question_video": null,
      "map_id": 34027807,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Dyskinesia. Dyskinesia refers to abnormal, involuntary movements, and is often seen as a result of dopamine receptor supersensitivity, particularly in patients with Parkinson's disease or those undergoing long-term treatment with dopaminergic medications (like levodopa). Dopamine receptor supersensitivity occurs when the brain's dopamine receptors become overly responsive due to chronic dopaminergic stimulation or depletion. This increased sensitivity can lead to the development of involuntary movements, such as tremors, tics, and chorea, which are collectively referred to as dyskinesia. Now, for the incorrect answers: B. Hyperphagia: Hyperphagia refers to excessive eating or overeating, often seen in conditions such as certain eating disorders or in response to damage to the hypothalamus. It is not directly related to dopamine receptor supersensitivity, though dopamine plays a role in regulating appetite and reward. Hyperphagia is not a typical consequence of dopamine receptor supersensitivity. C. Hyperpathia: Hyperpathia is a condition characterized by an exaggerated response to pain, often with a prolonged or heightened painful sensation. It is usually associated with nerve damage or certain neurological conditions, rather than dopamine receptor supersensitivity. It does not involve the abnormal movement patterns seen in dyskinesia. D. Hypomania: Hypomania refers to a mildly elevated mood state, typically associated with bipolar disorder. It involves increased energy, impulsivity, and activity but does not directly result from dopamine receptor supersensitivity. While dopamine plays a role in mood regulation, hypomania is not a typical consequence of altered dopamine receptor function.",
      "correct_choice_id": 236894,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56103801699003956/56103801699003956.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56103801699003956/56103801699003956.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81229,
      "choices": [
        {
          "id": 236898,
          "text": "Thioridazine"
        },
        {
          "id": 236899,
          "text": "Clozapine"
        },
        {
          "id": 236900,
          "text": "Chlorpromazine"
        },
        {
          "id": 236901,
          "text": "None of the above"
        },
        {
          "id": 236902,
          "text": "Extra questions"
        }
      ],
      "text": "Antipsychotic drug causing retinal pigmentation disorder is:",
      "unique_key": "Q8045186",
      "question_audio": null,
      "question_video": null,
      "map_id": 34298366,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Thioridazine. Thioridazine is an antipsychotic drug that is known to cause retinal pigmentation, a condition in which the retina develops abnormal pigmentation, which can impair vision. This side effect is dose-dependent and has been associated with long-term use of thioridazine. The retinal changes are typically detected by fundoscopic examination, and in severe cases, they may lead to permanent vision problems. As a result, thioridazine is used less frequently today, with other antipsychotics being preferred. Now, for the incorrect answers: B. Clozapine: Clozapine is an atypical antipsychotic known for its effectiveness in treatment-resistant schizophrenia, but it does not cause retinal pigmentation. Clozapine's main side effects are agranulocytosis (a dangerous reduction in white blood cells), sedation, and weight gain, rather than retinal changes. C. Chlorpromazine: Chlorpromazine is another first-generation antipsychotic, but it is not commonly associated with retinal pigmentation. It may cause other side effects such as sedation, hypotension, and extrapyramidal symptoms (movement disorders), but retinal pigmentation is not a typical adverse effect. D. None of the above: This option is incorrect because thioridazine, listed in option A, is known to cause retinal pigmentation, making \"none of the above\" an inappropriate choice.",
      "correct_choice_id": 236898,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30006671699003970/30006671699003970.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30006671699003970/30006671699003970.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81230,
      "choices": [
        {
          "id": 236903,
          "text": "It is caused by contractions of muscles resulting in abnormal movements of postures"
        },
        {
          "id": 236904,
          "text": "Characteristically these symptoms appear early in treatment with neuroleptics"
        },
        {
          "id": 236905,
          "text": "Young men appear to be at increased risk"
        },
        {
          "id": 236906,
          "text": "It is a benign condition"
        }
      ],
      "text": "Which of the following is incorrect about neuroleptic induced dystonia",
      "unique_key": "Q6247447",
      "question_audio": null,
      "question_video": null,
      "map_id": 34051446,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) It is a benign condition Acute dystonia may cause impaired swallowing or breathing ; laryngeal - pharyngeal spasm may necessitate urgent intervention. It may also cause oculogyric crises, with the eyes deviated, spasms of the jaw causing trismus or grimacing, difficulties with speech, or abnormal positioning of the head (torticollis), trunk, or limbs Onset is usually within 24 to 48 hours of starting a neuroleptic or after increases in dosage of such agents. treatment of acute dystonic reactions includes immediate intramuscular (Intravenous if laryngeal spasm) infections of antiparkinsonian agents such benztropine or diphenhydramine HCL. Risk factors include being young, male use of high- potency neuroleptics and high doses and parenteral administration of neuroleptics",
      "correct_choice_id": 236906,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75731951699003983/75731951699003983.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75731951699003983/75731951699003983.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81231,
      "choices": [
        {
          "id": 236907,
          "text": "It may be misdiagnosed as psychotic agitation or anxiety."
        },
        {
          "id": 236908,
          "text": "Middle-aged women appear to be at increased risk"
        },
        {
          "id": 236909,
          "text": "Beta-blockers, benzodiazepines, anti- cholinergic agents should be continued"
        },
        {
          "id": 236910,
          "text": "It may occurs in up to 30% of patient taking neuroleptics"
        }
      ],
      "text": "Which of the following is not true concerning neuroleptic- induced akathisia:",
      "unique_key": "Q6755913",
      "question_audio": null,
      "question_video": null,
      "map_id": 34682443,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Beta-blockers, benzodiazepines, anti-cholinergic agents should be continued. Neuroleptic-induced akathisia is a movement disorder characterized by restlessness, agitation, and an inability to sit still, which is commonly seen in patients taking antipsychotic medications (neuroleptics). In treating akathisia, it's important to avoid continuing beta-blockers, benzodiazepines, and anti-cholinergic agents as primary treatments for this condition, as they can often be ineffective or exacerbate the symptoms. Beta-blockers (like propranolol) and benzodiazepines can be helpful for some patients in managing the symptoms, but they are not the first-line treatments. In fact, adjusting the antipsychotic medication (such as reducing the dose or switching to a different one) is typically more effective. Anti-cholinergic agents, commonly used for managing extrapyramidal symptoms, do not address the core features of akathisia and might worsen the symptoms. Now, for the incorrect answers: A. It may be misdiagnosed as psychotic agitation or anxiety: This is true. Neuroleptic-induced akathisia can often be mistaken for psychotic agitation or anxiety because the symptoms—restlessness, agitation, pacing—are similar to those seen in these other conditions. Distinguishing akathisia from anxiety or agitation is important for proper treatment and management. B. Middle-aged women appear to be at increased risk: This is also true. Studies have shown that middle-aged women are at a higher risk for developing neuroleptic-induced akathisia, likely due to hormonal factors or other gender-related biological differences. Therefore, they are more susceptible to this side effect than other demographic groups. D. It may occur in up to 30% of patients taking neuroleptics: This is true as well. Neuroleptic-induced akathisia is a relatively common side effect of antipsychotic drugs, affecting up to 30% of patients depending on the drug and its dose. It is an important consideration for clinicians when prescribing these medications.",
      "correct_choice_id": 236909,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78917981699003995/78917981699003995.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78917981699003995/78917981699003995.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81232,
      "choices": [
        {
          "id": 236911,
          "text": "It is characterized by the triad of akinesia, muscle rigidity and tremor."
        },
        {
          "id": 236912,
          "text": "It is caused by postsynaptic D2 receptor blockade in the basal ganglia"
        },
        {
          "id": 236913,
          "text": "The tremor is seen at rest"
        },
        {
          "id": 236914,
          "text": "Tremor only affects the limbs"
        }
      ],
      "text": "Which of the following is false about neuroleptic induced parkinsonism:",
      "unique_key": "Q2756340",
      "question_audio": null,
      "question_video": null,
      "map_id": 34508054,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Tremor only affects the limbs The tremor may affect the limbs, head, mouth or even lips (rabbit syndrome) it may be intermittent, and sometimes can be suppressed by the patient. It is three to six cycles per second and is most no- ticeable at rest. Tremor is less common than muscle rigidity and akinesia (lack of spontaneous motor activity. Clinically it is identical to idiopathic Parkinsonism. the muscle rigidity may be continuous (lead –pipe) or cogwheel (ratchet like) in nature. the blockade of D2 receptor caus- es an imbalance between dopamine and acetylcholine. Prophylactic use of antipar- kinsonian agent remain controversial but should probably be used in those at known risk and tapered as soon as possible. Oth- erwise, consider lowering the neuroleptic dose, changing the neuroleptic, using low – dose antiparkinsonian agents",
      "correct_choice_id": 236914,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43591871699004020/43591871699004020.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43591871699004020/43591871699004020.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81233,
      "choices": [
        {
          "id": 236915,
          "text": "Clozapine"
        },
        {
          "id": 236916,
          "text": "Olanzapine"
        },
        {
          "id": 236917,
          "text": "Ziprasidone"
        },
        {
          "id": 236918,
          "text": "Haloperidol"
        }
      ],
      "text": "Patients using which of the following drugs is least likely to cause neuroleptic malignant syndrome? (NIMHANS 2015)",
      "unique_key": "Q5525228",
      "question_audio": null,
      "question_video": null,
      "map_id": 34121434,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Clozapine. Clozapine is the least likely antipsychotic to cause neuroleptic malignant syndrome (NMS). NMS is a rare but life-threatening condition associated with the use of antipsychotic medications, characterized by symptoms such as hyperthermia, muscle rigidity, altered mental status, and autonomic dysregulation. Clozapine, an atypical antipsychotic, has a lower risk of inducing NMS compared to other antipsychotics. This is because it has a unique receptor-binding profile and tends to cause fewer extrapyramidal side effects, which are thought to contribute to NMS. However, clozapine still requires careful monitoring due to other potential risks, such as agranulocytosis. Now, for the incorrect answers: B. Olanzapine: Olanzapine is another atypical antipsychotic that, while generally associated with a lower risk of NMS compared to first-generation antipsychotics, still carries a risk of NMS. Olanzapine can cause sedation, weight gain, and metabolic disturbances but is more likely than clozapine to lead to NMS, especially at higher doses or in combination with other medications that affect dopamine. C. Ziprasidone: Ziprasidone, another atypical antipsychotic, has been associated with a risk of NMS, although this risk is lower than with first-generation antipsychotics like haloperidol. It is less likely to cause NMS than some other atypicals like olanzapine, but it still remains a risk, especially when dosages are increased rapidly or in susceptible individuals. D. Haloperidol: Haloperidol, a first-generation antipsychotic (typical antipsychotic), is strongly associated with an increased risk of neuroleptic malignant syndrome. Due to its potent dopamine receptor antagonism, especially at higher doses, haloperidol can increase the likelihood of developing NMS. It is considered one of the antipsychotics with the highest risk for this severe side effect.",
      "correct_choice_id": 236915,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26687241699004033/26687241699004033.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26687241699004033/26687241699004033.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81234,
      "choices": [
        {
          "id": 236919,
          "text": "Autonomic dysregulation"
        },
        {
          "id": 236920,
          "text": "Hypothermia"
        },
        {
          "id": 236921,
          "text": "Muscle rigidity"
        },
        {
          "id": 236922,
          "text": "Catatonia and stupor"
        }
      ],
      "text": "Which of the following is NOT a symptom of neuroleptic malignant syndrome?",
      "unique_key": "Q5422108",
      "question_audio": null,
      "question_video": null,
      "map_id": 34045183,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hypothermia. Hypothermia is not a symptom of neuroleptic malignant syndrome (NMS). In fact, one of the hallmark features of NMS is hyperthermia, or an elevated body temperature (often above 40°C or 104°F). NMS is a life-threatening condition often caused by antipsychotic medications, and it leads to muscle rigidity, autonomic dysregulation, altered mental status, and hyperthermia—not hypothermia. Hypothermia is typically associated with different conditions such as exposure to cold environments, or other metabolic or neurological disorders, but it does not occur in NMS. Now, for the incorrect answers: A. Autonomic dysregulation: This is a classic symptom of NMS. It includes signs like fluctuating blood pressure, tachycardia, labile heart rate, and diaphoresis (sweating). Autonomic instability is a central feature of NMS due to the dysfunction in the autonomic nervous system caused by dopaminergic blockade. C. Muscle rigidity: Muscle rigidity is one of the hallmark symptoms of NMS. It typically presents as \"lead-pipe\" rigidity, which is a constant, severe muscle stiffness. This symptom is crucial for diagnosing NMS, as it reflects the profound dysfunction in the central nervous system caused by antipsychotic drugs. D. Catatonia and stupor: These are also common symptoms of NMS. Patients may exhibit catatonic behaviors, including immobility, lack of speech, and unresponsiveness, as well as stupor (a state of near-unconsciousness or lack of responsiveness). These symptoms result from the central nervous system dysfunction caused by neuroleptic drugs.",
      "correct_choice_id": 236920,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73759781699004046/73759781699004046.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73759781699004046/73759781699004046.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81235,
      "choices": [
        {
          "id": 236923,
          "text": "Clozapine"
        },
        {
          "id": 236924,
          "text": "Olanzapine"
        },
        {
          "id": 236925,
          "text": "Ziprasidone"
        },
        {
          "id": 236926,
          "text": "Haloperidol"
        }
      ],
      "text": "Patients using which of the following drugs are at greatest risk of develop- ment of neuroleptic malignant syn- drome? (NIMHANS 2013)",
      "unique_key": "Q5444759",
      "question_audio": null,
      "question_video": null,
      "map_id": 34232686,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Haloperidol. Haloperidol, a first-generation (typical) antipsychotic, is associated with the greatest risk for neuroleptic malignant syndrome (NMS). This drug is a potent dopamine antagonist, and its strong effect on dopamine receptors, especially in the basal ganglia, can lead to the severe side effect of NMS, a potentially life-threatening condition. NMS is characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic dysregulation, and haloperidol has a higher incidence of these symptoms compared to other antipsychotics, particularly when used at high doses or in combination with other medications that affect the dopaminergic system. Now, for the incorrect answers: A. Clozapine: Clozapine is an atypical antipsychotic and, while it has its own set of serious side effects (such as agranulocytosis), it has a lower risk of causing NMS compared to typical antipsychotics like haloperidol. Clozapine is less likely to induce NMS due to its different pharmacological profile, which involves a weaker dopaminergic blockade and a more balanced effect on neurotransmitter systems. B. Olanzapine: Olanzapine, also an atypical antipsychotic, has a lower risk of causing NMS compared to haloperidol. While it does carry some risk for NMS (especially in high doses or in susceptible individuals), this risk is significantly lower than with first-generation antipsychotics. Olanzapine tends to cause fewer extrapyramidal symptoms and has a more favorable side effect profile than typical antipsychotics. C. Ziprasidone: Ziprasidone is another atypical antipsychotic with a lower risk of inducing NMS. Like olanzapine and clozapine, it has a different mechanism of action that results in fewer extrapyramidal side effects and a reduced likelihood of NMS. While it still carries some risk for this rare condition, it is much lower than with drugs like haloperidol.",
      "correct_choice_id": 236926,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75459761699004065/75459761699004065.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75459761699004065/75459761699004065.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81236,
      "choices": [
        {
          "id": 236927,
          "text": "0.2-0.8 mEq/L"
        },
        {
          "id": 236928,
          "text": "0.7-1.2 mEq/L"
        },
        {
          "id": 236929,
          "text": "1.2-2.0 mEq/L"
        },
        {
          "id": 236930,
          "text": "2.0-2.5 mEq/L"
        }
      ],
      "text": "Prophylactic maintenance serum levels of lithium is:",
      "unique_key": "Q4267844",
      "question_audio": null,
      "question_video": null,
      "map_id": 34726914,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 0.2-0.8 mEq/L. The prophylactic maintenance serum level of lithium for individuals with bipolar disorder is generally maintained between 0.2-0.8 mEq/L. This range is considered optimal for preventing mood episodes, particularly mania, while minimizing the risk of lithium toxicity. Keeping the serum level in this lower therapeutic range helps achieve a balance between efficacy in mood stabilization and safety, as lithium has a narrow therapeutic index. Now, for the incorrect answers: B. 0.7-1.2 mEq/L: While this range is commonly used for acute treatment of manic episodes or when a higher level of lithium is required for mood stabilization, it is too high for prophylactic maintenance. Chronic maintenance therapy typically requires lower serum levels to avoid side effects like tremors, renal impairment, and thyroid dysfunction. C. 1.2-2.0 mEq/L: This serum range is generally considered too high for maintenance therapy and is associated with a significant risk of lithium toxicity. Levels above 1.2 mEq/L can lead to adverse effects like gastrointestinal issues, tremors, confusion, and, in severe cases, renal failure or coma. D. 2.0-2.5 mEq/L: This range represents a toxic level of lithium. At these levels, there is a high risk of life-threatening toxicity, including symptoms like severe nausea, vomiting, ataxia, convulsions, and even death. This is far beyond the appropriate therapeutic range for maintenance treatment.",
      "correct_choice_id": 236927,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58823351699004078/58823351699004078.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58823351699004078/58823351699004078.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81237,
      "choices": [
        {
          "id": 236931,
          "text": "Fluoxetine"
        },
        {
          "id": 236932,
          "text": "Lithium"
        },
        {
          "id": 236933,
          "text": "Carbamazepine"
        },
        {
          "id": 236934,
          "text": "Risperidone"
        }
      ],
      "text": "Which of the following drugs is mostly used to decrease the suicidal tendency in bipolar disorder? (NIMHANS 2015)",
      "unique_key": "Q1822084",
      "question_audio": null,
      "question_video": null,
      "map_id": 34013005,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Lithium. Lithium is the drug most commonly used to decrease the suicidal tendency in bipolar disorder. Multiple studies have demonstrated that lithium is effective not only in stabilizing mood and preventing manic and depressive episodes but also in significantly reducing the risk of suicide in patients with bipolar disorder. Lithium's effectiveness in preventing suicidal behavior is one of the key benefits that distinguish it from other mood stabilizers. It is the most well-established treatment for reducing the risk of suicide in this population. Now, for the incorrect answers: A. Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and is commonly used to treat depression. While it can be helpful for managing depressive episodes in bipolar disorder, it has not been shown to specifically reduce suicidal tendencies. In fact, antidepressants like fluoxetine can sometimes increase the risk of suicidal thoughts in young adults, particularly during the initial treatment phase. C. Carbamazepine: Carbamazepine is another mood stabilizer used in bipolar disorder, particularly for controlling mania and preventing mood swings. However, there is limited evidence to suggest that carbamazepine is specifically effective in reducing suicidal tendencies. Lithium has a more proven track record in this regard, which is why it is preferred when suicide prevention is a priority. D. Risperidone: Risperidone is an atypical antipsychotic used for the treatment of manic episodes and psychotic symptoms in bipolar disorder. While it can be effective for controlling mania and psychosis, it is not primarily used to decrease suicidal tendencies. Antipsychotics are generally not the first-line treatment for reducing suicide risk in bipolar disorder.",
      "correct_choice_id": 236932,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14969871699004091/14969871699004091.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14969871699004091/14969871699004091.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81238,
      "choices": [
        {
          "id": 236935,
          "text": "Elated mania"
        },
        {
          "id": 236936,
          "text": "In renal compromise"
        },
        {
          "id": 236937,
          "text": "Dysphoric mania"
        },
        {
          "id": 236938,
          "text": "Mania with psychosis"
        }
      ],
      "text": "Valproate is preferred over lithium in all of the following conditions except. (NIMHANS 2014)",
      "unique_key": "Q6628419",
      "question_audio": null,
      "question_video": null,
      "map_id": 34889307,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Elated mania. Valproate is preferred over lithium in several conditions because of its more favorable side effect profile in certain situations, but elated mania is not one of those conditions where valproate is preferred over lithium. In elated mania, where the patient exhibits elevated mood, high energy, and potentially impulsive behavior, lithium is actually preferred because it is particularly effective for euphoric or elated types of mania. Lithium has a proven track record in acute mania, especially for elated mania, because it stabilizes mood and has a strong anti-manic effect. Now, let's evaluate the incorrect options: B. In renal compromise: Valproate is preferred over lithium in patients with renal compromise. Lithium requires careful monitoring of kidney function due to its potential nephrotoxic effects. Valproate, on the other hand, does not carry the same risk of kidney dysfunction, making it a safer option in patients with renal impairment. C. Dysphoric mania: Valproate is often preferred in cases of dysphoric mania, which is characterized by irritability, mood swings, and distressing symptoms. Valproate has better efficacy in managing the mixed or dysphoric type of mania compared to lithium, making it the first-line choice in such cases. D. Mania with psychosis: Valproate is preferred in patients with mania associated with psychosis because it has strong mood-stabilizing properties and can address the psychotic symptoms associated with manic episodes. While lithium is effective for mood stabilization, valproate is generally considered a better option for patients with both mania and psychosis, as it has antipsychotic properties and a faster onset of action.",
      "correct_choice_id": 236935,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48532051699004105/48532051699004105.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48532051699004105/48532051699004105.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81239,
      "choices": [
        {
          "id": 236939,
          "text": "Tofisopam"
        },
        {
          "id": 236940,
          "text": "Haloperidol"
        },
        {
          "id": 236941,
          "text": "Alprazolam"
        },
        {
          "id": 236942,
          "text": "Sertraline"
        }
      ],
      "text": "Which of the following is NOT an anxiolytic drug?",
      "unique_key": "Q9247400",
      "question_audio": null,
      "question_video": null,
      "map_id": 34771057,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Haloperidol. Haloperidol is not an anxiolytic drug. It is an antipsychotic medication primarily used for the treatment of schizophrenia, acute psychosis, and in some cases, for severe agitation or tics. Haloperidol works by blocking dopamine receptors in the brain, but it does not have the calming or anxiety-reducing effects that are characteristic of anxiolytic drugs. While it may be used in certain psychiatric settings, it is not prescribed for anxiety management. Now, for the incorrect answers: A. Tofisopam: Tofisopam is an anxiolytic drug. It is a non-benzodiazepine medication used for treating anxiety and has mild sedative and anti-anxiety effects without the sedative properties typically seen with other anxiolytics like benzodiazepines. It acts on the central nervous system to help alleviate anxiety symptoms. C. Alprazolam: Alprazolam is a benzodiazepine and a well-known anxiolytic. It is commonly prescribed for the short-term relief of anxiety and panic disorders. Alprazolam works by enhancing the effect of a neurotransmitter called GABA in the brain, which has a calming effect on the nervous system, helping to reduce anxiety. D. Sertraline: Sertraline is an SSRI (Selective Serotonin Reuptake Inhibitor) and is used as an anxiolytic as well as an antidepressant. It is commonly prescribed for generalized anxiety disorder, panic disorder, and other anxiety-related conditions. By increasing serotonin levels in the brain, sertraline helps to reduce anxiety and improve mood.",
      "correct_choice_id": 236940,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53975741699004117/53975741699004117.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53975741699004117/53975741699004117.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81240,
      "choices": [
        {
          "id": 236943,
          "text": "Renal failure"
        },
        {
          "id": 236944,
          "text": "Aspiration"
        },
        {
          "id": 236945,
          "text": "Infection"
        },
        {
          "id": 236946,
          "text": "Stroke"
        }
      ],
      "text": "Complications of NMS may include all of the following except",
      "unique_key": "Q9362206",
      "question_audio": null,
      "question_video": null,
      "map_id": 34455260,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Stroke. Stroke is not typically considered a complication of neuroleptic malignant syndrome (NMS). NMS is a life-threatening reaction to antipsychotic medications, primarily characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic dysregulation. While it is a serious medical emergency, stroke is not one of the primary complications directly linked to NMS. The complications of NMS usually arise from the physical effects of the syndrome itself, such as organ failure or infections, rather than from a stroke. Now, for the incorrect answers: A. Renal failure: Renal failure is a common and serious complication of NMS, often resulting from the muscle rigidity and subsequent rhabdomyolysis (muscle breakdown). The release of muscle enzymes like myoglobin can overwhelm the kidneys, leading to acute renal failure. This is one of the key reasons why immediate medical attention is necessary for NMS. B. Aspiration: Aspiration is another potential complication of NMS, as altered mental status and muscle rigidity can lead to difficulty swallowing and an increased risk of food or liquids being inhaled into the lungs. This can result in aspiration pneumonia, which is a serious and potentially fatal condition if not treated promptly. C. Infection: Infections are a significant concern in NMS, especially due to the immobility caused by severe muscle rigidity and the possible compromised immune function from the stress response. Patients may develop infections like pneumonia or urinary tract infections due to prolonged hospitalization and other factors related to the syndrome.",
      "correct_choice_id": 236946,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36768171699004126/36768171699004126.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36768171699004126/36768171699004126.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81241,
      "choices": [
        {
          "id": 236947,
          "text": "In includes careful monitoring of vital respiratory and renal functions"
        },
        {
          "id": 236948,
          "text": "Antipsychotic medication be stopped"
        },
        {
          "id": 236949,
          "text": "It include dantrolene a muscle use intravenously"
        },
        {
          "id": 236950,
          "text": "Anticholinergic agents should be continued"
        }
      ],
      "text": "Which of the following is false concerning the management of NMS:",
      "unique_key": "Q8659529",
      "question_audio": null,
      "question_video": null,
      "map_id": 34025082,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Anticholinergic agents should be continued should Anticholinergic agents should be tapered slowly as they may interfere with ther- moregulation Management includes sup- portive treatment in an intensive care environment with careful monitoring of vital signs. and respiratory and renal function. pyrexia electrolyte abnormal- ities and blood pressure abnormalities should be treated symptomatically. an- tipsychotic medication must be stopped agitation may be treated with benzo- diazepines which may be an effective treatment in itself. Treatment includes dantrolene a direct acting muscle relax- ant intravenously initially and then orally when the patient can swallow. it should not be used in conjunctions with calcium channel blockers. Side effects include impaired respiratory or hepatic function and should be monitored. Bromocriptine or amantadine may also be used orally",
      "correct_choice_id": 236950,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33218781699004136/33218781699004136.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33218781699004136/33218781699004136.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81242,
      "choices": [
        {
          "id": 236951,
          "text": "Sertraline"
        },
        {
          "id": 236952,
          "text": "Paroxetine"
        },
        {
          "id": 236953,
          "text": "Amitryptiline"
        },
        {
          "id": 236954,
          "text": "Bupropion"
        }
      ],
      "text": "Which of the following antidepres- sants is relatively less likely to cause antidepressant induced mania?",
      "unique_key": "Q6829983",
      "question_audio": null,
      "question_video": null,
      "map_id": 34157872,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Bupropion. Bupropion is relatively less likely to cause antidepressant-induced mania compared to other antidepressants. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and works by increasing the levels of dopamine and norepinephrine in the brain. Unlike other classes of antidepressants, such as SSRIs and tricyclic antidepressants, bupropion has a lower risk of triggering manic episodes in patients with bipolar disorder or those predisposed to mania. It is considered a good option for patients who need an antidepressant but are at risk of switching into mania. Now, for the incorrect answers: A. Sertraline: Sertraline is an SSRI (selective serotonin reuptake inhibitor), which is effective for treating depression and anxiety disorders. However, SSRIs, including sertraline, are associated with a higher risk of inducing mania in patients with bipolar disorder, especially during the initial stages of treatment. This is due to the increased serotonergic activity that can precipitate a manic episode in susceptible individuals. B. Paroxetine: Paroxetine is also an SSRI and has a similar risk of inducing mania as sertraline. While it is effective for treating depression and anxiety, the serotonergic effects of SSRIs like paroxetine can trigger antidepressant-induced mania in individuals with bipolar disorder or those at risk for mania. Paroxetine is considered to have a slightly higher incidence of side effects compared to other SSRIs, including potential for activating mania. C. Amitryptyline: Amitriptyline is a tricyclic antidepressant (TCA), and while it is effective for treating depression, it has a significant risk of causing antidepressant-induced mania. TCAs, like amitriptyline, have a broad pharmacological profile, including effects on serotonin, norepinephrine, and other neurotransmitters. This can potentially trigger mania in patients with bipolar disorder or those predisposed to manic episodes.",
      "correct_choice_id": 236954,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75041561699004148/75041561699004148.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75041561699004148/75041561699004148.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81243,
      "choices": [
        {
          "id": 236955,
          "text": "Bupropion"
        },
        {
          "id": 236956,
          "text": "Paroxetine"
        },
        {
          "id": 236957,
          "text": "Imipramine"
        },
        {
          "id": 236958,
          "text": "Vilazodone"
        }
      ],
      "text": "Which of the following drugs can be useful in treatment of caffeine intoxication?",
      "unique_key": "Q1220347",
      "question_audio": null,
      "question_video": null,
      "map_id": 34633002,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Bupropion. Bupropion can be useful in the treatment of caffeine intoxication due to its dopaminergic and noradrenergic effects. Bupropion is primarily used as an antidepressant and smoking cessation aid, but it has been noted that its ability to influence dopamine and norepinephrine can help manage some symptoms of caffeine intoxication, such as agitation and restlessness. By regulating neurotransmitter systems that caffeine overstimulates, bupropion may provide symptomatic relief in cases of caffeine overdose or intoxication. Now, for the incorrect answers: B. Paroxetine: Paroxetine is an SSRI (selective serotonin reuptake inhibitor) used for the treatment of depression, anxiety disorders, and other mood-related conditions. While it modulates serotonin levels in the brain, it does not directly address the symptoms of caffeine intoxication. Paroxetine is not typically used for managing caffeine-related symptoms and might even exacerbate certain side effects, such as agitation or restlessness. C. Imipramine: Imipramine is a tricyclic antidepressant (TCA). While it affects serotonin and norepinephrine, it is not specifically useful for caffeine intoxication. In fact, TCAs like imipramine can have sedative effects and may interact with caffeine, possibly increasing the risk of side effects like tachycardia and confusion. TCAs are not first-line treatments for caffeine intoxication. D. Vilazodone: Vilazodone is another SSRI with partial agonist activity at serotonin receptors. Like paroxetine, it is primarily used for the treatment of depression and anxiety. It does not directly counteract the overstimulation caused by caffeine and is not used to treat caffeine intoxication. The drug’s mechanism does not address the core symptoms of caffeine toxicity, such as excessive nervousness or tremors.",
      "correct_choice_id": 236955,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45278011699004259/45278011699004259.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45278011699004259/45278011699004259.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81244,
      "choices": [
        {
          "id": 236959,
          "text": "Paroxetine"
        },
        {
          "id": 236960,
          "text": "Fluoxetine"
        },
        {
          "id": 236961,
          "text": "Bupropion"
        },
        {
          "id": 236962,
          "text": "Doxepin"
        }
      ],
      "text": "Which of the following drugs can be useful to treat hypoactive sexual desire disorder?",
      "unique_key": "Q3580024",
      "question_audio": null,
      "question_video": null,
      "map_id": 34159673,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Bupropion. Bupropion is considered the most useful drug for treating hypoactive sexual desire disorder (HSDD), especially because it has a neutral or even positive effect on sexual function compared to other antidepressants. Unlike many SSRIs (selective serotonin reuptake inhibitors), which are associated with sexual side effects such as decreased libido, delayed orgasm, and erectile dysfunction, bupropion has been shown to enhance sexual desire. This is primarily due to its dopaminergic and noradrenergic activity, which may help improve sexual motivation and function in individuals with HSDD. Now, for the incorrect answers: A. Paroxetine: Paroxetine is an SSRI commonly used to treat depression and anxiety disorders. While effective for mood-related conditions, SSRIs like paroxetine are well-known to cause sexual side effects, including reduced libido and sexual dysfunction. These side effects can worsen the symptoms of hypoactive sexual desire disorder, making paroxetine a poor choice for treating this condition. B. Fluoxetine: Like paroxetine, fluoxetine is an SSRI that can lower sexual desire in many individuals, especially at higher doses. SSRIs are often associated with sexual dysfunction, including decreased libido, difficulty achieving orgasm, and erectile dysfunction. Therefore, fluoxetine would not be helpful for improving hypoactive sexual desire disorder, as it may actually exacerbate the condition. D. Doxepin: Doxepin is a tricyclic antidepressant (TCA) that is sometimes used for anxiety, depression, and sleep disturbances. However, TCAs like doxepin can cause a variety of side effects, including sexual dysfunction, which may worsen the symptoms of HSDD. Sexual side effects such as delayed orgasm, erectile dysfunction, and reduced libido are common with doxepin, making it an inappropriate choice for treating hypoactive sexual desire disorder.",
      "correct_choice_id": 236961,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32435371699004270/32435371699004270.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32435371699004270/32435371699004270.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81245,
      "choices": [
        {
          "id": 236963,
          "text": "Sertraline"
        },
        {
          "id": 236964,
          "text": "Bupropion"
        },
        {
          "id": 236965,
          "text": "Mirtazapine"
        },
        {
          "id": 236966,
          "text": "Vilazodone"
        }
      ],
      "text": "Which of the following drugs causes increase in appetite and weight gain?",
      "unique_key": "Q3847356",
      "question_audio": null,
      "question_video": null,
      "map_id": 34656324,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Mirtazapine. Mirtazapine is known for its increase in appetite and weight gain as common side effects. This is largely due to its antihistaminergic properties, which increase appetite, as well as its effects on serotonin receptors, particularly the 5-HT2 and 5-HT3 receptors. Mirtazapine can also have a sedative effect due to its histamine-blocking action, leading to increased food intake, especially at lower doses. As a result, it is often associated with significant weight gain, which can be beneficial for patients who need to gain weight but may be undesirable for others. Now, for the incorrect answers: A. Sertraline: Sertraline is an SSRI (selective serotonin reuptake inhibitor) commonly used to treat depression and anxiety. While it can cause mild changes in appetite or weight in some individuals, it is generally not associated with significant weight gain. In fact, SSRIs like sertraline are more likely to cause weight loss or no change in weight compared to medications like mirtazapine. B. Bupropion: Bupropion is an NDRI (norepinephrine-dopamine reuptake inhibitor) that is often used for depression and smoking cessation. It is less likely to cause weight gain and is actually associated with weight loss in some patients. Bupropion is often chosen for patients who are concerned about the weight gain side effects of other antidepressants. D. Vilazodone: Vilazodone is a SSRI with partial agonist activity at serotonin receptors. Like sertraline, it is not typically associated with weight gain. SSRIs such as vilazodone tend to have either no effect or a small effect on weight, with weight gain being a rare side effect. Therefore, vilazodone would not be expected to increase appetite or cause significant weight gain.",
      "correct_choice_id": 236965,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29296271699004280/29296271699004280.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29296271699004280/29296271699004280.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81246,
      "choices": [
        {
          "id": 236967,
          "text": "Restless legs syndrome"
        },
        {
          "id": 236968,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236969,
          "text": "Akathisia"
        },
        {
          "id": 236970,
          "text": "Tardive dyskinesia"
        }
      ],
      "text": "A 22-year-old man with schizophrenia who has been taking an antipsychotic for the past 3 months reports that re- cently he has experienced an uncom- fortable sensation in his arms and legs during the day and must constantly move them. Because of this, he can sit still for only a few minutes at a time. This medication side effect is best de- scribed as",
      "unique_key": "Q6951802",
      "question_audio": null,
      "question_video": null,
      "map_id": 34508944,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Akathisia. Akathisia is a side effect commonly associated with antipsychotic medications, particularly within the first few months of treatment. It is characterized by a restlessness and an urge to move, which leads to discomfort in the limbs and an inability to sit still. Patients often report feeling anxious, agitated, or compelled to constantly move their legs or arms, as described in the scenario. This condition is distinct from other movement disorders because it is specifically induced by medications, particularly dopamine antagonists, which are found in many antipsychotic drugs. Now, for the incorrect answers: A. Restless legs syndrome: While restless legs syndrome (RLS) does involve a similar sensation of discomfort and an urge to move the legs, it is typically not caused by antipsychotic medications. RLS is a neurological disorder that primarily affects the legs, often presenting with symptoms at night. Unlike akathisia, it is not usually related to medication use and tends to be more related to underlying conditions such as iron deficiency or chronic kidney disease. B. Neuroleptic malignant syndrome: Neuroleptic malignant syndrome (NMS) is a life-threatening condition that can also result from antipsychotic medications, but it presents with much more severe symptoms, including hyperthermia, muscle rigidity, autonomic dysregulation, and altered mental status. Unlike akathisia, NMS involves systemic signs and is an emergency that requires immediate treatment. The patient in the scenario does not report any of these life-threatening symptoms, making NMS unlikely. D. Tardive dyskinesia: Tardive dyskinesia is a movement disorder that typically develops after long-term use of antipsychotic drugs. It is characterized by involuntary, repetitive movements such as lip smacking, tongue protrusion, or abnormal facial movements. This condition develops more gradually and is not characterized by the restlessness and compulsion to move seen in akathisia, making it a less likely diagnosis in this case.",
      "correct_choice_id": 236969,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10144311699004294/10144311699004294.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10144311699004294/10144311699004294.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81247,
      "choices": [
        {
          "id": 236971,
          "text": "Risperidone"
        },
        {
          "id": 236972,
          "text": "Thioridazine"
        },
        {
          "id": 236973,
          "text": "Olanzapine"
        },
        {
          "id": 236974,
          "text": "Haloperidol"
        }
      ],
      "text": "A 22-year-old man with schizophrenia who has been taking an antipsychotic for the past 3 months reports that re- cently he has experienced an uncom- fortable sensation in his arms and legs during the day and must constantly move them. Because of this, he can sit still for only a few minutes at a time. The antipsychotic agent that this pa- tient is most likely to be taking is",
      "unique_key": "Q3644779",
      "question_audio": null,
      "question_video": null,
      "map_id": 34230361,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Haloperidol The symptom that this patient describes is akathisia, a subjective, uncomfortable feeling of motor restlessness related to use of some antipsychotics. Restless legs syndrome also involves uncomfortable sensations in the legs, but it is a sleep disorder, which causes difficulty falling and staying asleep. Other antipsychotic side effects include neuroleptic malignant syndrome (high fever, sweating, increased pulse and blood pressure, and muscular rigidity), pseudoparkinsonism (muscle rigidity, shuffling gait, resting tremor, and mask-like facial expression), and tardive dyskinesia (involuntary movements including chewing and lip- smacking). High potency antipsychotics, such as haloperidol, are more likely to cause these neurologic side effects than low-potency agents such as thioridizine, or atypical agents, such as risperidone, olanzapine, and clozapine",
      "correct_choice_id": 236974,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41475301699004305/41475301699004305.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41475301699004305/41475301699004305.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81248,
      "choices": [
        {
          "id": 236975,
          "text": "Restless legs syndrome"
        },
        {
          "id": 236976,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236977,
          "text": "Akathisia"
        },
        {
          "id": 236978,
          "text": "Tardive dyskinesia"
        }
      ],
      "text": "A 54-year-old woman with schizo- phrenia who has been taking a high-potency antipsychotic agent for the past 5 years has begun to show involuntary chewing and lip-smack- ing movements. This sign indicates that the patient is experiencing a side effect of antipsychotic medica- tion known as",
      "unique_key": "Q1936003",
      "question_audio": null,
      "question_video": null,
      "map_id": 34825707,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Tardive dyskinesia. Tardive dyskinesia (TD) is a long-term side effect of antipsychotic medications, particularly those that are dopamine antagonists, such as high-potency antipsychotics. It is characterized by involuntary, repetitive movements, which often include chewing, lip-smacking, facial grimacing, and tongue movements. These symptoms, as seen in this patient with a history of 5 years of antipsychotic use, are classic signs of tardive dyskinesia. TD typically develops after prolonged exposure to antipsychotic drugs, and while it can be reversible in some cases, it is often persistent and difficult to treat. Now, for the incorrect answers: A. Restless legs syndrome: Restless legs syndrome (RLS) involves an urge to move the legs and discomfort, usually when the patient is at rest, particularly during the night. It is not characterized by involuntary facial movements like lip-smacking or chewing, which are the hallmark signs of tardive dyskinesia. RLS is not a common side effect of antipsychotic medications, and its primary symptom is not associated with involuntary or repetitive movements of the face or mouth. B. Neuroleptic malignant syndrome: Neuroleptic malignant syndrome (NMS) is a life-threatening reaction to antipsychotic medications, characterized by fever, muscle rigidity, autonomic instability (e.g., fluctuating blood pressure), and altered mental status. Unlike tardive dyskinesia, NMS involves acute symptoms and can result in severe complications if untreated. It is not associated with the involuntary chewing or lip-smacking movements seen in this patient, which are more indicative of tardive dyskinesia. C. Akathisia: Akathisia refers to a feeling of restlessness and an urge to move, often accompanied by agitation, irritability, and an inability to sit still. It is another common side effect of antipsychotic medications, but it does not involve the involuntary, repetitive facial movements (such as lip-smacking or chewing) seen in this patient. Akathisia is typically associated with motor restlessness, not tardive dyskinesia-like movements.",
      "correct_choice_id": 236978,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13773801699004323/13773801699004323.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13773801699004323/13773801699004323.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81249,
      "choices": [
        {
          "id": 236979,
          "text": "By changing to a low-potency or atypical antipsychotic agent"
        },
        {
          "id": 236980,
          "text": "With an antianxiety agent"
        },
        {
          "id": 236981,
          "text": "With an antidepressant agent"
        },
        {
          "id": 236982,
          "text": "By stopping the antipsychotic agent"
        }
      ],
      "text": "A 54-year-old woman with schizo- phrenia who has been taking a high-potency antipsychotic agent for the past 5 years has begun to show involuntary chewing and lip-smack- ing movements. This side effect de- scribed is best treated initially",
      "unique_key": "Q8023937",
      "question_audio": null,
      "question_video": null,
      "map_id": 34218948,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) By changing to a low-potency or atypical antipsychotic agent. Tardive dyskinesia (TD), which is indicated by the involuntary chewing and lip-smacking movements in this patient, is a long-term side effect of high-potency antipsychotic medications. The first step in managing TD is often to switch to a low-potency or atypical antipsychotic agent. Atypical antipsychotics, such as clozapine, quetiapine, and aripiprazole, are generally associated with a lower risk of causing tardive dyskinesia. These medications are considered to have a more favorable side effect profile in terms of movement disorders compared to first-generation high-potency antipsychotics. By switching to one of these agents, you may reduce or stabilize the symptoms of TD. Now, for the incorrect answers: B. With an antianxiety agent: Antianxiety agents, such as benzodiazepines, may be helpful for addressing generalized anxiety or agitation, but they are not effective in treating tardive dyskinesia. TD is a movement disorder caused by dopamine receptor antagonism, and antianxiety agents do not target this underlying issue. Therefore, antianxiety medications would not be appropriate as a treatment for TD. C. With an antidepressant agent: Antidepressants, including SSRIs and SNRIs, are primarily used for treating mood disorders such as depression and anxiety. However, antidepressants do not address the underlying dopamine imbalance that causes tardive dyskinesia. Using antidepressants in this context is not an effective treatment for managing the involuntary movements characteristic of TD. D. By stopping the antipsychotic agent: Abruptly stopping the antipsychotic medication can lead to relapse of psychotic symptoms, and it is generally not advisable unless there is an urgent reason. While discontinuing the antipsychotic may alleviate TD symptoms, it would put the patient at risk of psychiatric decompensation, such as a return of schizophrenia symptoms. Therefore, stopping the antipsychotic medication is not the first-line approach for managing tardive dyskinesia.",
      "correct_choice_id": 236979,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37581061699004335/37581061699004335.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37581061699004335/37581061699004335.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81250,
      "choices": [
        {
          "id": 236983,
          "text": "Restless legs syndrome"
        },
        {
          "id": 236984,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 236985,
          "text": "Akathisia"
        },
        {
          "id": 236986,
          "text": "Tardive dyskinesia"
        }
      ],
      "text": "A 25-year-old patient who has taken haloperidol for the past 2 months is brought to the hospital with a temperature of 104°F, blood pressure of 190/110, and muscular rigidity. These signs indicate that the patient has an antipsychotic medication side effect known as",
      "unique_key": "Q2626689",
      "question_audio": null,
      "question_video": null,
      "map_id": 34282153,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Neuroleptic malignant syndrome. Neuroleptic malignant syndrome (NMS) is a life-threatening side effect of antipsychotic medications like haloperidol. It is characterized by the following classic features: Hyperthermia (elevated temperature, in this case 104°F) Muscle rigidity (severe, generalized muscle stiffness) Autonomic dysregulation (e.g., elevated blood pressure of 190/110 in this patient) Altered mental status (which could include confusion or delirium, though it’s not explicitly mentioned here) NMS is most commonly associated with high-potency antipsychotics like haloperidol. The condition occurs due to dopamine receptor antagonism in the central nervous system, which leads to dysregulation of temperature and muscle tone. NMS requires immediate medical intervention because of its potential to cause significant complications like organ failure. Now, for the incorrect answers: A. Restless legs syndrome: Restless legs syndrome (RLS) is characterized by an urge to move the legs, often accompanied by discomfort. It typically occurs when a person is at rest and is relieved by movement. While it can cause restlessness and discomfort, RLS does not cause the severe muscle rigidity, hyperthermia, or autonomic dysfunction seen in NMS. It is also not associated with high fever or blood pressure elevations. C. Akathisia: Akathisia is a movement disorder characterized by an internal sense of restlessness and an urge to move. Unlike NMS, akathisia is usually less severe and does not cause hyperthermia or muscle rigidity. It presents as agitation and an inability to sit still, often seen in the early stages of antipsychotic use. Akathisia is uncomfortable but not life-threatening, unlike NMS. D. Tardive dyskinesia: Tardive dyskinesia (TD) is a chronic movement disorder characterized by involuntary, repetitive movements such as lip-smacking, tongue protrusion, or facial grimacing. It develops after long-term use of antipsychotics, typically over months or years, and is not associated with acute symptoms like fever, muscle rigidity, or autonomic instability. TD is not life-threatening like NMS.",
      "correct_choice_id": 236984,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1012591699004350/1012591699004350.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1012591699004350/1012591699004350.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81251,
      "choices": [
        {
          "id": 236987,
          "text": "By changing to a low-potency antipsychotic agent"
        },
        {
          "id": 236988,
          "text": "With an antianxiety agent"
        },
        {
          "id": 236989,
          "text": "With an antidepressant agent"
        },
        {
          "id": 236990,
          "text": "By stopping the antipsychotic agent"
        }
      ],
      "text": "A 25-year-old patient who has taken haloperidol for the past 2 months is brought to the hospital with a temperature of 104°F, blood pressure of 190/110, and muscular rigidity. The side effect is best treated initially",
      "unique_key": "Q9339544",
      "question_audio": null,
      "question_video": null,
      "map_id": 34645563,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) By stopping the antipsychotic agent. The patient is showing symptoms consistent with Neuroleptic Malignant Syndrome (NMS), a life-threatening condition that can occur with antipsychotic use, especially high-potency ones like haloperidol. The symptoms—hyperthermia (104°F), severe muscle rigidity, and autonomic instability (high blood pressure)—are classic signs of NMS. The first and most critical step in treating NMS is to immediately discontinue the antipsychotic medication, as it is the primary cause of the condition. Stopping the drug halts the dopamine receptor blockade that leads to NMS and prevents further complications. Now, for the incorrect answers: A. By changing to a low-potency antipsychotic agent: While low-potency antipsychotics and atypical antipsychotics may have a lower risk of causing NMS, simply changing medications is not an adequate first response in the case of NMS. The immediate priority is to discontinue the current antipsychotic (haloperidol in this case), as NMS is a direct result of the drug's effects. Swapping medications without stopping the offending agent could worsen the condition. B. With an antianxiety agent: Antianxiety agents (such as benzodiazepines) are not effective in treating NMS, as the condition involves dopamine dysregulation, hyperthermia, and muscle rigidity, none of which are directly addressed by antianxiety medications. While benzodiazepines may help with agitation, they are not the primary treatment for the underlying cause of NMS. Therefore, antianxiety agents do not address the root cause of the symptoms. C. With an antidepressant agent: Antidepressants (such as SSRIs or SNRIs) do not treat NMS and are not indicated in this situation. NMS is caused by dopamine antagonism due to antipsychotic drugs, and antidepressants target serotonin and norepinephrine pathways, which do not help in managing the severe dopamine dysregulation seen in NMS. Therefore, antidepressants are not effective in treating this condition.",
      "correct_choice_id": 236990,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70367621699004361/70367621699004361.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70367621699004361/70367621699004361.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81252,
      "choices": [
        {
          "id": 236991,
          "text": "Fluoxetine"
        },
        {
          "id": 236992,
          "text": "Lithium"
        },
        {
          "id": 236993,
          "text": "Nortriptyline"
        },
        {
          "id": 236994,
          "text": "Tranylcypromine"
        }
      ],
      "text": "A 26-year-old man comes to the emergency department with elevat- ed blood pressure, sweating, head- ache, and vomiting. His companion tells the physician that the patient became ill at a party where he ate pizza and drank alcoholic punch. The drug that this patient is most likely to be taking is",
      "unique_key": "Q1712772",
      "question_audio": null,
      "question_video": null,
      "map_id": 34084053,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Tranylcypromine. The patient's symptoms—elevated blood pressure, sweating, headache, and vomiting—are indicative of hypertensive crisis, a potentially life-threatening condition that can occur when a person on a monoamine oxidase inhibitor (MAOI) like tranylcypromine consumes tyramine-rich foods (such as aged cheese, cured meats, or alcoholic beverages like the punch described in the scenario). Tyramine is usually broken down by monoamine oxidase (MAO) in the gastrointestinal tract, but when a patient is taking an MAOI, this breakdown is inhibited, leading to elevated levels of tyramine, which can cause vasoconstriction and a rapid increase in blood pressure. The accompanying symptoms (sweating, headache, vomiting) are typical of this crisis. Tranylcypromine is an MAOI, and this kind of food interaction can trigger this life-threatening event. Now, for the incorrect answers: A. Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). While SSRIs can have side effects like nausea or headaches, they are not associated with hypertensive crises or interactions with tyramine-containing foods. Fluoxetine would not cause the acute symptoms of elevated blood pressure, sweating, and vomiting in response to food intake, making it an unlikely cause for this patient's presentation. B. Lithium: Lithium is used to treat bipolar disorder and is not typically associated with hypertensive crises. Although lithium toxicity can present with symptoms such as nausea, vomiting, tremors, and confusion, it does not specifically cause the elevated blood pressure and other symptoms seen here, especially related to tyramine ingestion. Therefore, lithium is unlikely to be the cause in this case. C. Nortriptyline: Nortriptyline is a tricyclic antidepressant (TCA). While TCAs can cause anticholinergic side effects (e.g., dry mouth, constipation, urinary retention) and orthostatic hypotension, they do not generally cause the hypertensive crisis associated with MAOIs when consuming tyramine-rich foods. Unlike MAOIs, TCAs do not block the breakdown of tyramine, so nortriptyline would not be the most likely culprit for this patient’s symptoms.",
      "correct_choice_id": 236994,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52255051699004371/52255051699004371.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52255051699004371/52255051699004371.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81253,
      "choices": [
        {
          "id": 236995,
          "text": "A high-potency antipsychotic agent"
        },
        {
          "id": 236996,
          "text": "An anticholinergic agent"
        },
        {
          "id": 236997,
          "text": "An antianxiety agent"
        },
        {
          "id": 236998,
          "text": "An antidepressant agent"
        }
      ],
      "text": "A 30-year-old woman tells the physician that she must drive the route she takes home from work each day at least three times to be sure that she did not hit an animal in the road. Of the following, the most appropriate long-term pharmacological management for this patient is",
      "unique_key": "Q1345166",
      "question_audio": null,
      "question_video": null,
      "map_id": 34465144,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) An antidepressant agent. This patient is exhibiting signs of obsessive-compulsive disorder (OCD), which is characterized by recurrent, intrusive thoughts (in this case, the worry about hitting an animal in the road) and repetitive behaviors or mental acts performed to reduce anxiety (such as driving the route multiple times). Selective serotonin reuptake inhibitors (SSRIs), which are commonly prescribed antidepressants like fluoxetine, sertraline, and paroxetine, are first-line pharmacologic treatments for OCD. These medications work by increasing serotonin availability in the brain, which helps reduce the frequency and intensity of obsessive thoughts and compulsive behaviors. Now, for the incorrect answers: A. A high-potency antipsychotic agent: High-potency antipsychotics (e.g., haloperidol) are used primarily for schizophrenia or acute psychosis and are not typically indicated for treating OCD. While antipsychotic medications may be used in treatment-resistant cases of OCD, they are not considered first-line therapy, especially in a patient with no signs of psychosis. SSRIs are preferred over antipsychotics for OCD treatment. B. An anticholinergic agent: Anticholinergic agents (such as atropine or benztropine) are typically used to treat conditions like Parkinson's disease or extrapyramidal symptoms due to antipsychotic medications. They are not used to treat OCD. The patient's symptoms are more appropriately treated with SSRIs, not anticholinergics. C. An antianxiety agent: Antianxiety agents (e.g., benzodiazepines like lorazepam or diazepam) are often used for acute anxiety or generalized anxiety disorder. However, they are not the best treatment for OCD, which requires long-term management targeting obsessive thoughts and compulsive behaviors. Antidepressants, particularly SSRIs, are preferred for OCD as they address the underlying neurobiological aspects of the disorder.",
      "correct_choice_id": 236998,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10225301699004383/10225301699004383.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10225301699004383/10225301699004383.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81254,
      "choices": [
        {
          "id": 236999,
          "text": "Is more effective"
        },
        {
          "id": 237000,
          "text": "Works faster"
        },
        {
          "id": 237001,
          "text": "Has fewer side effects"
        },
        {
          "id": 237002,
          "text": "Is less likely to be abused"
        },
        {
          "id": 237003,
          "text": "Is long lasting"
        }
      ],
      "text": "A 45-year-old woman presents with the symptoms of a major depressive episode. The patient has never previously taken an antidepressant. Her physician decides to prescribe fluoxetine. The most likely reason for this choice is that, when compared to a heterocyclic antidepressant, fluoxetine",
      "unique_key": "Q5428737",
      "question_audio": null,
      "question_video": null,
      "map_id": 34830484,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Has fewer side effects. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and is generally preferred over heterocyclic antidepressants (such as tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs)) primarily because it tends to have a better side effect profile. SSRIs like fluoxetine are less likely to cause anticholinergic side effects (such as dry mouth, constipation, and blurred vision) or sedation compared to heterocyclic antidepressants. They also have a lower risk of overdose and are generally safer in patients with certain medical conditions (e.g., cardiovascular disease), making them a first-line treatment for major depressive disorder. Now, for the incorrect answers: A. Is more effective: Fluoxetine and other SSRIs are generally considered to be equally effective as heterocyclic antidepressants for treating major depressive disorder. While there can be individual variations in response, the overall efficacy between SSRIs and heterocyclic antidepressants does not significantly favor one over the other. The choice of medication is often based on side effect profile and tolerability rather than superior effectiveness. B. Works faster: SSRIs, including fluoxetine, generally do not work faster than heterocyclic antidepressants. Both classes typically require several weeks (usually 2 to 4 weeks) to show significant improvements in depressive symptoms. The onset of action for fluoxetine is not necessarily faster than that of tricyclic antidepressants, and neither class provides immediate relief. D. Is less likely to be abused: Both fluoxetine (SSRI) and heterocyclic antidepressants are not typically abused. Fluoxetine has a low potential for abuse, similar to other SSRIs and most heterocyclic antidepressants. However, some medications like methylphenidate or benzodiazepines have a higher potential for misuse. The decision to prescribe fluoxetine is more often based on its side effect profile and safety rather than concerns about abuse. E. Is long-lasting: Fluoxetine has a long half-life compared to many other SSRIs, which means it stays in the system for a longer time. However, this characteristic is not the main reason for its selection over heterocyclic antidepressants. The long half-life of fluoxetine can have benefits in terms of consistent blood levels and potentially fewer withdrawal symptoms compared to other SSRIs, but fewer side effects is the most significant reason for its preference.",
      "correct_choice_id": 237001,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37365431699004394/37365431699004394.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37365431699004394/37365431699004394.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81255,
      "choices": [
        {
          "id": 237004,
          "text": "Zolpidem"
        },
        {
          "id": 237005,
          "text": "Flurazepam"
        },
        {
          "id": 237006,
          "text": "Clonazepam"
        },
        {
          "id": 237007,
          "text": "Buspirone"
        },
        {
          "id": 237008,
          "text": "Chlordiazepoxide"
        }
      ],
      "text": "The best choice of antianxiety agent for a 40-year-old woman with generalized anxiety disorder and a history of benzodiazepine abuse is",
      "unique_key": "Q1925545",
      "question_audio": null,
      "question_video": null,
      "map_id": 34712694,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Buspirone. Buspirone is an anxiolytic medication that is particularly useful in treating generalized anxiety disorder (GAD), especially in patients with a history of benzodiazepine abuse. Unlike benzodiazepines, buspirone is not addictive and has a low potential for abuse, making it an excellent choice for patients with a history of substance misuse. It works by modulating serotonin and dopamine receptors, and it does not cause sedation or dependence like benzodiazepines, making it a safer option for individuals who need treatment for anxiety but are at risk of misuse. Now, for the incorrect answers: A. Zolpidem: Zolpidem is a non-benzodiazepine hypnotic used primarily for insomnia and not for generalized anxiety disorder (GAD). While it works on the GABA receptors similarly to benzodiazepines, its primary indication is for sleep disorders, not anxiety. Zolpidem also has the potential for abuse, which makes it unsuitable for someone with a history of benzodiazepine abuse. B. Flurazepam: Flurazepam is a long-acting benzodiazepine used primarily for the treatment of insomnia. Although it is effective for anxiety in the short term, its sedative properties and high potential for abuse make it an inappropriate choice for someone with a history of benzodiazepine abuse. Benzodiazepines like flurazepam can lead to dependence and are not recommended for this patient population. C. Clonazepam: Clonazepam is another benzodiazepine that is often used for anxiety disorders, including generalized anxiety disorder (GAD). However, due to the patient's history of benzodiazepine abuse, clonazepam would not be the most appropriate choice because it carries a high risk of dependence and abuse. Using a benzodiazepine in this situation could lead to relapse or misuse. E. Chlordiazepoxide: Chlordiazepoxide is a benzodiazepine primarily used for alcohol withdrawal and anxiety. Like other benzodiazepines, it carries the risk of addiction and abuse, which makes it an unsuitable option for a patient with a history of benzodiazepine abuse.",
      "correct_choice_id": 237007,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71417351699004405/71417351699004405.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71417351699004405/71417351699004405.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81256,
      "choices": [
        {
          "id": 237009,
          "text": "Zaleplon"
        },
        {
          "id": 237010,
          "text": "Flurazepam"
        },
        {
          "id": 237011,
          "text": "Clonazepam"
        },
        {
          "id": 237012,
          "text": "Buspirone"
        },
        {
          "id": 237013,
          "text": "Chlordiazepoxide"
        }
      ],
      "text": "A 40-year-old businessman who has been a physician’s patient for the past 5 years asks her for a medication to help him sleep on an overnight flight to Australia. Of the following, the best agent for this use is",
      "unique_key": "Q6636418",
      "question_audio": null,
      "question_video": null,
      "map_id": 34599830,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Zaleplon. Zaleplon is a short-acting hypnotic used for the treatment of insomnia and is particularly effective for helping patients fall asleep. It has a very short half-life, making it ideal for short-term use, such as helping a patient sleep during an overnight flight without causing excessive daytime sedation or hangover effects. Since the patient is looking for a medication to help him sleep for a relatively short duration (overnight flight), zaleplon would be the best option because it will allow him to sleep and then wake up feeling refreshed without feeling groggy the next day. Now, for the incorrect answers: B. Flurazepam: Flurazepam is a long-acting benzodiazepine that is typically used to treat insomnia. However, its long half-life can result in prolonged sedation and a hangover effect the next day, which would be undesirable for a patient taking it just to sleep on a short flight. It's better suited for longer-term use and not for short-term sleep induction like in this case. C. Clonazepam: Clonazepam is a benzodiazepine used primarily for anxiety and seizure disorders, although it has sedative properties. While it could help with sleep, it is not ideal for this situation because it has a longer half-life compared to medications like zaleplon. This means it may cause prolonged sedation and potentially lead to daytime drowsiness, making it less appropriate for a short-term sleep aid for a flight. D. Buspirone: Buspirone is an anxiolytic used primarily for generalized anxiety disorder. It does not have sedative effects and is not effective for inducing sleep. Therefore, it is not a suitable option for helping someone sleep during a flight. E. Chlordiazepoxide: Chlordiazepoxide is a long-acting benzodiazepine, primarily used for alcohol withdrawal and anxiety. Like flurazepam, it has a long half-life, which can result in next-day sedation and cognitive impairment. It is not appropriate for short-term use to help with sleep during a flight, as it would likely cause undesirable side effects.",
      "correct_choice_id": 237009,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24183621699004416/24183621699004416.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24183621699004416/24183621699004416.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81257,
      "choices": [
        {
          "id": 237014,
          "text": "Zaleplon"
        },
        {
          "id": 237015,
          "text": "Flurazepam"
        },
        {
          "id": 237016,
          "text": "Clonazepam"
        },
        {
          "id": 237017,
          "text": "Buspirone"
        },
        {
          "id": 237018,
          "text": "Chlordiazepoxide"
        }
      ],
      "text": "A 57-year-old male patient with a his- tory of alcoholism has decided to stop drinking. Of the following, the agent most commonly used to treat anxiety and agitation associated with the ini- tial stages of alcohol withdrawal is",
      "unique_key": "Q6421390",
      "question_audio": null,
      "question_video": null,
      "map_id": 34023534,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (E) Chlordiazepoxide. Chlordiazepoxide is a benzodiazepine that is commonly used to treat anxiety and agitation associated with the initial stages of alcohol withdrawal. Benzodiazepines are particularly effective in this setting because they help to calm the central nervous system, reducing withdrawal symptoms such as anxiety, agitation, tremors, and seizures. Chlordiazepoxide has a long half-life, which makes it useful in managing withdrawal symptoms over several days. It is often the drug of choice due to its ability to prevent the most serious complications of alcohol withdrawal, such as seizures and delirium tremens (DTs). Now, for the incorrect answers: A. Zaleplon: Zaleplon is a short-acting hypnotic used primarily to treat insomnia. It does not have the anxiolytic or sedative properties required to manage alcohol withdrawal symptoms. Additionally, it has a very short half-life, which makes it unsuitable for managing prolonged withdrawal symptoms. B. Flurazepam: Flurazepam is a long-acting benzodiazepine used to treat insomnia. While it can have sedative effects, it is not typically the first-line treatment for alcohol withdrawal because its long half-life can increase the risk of sedation and toxicity in patients with alcohol dependence. Chlordiazepoxide is preferred over flurazepam in this context. C. Clonazepam: Clonazepam is a benzodiazepine used for anxiety and seizure disorders, but it is not commonly used in the management of alcohol withdrawal. While it can help with anxiety, clonazepam has a longer half-life and potent anticonvulsant properties, which might not be necessary for alcohol withdrawal management compared to chlordiazepoxide, which is more routinely prescribed in this context. D. Buspirone: Buspirone is an anxiolytic used to treat generalized anxiety disorder, but it does not have the sedative or anticonvulsant properties required for managing alcohol withdrawal symptoms. Buspirone is not effective for acute withdrawal and does not address the more dangerous aspects of withdrawal, such as the potential for seizures or delirium tremens.",
      "correct_choice_id": 237018,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11095161699004431/11095161699004431.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11095161699004431/11095161699004431.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81258,
      "choices": [
        {
          "id": 237019,
          "text": "Diazepam"
        },
        {
          "id": 237020,
          "text": "Haloperidol"
        },
        {
          "id": 237021,
          "text": "Fluoxetine"
        },
        {
          "id": 237022,
          "text": "Buspirone"
        },
        {
          "id": 237023,
          "text": "Lithium"
        }
      ],
      "text": "Which of the following psychotropic agents is most likely to be abused?",
      "unique_key": "Q8636743",
      "question_audio": null,
      "question_video": null,
      "map_id": 34012731,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Diazepam. Diazepam is a benzodiazepine that has a high potential for abuse due to its sedative and anxiolytic properties. It works by enhancing the effect of GABA, a neurotransmitter that inhibits brain activity, leading to feelings of relaxation and euphoria. This sedative effect, combined with the potential for tolerance, dependence, and withdrawal symptoms, makes diazepam a commonly misused substance, especially among individuals seeking relief from stress or anxiety. Benzodiazepines like diazepam are well-known for their addictive potential. Now, for the incorrect answers: B. Haloperidol: Haloperidol is a high-potency antipsychotic used to treat schizophrenia and other psychiatric disorders. While it can cause side effects like sedation, it does not produce the euphoric effects or rewarding sensations that lead to abuse. Haloperidol has a low potential for misuse compared to benzodiazepines or other substances that cause euphoria. C. Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat depression, anxiety disorders, and obsessive-compulsive disorder. While it may cause side effects such as sexual dysfunction or insomnia, fluoxetine does not lead to euphoria or addictive behaviors, and thus has a low potential for abuse. D. Buspirone: Buspirone is an anxiolytic used for generalized anxiety disorder. Unlike benzodiazepines, buspirone does not cause sedation or a sense of euphoria and is not associated with dependence or abuse. It has a low potential for misuse and is considered a safer option for chronic anxiety treatment. E. Lithium: Lithium is a mood stabilizer used primarily for bipolar disorder. It helps to regulate mood swings and prevent manic episodes, but it does not produce the euphoric effects that lead to abuse. Lithium has a narrow therapeutic window, meaning it must be closely monitored to avoid toxicity, but it does not have the same addictive potential as benzodiazepines.",
      "correct_choice_id": 237019,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56993871699004442/56993871699004442.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56993871699004442/56993871699004442.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81259,
      "choices": [
        {
          "id": 237024,
          "text": "Diazepam"
        },
        {
          "id": 237025,
          "text": "Electroconvulsive therapy (ECT)"
        },
        {
          "id": 237026,
          "text": "Psychotherapy"
        },
        {
          "id": 237027,
          "text": "Buspirone"
        },
        {
          "id": 237028,
          "text": "Lithium"
        }
      ],
      "text": "An 80-year-old man is brought to the emergency room by his wife. The man, who has a history of depression and suicidal behavior, refuses to eat and states that life is not worth living anymore. Consultations with his pri- mary care physician and a consulting psychiatrist reveal that the patient has not responded to at least three different antidepressant medications that he has taken in adequate doses and for adequate time periods in the past 2 years. The most appropriate next step in the management of this patient is to recommend",
      "unique_key": "Q6048545",
      "question_audio": null,
      "question_video": null,
      "map_id": 34186764,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Electroconvulsive therapy (ECT). In this case, the patient is an 80-year-old man with treatment-resistant depression and a history of suicidal behavior. He has not responded to at least three different antidepressants, even though they were given at adequate doses and durations. This scenario suggests treatment-resistant depression (TRD), which is characterized by inadequate response to at least two different antidepressants from different classes. In treatment-resistant depression, particularly in patients with a history of suicidal behavior and severe depression, Electroconvulsive Therapy (ECT) is often the most appropriate next step. ECT is a highly effective treatment for severe depression, especially when patients are at high risk of suicide, as it can work quickly and often leads to significant symptom improvement when medications alone have failed. It is particularly useful in elderly patients and those with significant medical comorbidities who may not tolerate other treatments as well. Now, for the incorrect answers: A. Diazepam: Diazepam is a benzodiazepine used for anxiety and sedation. While it may offer temporary relief from anxiety, it is not effective for treating depression and should not be used as a primary treatment in depression. Additionally, benzodiazepines can have side effects like sedation and the potential for dependence or abuse, which are not appropriate in the management of major depressive disorder, especially in a patient with a history of suicidal ideation. C. Psychotherapy: While psychotherapy can be beneficial in the treatment of depression, it is typically used in conjunction with medications, especially when a patient has resistant depression. In this case, the patient has already failed three different antidepressants, and psychotherapy alone is unlikely to provide the rapid and robust relief required for someone at high risk of suicide. Therefore, ECT is a better option for this severely depressed patient who needs immediate intervention. D. Buspirone: Buspirone is an anxiolytic medication primarily used for generalized anxiety disorder. It does not have significant effects on depression and would not be appropriate in a case of treatment-resistant depression. This medication would not address the patient's underlying depressive symptoms and suicidal ideation. E. Lithium: Lithium is a mood stabilizer commonly used for bipolar disorder, particularly to prevent manic episodes. While it may be used as an adjunct in unipolar depression (especially in cases with mood instability), it is generally not the first-line treatment for major depressive disorder that has not responded to antidepressants. It is not typically used when there is a clear failure of multiple antidepressant trials, and in this case, it would not be the most appropriate next step.",
      "correct_choice_id": 237025,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4332291699004458/4332291699004458.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4332291699004458/4332291699004458.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81260,
      "choices": [
        {
          "id": 237029,
          "text": "Risperidone"
        },
        {
          "id": 237030,
          "text": "Thioridazine"
        },
        {
          "id": 237031,
          "text": "Olanzapine"
        },
        {
          "id": 237032,
          "text": "Haloperidol"
        },
        {
          "id": 237033,
          "text": "Clozapine"
        }
      ],
      "text": "A 30-year-old man with schizophre- nia has been very withdrawn and apathetic for more than 10 years. He now is taking an antipsychotic agent that is helping him to be more outgoing and sociable. However, the patient is experiencing seizures, and agranulocytosis. The antipsychotic agent that this patient is most likely to be taking is",
      "unique_key": "Q8860612",
      "question_audio": null,
      "question_video": null,
      "map_id": 34820750,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (E) Clozapine. This patient with schizophrenia has been experiencing withdrawal and apathy for more than 10 years and is now improving with antipsychotic treatment. However, he is developing seizures and agranulocytosis (a severe reduction in white blood cells, increasing infection risk). These are well-known side effects of clozapine, a second-generation antipsychotic. Clozapine is effective in patients with treatment-resistant schizophrenia, particularly those who are apathetic or withdrawn, and it has a unique ability to improve negative symptoms of schizophrenia. However, it carries a risk of agranulocytosis, which is why regular blood monitoring is required to detect this rare but serious side effect early. Seizures are also a known adverse effect of clozapine, particularly at higher doses. Now, for the incorrect responses: A. Risperidone: Risperidone is a second-generation antipsychotic that is commonly used to treat schizophrenia, but it does not have the same risk of agranulocytosis or seizures that clozapine does. It is generally better tolerated and does not require the intense blood monitoring necessary for clozapine. Risperidone can cause side effects like weight gain, sedation, and extrapyramidal symptoms, but agranulocytosis is not a typical concern. B. Thioridazine: Thioridazine is a first-generation antipsychotic. While it can cause side effects such as cardiac arrhythmias and extrapyramidal symptoms, it does not carry a risk of agranulocytosis or seizures in the same way that clozapine does. It is an older medication with a higher likelihood of causing neurologic side effects compared to second-generation antipsychotics, but it is not as commonly used today due to safety concerns. C. Olanzapine: Olanzapine is another second-generation antipsychotic that can be used to treat schizophrenia. It is effective in treating both positive and negative symptoms and is generally well tolerated. However, agranulocytosis and seizures are not common side effects of olanzapine. It is more likely to cause weight gain, diabetes, and metabolic syndrome, but seizures and agranulocytosis are much less of a concern. D. Haloperidol: Haloperidol is a first-generation antipsychotic, known for its high potency and higher risk of extrapyramidal symptoms like tremors, rigidity, and tardive dyskinesia. While it is effective for treating positive symptoms of schizophrenia, it does not cause agranulocytosis or seizures like clozapine. It is generally not as effective at treating negative symptoms and has a less favorable side effect profile compared to second-generation antipsychotics like clozapine.",
      "correct_choice_id": 237033,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40121911699004471/40121911699004471.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40121911699004471/40121911699004471.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81261,
      "choices": [
        {
          "id": 237034,
          "text": "Lithium"
        },
        {
          "id": 237035,
          "text": "Lamotrigine"
        },
        {
          "id": 237036,
          "text": "Oxcarbazepine"
        },
        {
          "id": 237037,
          "text": "Sodium Valproate"
        }
      ],
      "text": "Which of the following mood stabilizer is having anti-suicidal properties? (AIIMS 2017)",
      "unique_key": "Q1207417",
      "question_audio": null,
      "question_video": null,
      "map_id": 34998638,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Lithium. Lithium is the mood stabilizer most commonly associated with anti-suicidal properties. Studies have shown that lithium not only helps stabilize mood in individuals with bipolar disorder and major depression but also significantly reduces the risk of suicide in patients with mood disorders. It is one of the few medications that has been demonstrated to lower suicide rates, making it the treatment of choice for patients with a history of suicidality. This unique benefit is a key reason lithium remains widely used in clinical practice for mood stabilization. Now, for the incorrect responses: B. Lamotrigine: While lamotrigine is an effective mood stabilizer, especially for the depressive episodes of bipolar disorder, it does not have the same established evidence for anti-suicidal properties as lithium. Lamotrigine is primarily used for maintenance therapy and to prevent depressive episodes, but it has not been shown to significantly reduce suicide risk in the way that lithium does. C. Oxcarbazepine: Oxcarbazepine is an anticonvulsant that is sometimes used as a mood stabilizer, particularly in the treatment of bipolar disorder. However, there is no substantial evidence suggesting that oxcarbazepine has any anti-suicidal effects. It is not commonly associated with the suicide-reducing benefits seen with lithium. D. Sodium Valproate: Sodium valproate (or valproic acid) is another mood stabilizer used to treat bipolar disorder and epilepsy. While it is effective for controlling mania and preventing manic episodes, there is no strong evidence linking valproate with anti-suicidal properties. It is primarily used for its antimanic effects and does not have the same protective benefit against suicidal behavior as lithium.",
      "correct_choice_id": 237034,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42626621699004481/42626621699004481.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42626621699004481/42626621699004481.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81262,
      "choices": [
        {
          "id": 237038,
          "text": "Clozapine"
        },
        {
          "id": 237039,
          "text": "Olanzapine"
        },
        {
          "id": 237040,
          "text": "Haloperidol"
        },
        {
          "id": 237041,
          "text": "Fluphenazine"
        }
      ],
      "text": "Which of the following antipsychotic has “anti-suicidal” properties?",
      "unique_key": "Q3993338",
      "question_audio": null,
      "question_video": null,
      "map_id": 34682688,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Clozapine. Clozapine is the antipsychotic with established anti-suicidal properties. Research has shown that clozapine significantly reduces the risk of suicide in patients with schizophrenia, particularly in those who are treatment-resistant. It is particularly effective in reducing suicidality in patients who have a history of suicidal behavior, and it is considered one of the most effective treatments for schizophrenia with comorbid suicidality. Clozapine's ability to reduce suicidal behavior is one of the key reasons it is often used as a last-line treatment for refractory schizophrenia. Now, for the incorrect responses: B. Olanzapine: While olanzapine is an atypical antipsychotic used to treat schizophrenia and bipolar disorder, it does not have the same anti-suicidal properties as clozapine. Although olanzapine is effective for managing positive and negative symptoms of schizophrenia, there is no substantial evidence suggesting that it significantly reduces suicidal behavior or suicide risk in the same way clozapine does. C. Haloperidol: Haloperidol is a first-generation antipsychotic (typical antipsychotic) used to treat schizophrenia and acute psychotic episodes. It is effective for positive symptoms but does not have any documented anti-suicidal properties. In fact, its side effects, particularly extrapyramidal symptoms, can be debilitating, and it does not offer the same benefits as clozapine in terms of reducing suicidal ideation or behavior. D. Fluphenazine: Like haloperidol, fluphenazine is a first-generation antipsychotic. It is effective for managing psychotic symptoms but has not been shown to have anti-suicidal properties. It is primarily used for long-term treatment of schizophrenia and other psychotic disorders but does not offer the suicide-reducing benefits seen with clozapine.",
      "correct_choice_id": 237038,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46064801699004495/46064801699004495.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46064801699004495/46064801699004495.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81263,
      "choices": [
        {
          "id": 237042,
          "text": "Venlafaxine"
        },
        {
          "id": 237043,
          "text": "Tranylcypromine"
        },
        {
          "id": 237044,
          "text": "Trazodone"
        },
        {
          "id": 237045,
          "text": "Fluoxetine"
        }
      ],
      "text": "What is the most appropriate agent for a doctor to recommend for a 34-year-old, overweight, depressed patient who needs to take an antidepressant but is afraid of gaining weight?",
      "unique_key": "Q6873325",
      "question_audio": null,
      "question_video": null,
      "map_id": 34115260,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Fluoxetine. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is generally considered the best option for this patient due to its lower likelihood of causing weight gain compared to other antidepressants. SSRIs like fluoxetine are typically associated with either weight neutrality or slight weight loss during treatment, especially in the initial stages. For patients who are concerned about weight gain, fluoxetine offers a safer choice, as it is one of the most well-tolerated antidepressants in terms of weight management. Additionally, it is highly effective for treating depression and has a relatively favorable side effect profile. Now, for the incorrect responses: A. Venlafaxine: Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that can be effective for treating depression and anxiety. However, it is associated with a higher risk of weight gain compared to SSRIs, particularly at higher doses. Weight gain is not as common as with some other antidepressants, but it is a potential concern, especially in patients who are already overweight. B. Tranylcypromine: Tranylcypromine is a monoamine oxidase inhibitor (MAOI). While MAOIs can be effective for depression, they are typically not first-line treatments due to their serious dietary restrictions and the potential for dangerous interactions with certain foods and medications. Weight gain can also be a side effect of tranylcypromine, which makes it a less appropriate choice for someone who is already concerned about weight issues. C. Trazodone: Trazodone is an atypical antidepressant that is often used for its sedative properties. While it is effective for treating depression, it is not typically recommended as a first-line treatment due to its sedative effects and the potential for drowsiness. Additionally, weight gain can still occur, particularly with long-term use. Therefore, it may not be the best choice for a patient who is worried about weight gain.",
      "correct_choice_id": 237045,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47258981699004506/47258981699004506.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47258981699004506/47258981699004506.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81264,
      "choices": [
        {
          "id": 237046,
          "text": "Venlafaxine"
        },
        {
          "id": 237047,
          "text": "Tranylcypromine"
        },
        {
          "id": 237048,
          "text": "Trazodone"
        },
        {
          "id": 237049,
          "text": "Doxepin"
        }
      ],
      "text": "What is the antidepressant agent most likely to cause persistent erections (priapism) in a 40-year-old male patient?",
      "unique_key": "Q1906939",
      "question_audio": null,
      "question_video": null,
      "map_id": 34527357,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Trazodone. Trazodone is an atypical antidepressant that is most commonly associated with priapism, a condition characterized by prolonged and painful erections. This side effect is thought to occur due to trazodone's alpha-adrenergic antagonist properties, which can lead to vascular effects in the penis. Priapism is a known, though rare, side effect of trazodone, particularly at higher doses. Because of this potential risk, patients on trazodone, especially those at higher doses, should be monitored closely for any signs of priapism. Although priapism is rare, it is important for patients to be educated on this risk. Now, for the incorrect responses: A. Venlafaxine: Venlafaxine, an SNRI, is generally well tolerated in terms of sexual side effects, but it is not commonly associated with priapism. Venlafaxine can cause other sexual side effects like decreased libido, delayed ejaculation, and erectile dysfunction, but priapism is not a typical or well-documented side effect of this medication. B. Tranylcypromine: Tranylcypromine is a monoamine oxidase inhibitor (MAOI) used in the treatment of depression. While MAOIs can cause side effects such as sexual dysfunction (including impotence or reduced libido), priapism is not a typical or known side effect of tranylcypromine. The main concerns with MAOIs are their dietary restrictions and potential hypertensive crises when combined with certain foods or medications. D. Doxepin: Doxepin is a tricyclic antidepressant (TCA) that is primarily used for depression and anxiety disorders. While TCAs can cause sexual side effects such as decreased libido or erectile dysfunction, they are not commonly associated with priapism. Doxepin's side effects are more likely to include anticholinergic effects (like dry mouth, constipation, blurred vision) and sedation.",
      "correct_choice_id": 237048,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61189751699004518/61189751699004518.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61189751699004518/61189751699004518.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81265,
      "choices": [
        {
          "id": 237050,
          "text": "Venlafaxine"
        },
        {
          "id": 237051,
          "text": "Tranylcypromine"
        },
        {
          "id": 237052,
          "text": "Trazodone"
        },
        {
          "id": 237053,
          "text": "Doxepin"
        },
        {
          "id": 237054,
          "text": "Amoxapine"
        }
      ],
      "text": "Which of the following antidepressant agents is most likely to cause gyneco- mastia and parkinsonian symptoms in a 45-year-old male patient?",
      "unique_key": "Q6483356",
      "question_audio": null,
      "question_video": null,
      "map_id": 34956348,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (E) Amoxapine. Amoxapine is a tetracyclic antidepressant that has dopaminergic antagonism as part of its mechanism of action. This can lead to side effects commonly seen in antipsychotics, including parkinsonian symptoms such as tremors, rigidity, and bradykinesia. Additionally, because of its dopamine receptor blockade, amoxapine can also cause gynecomastia (enlarged breasts in males). This side effect is more commonly associated with drugs that block dopamine receptors, which can lead to an imbalance in prolactin levels and subsequently increase the risk of gynecomastia. Now, for the incorrect responses: A. Venlafaxine: Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It can cause sexual dysfunction, insomnia, and other side effects, but it is not typically associated with gynecomastia or parkinsonian symptoms. Although venlafaxine has effects on serotonin and norepinephrine, it does not significantly impact dopamine pathways in a way that would lead to these particular side effects. B. Tranylcypromine: Tranylcypromine is a monoamine oxidase inhibitor (MAOI). It is effective for treating depression but is not typically associated with parkinsonian symptoms or gynecomastia. The side effects of tranylcypromine are more often related to hypertensive crises and dietary restrictions due to the risk of tyramine interactions, rather than dopamine dysregulation leading to the issues described in the question. C. Trazodone: Trazodone is an atypical antidepressant that is commonly used for its sedative properties. It can cause sexual side effects like erectile dysfunction or decreased libido, but gynecomastia and parkinsonian symptoms are not typical side effects. Its primary side effects are related to sedation, orthostatic hypotension, and priapism. D. Doxepin: Doxepin is a tricyclic antidepressant (TCA) that has anticholinergic effects, such as dry mouth, constipation, and blurred vision, but it is not typically associated with gynecomastia or parkinsonian symptoms. While TCAs can have significant side effects, dopaminergic effects are not a major concern with doxepin.",
      "correct_choice_id": 237054,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36637971699004529/36637971699004529.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36637971699004529/36637971699004529.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81266,
      "choices": [
        {
          "id": 237055,
          "text": "Venlafaxine"
        },
        {
          "id": 237056,
          "text": "Tranylcypromine"
        },
        {
          "id": 237057,
          "text": "Trazodone"
        },
        {
          "id": 237058,
          "text": "Doxepin"
        }
      ],
      "text": "What is the most appropriate antidepressant agent for rapid relief of the symptoms of depression in a 25-year-old woman?",
      "unique_key": "Q8080988",
      "question_audio": null,
      "question_video": null,
      "map_id": 34442446,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Venlafaxine. Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that is considered a good choice for rapid relief of depression symptoms, especially in cases where a quick improvement is desired. It works by increasing the levels of serotonin and norepinephrine in the brain, both of which play crucial roles in mood regulation. Venlafaxine is often chosen because it can be effective more quickly than some other antidepressants, especially in moderate to severe cases of depression. Additionally, it has a well-established efficacy profile and can be an excellent option for those who may not have responded well to selective serotonin reuptake inhibitors (SSRIs) or other first-line agents. Now, for the incorrect responses: B. Tranylcypromine: Tranylcypromine is a monoamine oxidase inhibitor (MAOI). While it can be effective for treating depression, MAOIs typically take longer to show effects compared to SNRIs like venlafaxine. Additionally, tranylcypromine comes with more dietary restrictions and interaction risks (such as hypertensive crises when combined with tyramine-containing foods), which make it less ideal for rapid treatment. Therefore, it's generally not considered a first-line treatment for rapid symptom relief. C. Trazodone: Trazodone is often used as an adjunctive treatment for depression, particularly for individuals who have insomnia as a co-occurring symptom. However, it is generally not considered the best option for rapid relief of depressive symptoms. Its primary side effects include sedation, and it is not known to work as quickly or as effectively in alleviating depressive symptoms as other antidepressants like venlafaxine. Therefore, it would not be the most appropriate choice for rapid symptom relief. D. Doxepin: Doxepin is a tricyclic antidepressant (TCA), which, like MAOIs, can have more side effects and a slower onset of action compared to SNRIs like venlafaxine. TCAs are effective but are generally not the first choice for treating depression in modern practice due to their higher risk of anticholinergic effects (e.g., dry mouth, constipation) and the potential for cardiovascular side effects. While effective, doxepin is not known for providing rapid relief of depressive symptoms, making it less suitable for the patient's needs in this case.",
      "correct_choice_id": 237055,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52396511699004540/52396511699004540.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52396511699004540/52396511699004540.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81267,
      "choices": [
        {
          "id": 237059,
          "text": "Venlafaxine"
        },
        {
          "id": 237060,
          "text": "Tranylcypromine"
        },
        {
          "id": 237061,
          "text": "Trazodone"
        },
        {
          "id": 237062,
          "text": "Doxepin"
        }
      ],
      "text": "Which of the following antidepressant agents is most likely to cause extreme sedation?",
      "unique_key": "Q9602558",
      "question_audio": null,
      "question_video": null,
      "map_id": 34661211,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Trazodone. Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) that is most commonly used for depression, but it is particularly well known for its sedative effects. One of its most common side effects is extreme sedation, making it an effective sleep aid in patients who have insomnia alongside depression. Because of its sedative properties, trazodone is often prescribed off-label for sleep disturbances, even in the absence of depression. This extreme sedation occurs due to its strong histaminergic blockade and its action on serotonin receptors that promote sleepiness. Now, for the incorrect responses: A. Venlafaxine: Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression and anxiety disorders. While it can cause some side effects, including insomnia in some individuals, it is not typically associated with extreme sedation. In fact, some patients may experience increased energy or agitation when taking venlafaxine, particularly at higher doses. Therefore, it is less likely to cause sedation compared to trazodone. B. Tranylcypromine: Tranylcypromine is a monoamine oxidase inhibitor (MAOI) that is effective in treating depression, particularly in patients with treatment-resistant depression. However, it does not commonly cause extreme sedation. Instead, it is more likely to cause insomnia or stimulation due to its effect on increasing norepinephrine and dopamine levels. Tranylcypromine is generally more energizing than sedating. D. Doxepin: Doxepin is a tricyclic antidepressant (TCA) that can cause sedation due to its antihistaminergic properties, but it is not as likely to cause the extreme sedation seen with trazodone. Although doxepin can have sedative effects, particularly at lower doses, it is not as commonly prescribed for sedation as trazodone. The sedative effect of doxepin is generally less intense, and its use is more limited due to its potential for anticholinergic side effects and cardiovascular toxicity.",
      "correct_choice_id": 237061,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48595301699004552/48595301699004552.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48595301699004552/48595301699004552.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81268,
      "choices": [
        {
          "id": 237063,
          "text": "Progesterone"
        },
        {
          "id": 237064,
          "text": "Testosterone"
        },
        {
          "id": 237065,
          "text": "Prolactin"
        },
        {
          "id": 237066,
          "text": "Estrogen"
        }
      ],
      "text": "A 30-year-old woman who is taking an antipsychotic medication reports that she has been experiencing fluid discharge from the nipples. Which of the following hormones is most like- ly to be responsible for this problem?",
      "unique_key": "Q2815840",
      "question_audio": null,
      "question_video": null,
      "map_id": 34127376,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Prolactin. Prolactin is the hormone most commonly responsible for nipple discharge, especially in the context of antipsychotic medication use. Many antipsychotic drugs, particularly dopamine antagonists, can increase prolactin levels in the body. Dopamine typically inhibits prolactin secretion, so when dopamine's action is blocked by antipsychotic medications, prolactin levels rise. Elevated prolactin levels can lead to galactorrhea, which is the abnormal discharge of milk or fluid from the nipples, even in individuals who are not pregnant or breastfeeding. Now, for the incorrect options: A. Progesterone: Progesterone is a hormone primarily involved in regulating the menstrual cycle and maintaining pregnancy. While it does play a role in breast tissue development, progesterone is not directly responsible for nipple discharge. Hormones like prolactin and estrogen are more directly linked to the production of breast milk or fluid. B. Testosterone: Testosterone is a male sex hormone, although it is present in smaller amounts in females. While testosterone can affect libido, mood, and muscle mass, it is not typically associated with nipple discharge. High levels of testosterone in women might lead to symptoms like hirsutism (excessive body hair), but it does not cause galactorrhea. D. Estrogen: Estrogen is a hormone that plays a key role in breast tissue development, especially in females. However, while it contributes to breast tissue changes and milk duct development, it is not as likely to cause nipple discharge as prolactin. Estrogen can influence prolactin levels, but the direct cause of nipple discharge in this case is typically the increased prolactin secretion due to antipsychotic medications.",
      "correct_choice_id": 237065,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77862981699004564/77862981699004564.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77862981699004564/77862981699004564.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81269,
      "choices": [
        {
          "id": 237067,
          "text": "A high-potency antipsychotic agent"
        },
        {
          "id": 237068,
          "text": "An anticholinergic agent"
        },
        {
          "id": 237069,
          "text": "An antianxiety agent"
        },
        {
          "id": 237070,
          "text": "An antidepressant agent"
        }
      ],
      "text": "A 35-year-old man who has been taking haloperidol for the last year develops a resting tremor, mask- like facial expression, and difficulty initiating body movements. After reducing the haloperidol dose, the next step the physician should take to relieve these symptoms is to give the patient",
      "unique_key": "Q1210625",
      "question_audio": null,
      "question_video": null,
      "map_id": 34466641,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) An anticholinergic agent. The symptoms described—resting tremor, mask-like facial expression, and difficulty initiating movements—are suggestive of parkinsonism, a movement disorder commonly seen as a side effect of antipsychotic medications like haloperidol. This condition is often referred to as drug-induced parkinsonism, and it occurs because antipsychotic drugs, particularly dopamine antagonists like haloperidol, block dopamine receptors in the brain, leading to a dopamine deficiency in areas responsible for controlling movement, such as the basal ganglia. The best approach to treat drug-induced parkinsonism is to give the patient an anticholinergic agent, such as benztropine or trihexyphenidyl. These medications help restore the balance between dopamine and acetylcholine, which can alleviate the symptoms of parkinsonism. Now, let’s look at the incorrect responses: A. A high-potency antipsychotic agent: This is incorrect because giving a high-potency antipsychotic agent would likely worsen the symptoms. Haloperidol itself is a high-potency antipsychotic, and increasing the dose or switching to another high-potency antipsychotic would lead to a further increase in dopamine blockade, exacerbating the parkinsonism and potentially worsening the patient’s symptoms. C. An antianxiety agent: This is also incorrect because antianxiety agents (like benzodiazepines) do not address the underlying cause of the symptoms, which is a dopamine deficiency caused by the antipsychotic. While antianxiety agents can be helpful for anxiety, they do not treat parkinsonism or the movement-related side effects of antipsychotic medications. D. An antidepressant agent: Antidepressants are not appropriate for treating drug-induced parkinsonism. They are useful for treating mood disorders such as depression but do not have any effect on dopamine pathways or movement symptoms caused by dopamine blockade from antipsychotic drugs. Using an antidepressant in this case would not relieve the motor symptoms.",
      "correct_choice_id": 237068,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74090461699004575/74090461699004575.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74090461699004575/74090461699004575.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81270,
      "choices": [
        {
          "id": 237071,
          "text": "Bupropion"
        },
        {
          "id": 237072,
          "text": "Fluoxetine"
        },
        {
          "id": 237073,
          "text": "Lorazepam"
        },
        {
          "id": 237074,
          "text": "Valproic acid"
        },
        {
          "id": 237075,
          "text": "Imipramine"
        }
      ],
      "text": "A 45-year-old man presents in the emergency room with sinus tachy- cardia (112/ bpm), flattening of T waves and prolonged QT interval. The patient tells the physician that he is taking “nerve pills.” Which of the following medications is this pa- tient most likely to be taking?",
      "unique_key": "Q7460542",
      "question_audio": null,
      "question_video": null,
      "map_id": 34162407,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (E) Imipramine. This patient presents with sinus tachycardia, flattening of T waves, and a prolonged QT interval, which are all suggestive of cardiac conduction abnormalities. These findings are commonly associated with tricyclic antidepressants (TCAs), particularly imipramine. TCAs, like imipramine, can have anticholinergic effects, and cardiovascular toxicity is a known side effect, including QT prolongation and sinus tachycardia. The prolonged QT interval can increase the risk of torsades de pointes, a potentially life-threatening arrhythmia. Thus, based on these findings, imipramine is the most likely drug the patient is taking. Now, let’s discuss the incorrect options: A. Bupropion: While bupropion is an antidepressant, it is not typically associated with QT prolongation or sinus tachycardia. Bupropion is more likely to cause seizures, especially in overdose situations, but does not generally affect cardiac conduction in the way that TCAs like imipramine do. B. Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and is not known to cause QT prolongation or significant cardiac conduction issues. While SSRIs like fluoxetine can have side effects like sexual dysfunction or gastrointestinal upset, they are less likely to cause cardiovascular abnormalities compared to tricyclic antidepressants. C. Lorazepam: Lorazepam is a benzodiazepine used for anxiety and sedation. It does not typically affect cardiac conduction, and it is not associated with QT prolongation or sinus tachycardia. While benzodiazepines can cause drowsiness or sedation, they do not produce the specific electrocardiogram changes seen with tricyclic antidepressants. D. Valproic acid: Valproic acid is an anticonvulsant and mood-stabilizing agent, used primarily in the treatment of epilepsy and bipolar disorder. While valproic acid can have side effects such as hepatic toxicity or weight gain, it is not typically associated with cardiac conduction abnormalities like QT prolongation or sinus tachycardia.",
      "correct_choice_id": 237075,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30131621699004587/30131621699004587.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30131621699004587/30131621699004587.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81271,
      "choices": [
        {
          "id": 237076,
          "text": "Quetiapine"
        },
        {
          "id": 237077,
          "text": "Ziprasidone"
        },
        {
          "id": 237078,
          "text": "Aripiprazole"
        },
        {
          "id": 237079,
          "text": "Clozapine"
        },
        {
          "id": 237080,
          "text": "Olanzapine"
        }
      ],
      "text": "A 45-year-old woman with schizophrenia has been taking an atypical antipsychotic for the past year. Since starting the medication she has gained 35 pounds, has developed diabetes mellitus, and shows a prolonged QT interval. Because of these medication side effects her physician would like to switch her to a different atypical agent. Of the following atypical agents, which is likely to be the best choice for this patient?",
      "unique_key": "Q8944184",
      "question_audio": null,
      "question_video": null,
      "map_id": 34338162,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Aripiprazole. This patient has developed significant side effects from her current atypical antipsychotic, including weight gain, diabetes mellitus, and a prolonged QT interval. These side effects are commonly associated with certain atypical antipsychotics like olanzapine and clozapine. Aripiprazole, however, is considered one of the atypical antipsychotics with a favorable side effect profile compared to other atypical agents. It is associated with minimal weight gain, lower metabolic side effects, and no significant risk of QT prolongation. Therefore, aripiprazole is the most appropriate choice for switching this patient to another atypical antipsychotic. Now, let's look at why the other options are less suitable: A. Quetiapine: Quetiapine is an atypical antipsychotic that is known to have a higher risk of weight gain and metabolic side effects, similar to olanzapine. It can also cause sedation. While quetiapine does have some advantages, such as being useful in treating both positive and negative symptoms of schizophrenia, its side effect profile makes it less ideal for a patient with weight gain, diabetes, and prolonged QT interval. B. Ziprasidone: Ziprasidone is another atypical antipsychotic, and while it has a lower risk of weight gain compared to drugs like olanzapine, it is still associated with QT prolongation. Since this patient already has a prolonged QT interval, ziprasidone would not be the best choice, as it could exacerbate the problem. D. Clozapine: Clozapine is an effective antipsychotic, especially for treatment-resistant schizophrenia. However, it has a high risk of weight gain, metabolic disturbances, and agranulocytosis (a serious side effect requiring regular blood monitoring). Given the patient's history of weight gain and diabetes, clozapine is not the best choice for her. E. Olanzapine: Olanzapine is another atypical antipsychotic that is known to cause significant weight gain, diabetes, and increased risk of metabolic syndrome. Given that this patient has already experienced these side effects on her current medication, olanzapine is not a suitable option.",
      "correct_choice_id": 237078,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73648261699004601/73648261699004601.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73648261699004601/73648261699004601.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81272,
      "choices": [
        {
          "id": 237081,
          "text": "Aspirin"
        },
        {
          "id": 237082,
          "text": "Digoxin"
        },
        {
          "id": 237083,
          "text": "Erythromycin"
        },
        {
          "id": 237084,
          "text": "Fluoxetine"
        },
        {
          "id": 237085,
          "text": "Metoclopramide"
        }
      ],
      "text": "A resident is called to assess an oncology patient on a general medical floor who has developed a muscle spasm causing her neck to twist uncontrollably to the left. The intern evaluates the patient’s list of medications and concludes that her new symptoms are probably due to which of the following?",
      "unique_key": "Q7547730",
      "question_audio": null,
      "question_video": null,
      "map_id": 34063003,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (E) Metoclopramide. This patient’s symptoms, which include a muscle spasm causing her neck to twist uncontrollably, are most likely due to metoclopramide, a drug commonly used to treat nausea and vomiting and to promote gastric motility. Metoclopramide is a dopamine antagonist, and one of its potential side effects is extrapyramidal symptoms (EPS), which can include dystonia (involuntary muscle contractions), tardive dyskinesia, and akathisia. The patient’s neck twisting is indicative of cervical dystonia or torticollis, which is a type of dystonia and a well-known side effect of metoclopramide. This side effect can occur even after short-term use, especially in older patients. Now, let's look at the incorrect options: A. Aspirin: Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for pain relief and inflammation. It is not typically associated with causing muscle spasms or extrapyramidal symptoms. While it can cause gastrointestinal bleeding or renal issues in certain patients, it does not have any known connection to dystonic reactions like the one described in this case. B. Digoxin: Digoxin is a medication used to treat heart failure and atrial arrhythmias. While digoxin toxicity can cause a variety of symptoms like nausea, vomiting, confusion, and visual disturbances, it is not typically associated with muscle spasms or dystonic reactions. This makes digoxin an unlikely cause of the patient’s symptoms in this scenario. C. Erythromycin: Erythromycin is an antibiotic used to treat a variety of bacterial infections. It is known to interact with cytochrome P450 enzymes and can sometimes lead to QT prolongation and arrhythmias. However, erythromycin is not commonly associated with causing muscle spasms or extrapyramidal symptoms. Thus, it is unlikely to be the cause of this patient’s symptoms. D. Fluoxetine: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression, anxiety, and other mood disorders. While SSRIs can cause a variety of side effects, including sexual dysfunction, gastrointestinal issues, and sleep disturbances, muscle spasms or dystonic reactions are not common. Although fluoxetine can occasionally cause serotonin syndrome (which may involve hyperreflexia and rigidity), this patient's symptoms are more consistent with dystonia, a side effect more commonly associated with dopamine antagonists like metoclopramide.",
      "correct_choice_id": 237085,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29197341699004613/29197341699004613.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29197341699004613/29197341699004613.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81273,
      "choices": [
        {
          "id": 237086,
          "text": "Benign essential tremor"
        },
        {
          "id": 237087,
          "text": "Antipsychotic-induced parkinsonism"
        },
        {
          "id": 237088,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 237089,
          "text": "Parkinson disease"
        },
        {
          "id": 237090,
          "text": "Tardive dyskinesia"
        }
      ],
      "text": "A 23-year-old man with a diagnosis of schizophrenia, paranoid type, has been maintained on a low dose of haloperidol for the past 3 years. For the past month, his symptoms of paranoia and auditory hallucinations have been more prominent, and his psychiatrist decides to increase his dose of haloperidol. The patient’s mother calls the psychiatrist, concerned that he seems slower than usual and has a fine resting tremor of his upper extremities. Furthermore, the patient complains that he feels “stiff.” This clinical picture suggests that the patient is experiencing which of the following?",
      "unique_key": "Q9561898",
      "question_audio": null,
      "question_video": null,
      "map_id": 34355508,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Antipsychotic-induced parkinsonism. This patient is exhibiting symptoms that are commonly associated with antipsychotic-induced parkinsonism. Specifically, he has developed a resting tremor and muscle stiffness (rigidity), which are hallmark features of parkinsonism, a side effect of antipsychotic medications, particularly haloperidol, a first-generation (typical) antipsychotic. These symptoms occur due to the medication's dopamine antagonism in the brain, particularly in the nigrostriatal pathway, which is involved in motor control. Increasing the dose of haloperidol is likely to have precipitated this extrapyramidal side effect (EPS), which presents as resting tremor, rigidity, and bradykinesia (slowness of movement). These symptoms are commonly seen in patients on long-term or higher doses of antipsychotic medications. Now, let's evaluate the incorrect options: A. Benign essential tremor: Benign essential tremor is a neurological disorder characterized by a kinetic tremor (tremor that occurs during voluntary movement), not a resting tremor as seen in this patient. Essential tremor typically involves the hands, head, or voice, and it is not associated with muscle rigidity or bradykinesia. Therefore, benign essential tremor is unlikely given the patient's history of antipsychotic use and the presence of other parkinsonian features. C. Neuroleptic malignant syndrome (NMS): Neuroleptic malignant syndrome is a life-threatening condition associated with antipsychotic medications, characterized by fever, muscle rigidity, autonomic dysregulation (e.g., unstable blood pressure), and altered mental status. Although this patient has muscle stiffness, there is no fever or autonomic instability (such as blood pressure changes or sweating), which are key features of NMS. The patient's symptoms are more consistent with parkinsonism rather than NMS. D. Parkinson disease: Parkinson disease is a neurodegenerative disorder that presents with a resting tremor, rigidity, and bradykinesia, similar to this patient's symptoms. However, the key distinguishing factor here is the patient's history of antipsychotic use, which is the most likely cause of his motor symptoms. In Parkinson disease, these symptoms would not typically develop in the context of medication use. Moreover, the patient's age (23 years) and medication history make antipsychotic-induced parkinsonism more likely than Parkinson disease, which usually manifests later in life. E. Tardive dyskinesia: Tardive dyskinesia is another extrapyramidal side effect of long-term antipsychotic use, but it is characterized by involuntary, repetitive movements such as grimacing, tongue protrusion, and lip smacking. It typically involves choreiform movements (irregular, jerky motions), not the resting tremor and muscle rigidity seen in this patient. Tardive dyskinesia develops over months to years and is generally not associated with the acute onset of parkinsonism that this patient is experiencing after an increase in the haloperidol dose.",
      "correct_choice_id": 237087,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2659411699004629/2659411699004629.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2659411699004629/2659411699004629.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81274,
      "choices": [
        {
          "id": 237091,
          "text": "Dermatological side effect"
        },
        {
          "id": 237092,
          "text": "Agranulocytosis"
        },
        {
          "id": 237093,
          "text": "Hyponatremia"
        },
        {
          "id": 237094,
          "text": "Visual side effects"
        }
      ],
      "text": "Which of the following side effects is more commonly seen with oxcarbazepine as compared to that of carbamazepine?",
      "unique_key": "Q2623412",
      "question_audio": null,
      "question_video": null,
      "map_id": 34864475,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hyponatremia. Oxcarbazepine, a newer generation anticonvulsant, is more commonly associated with hyponatremia than carbamazepine. Both drugs are used to treat seizure disorders and bipolar disorder, but oxcarbazepine has a higher risk of causing low sodium levels in the blood (hyponatremia). This occurs because oxcarbazepine can increase the secretion of antidiuretic hormone (ADH), leading to water retention and dilution of sodium in the body. This side effect can occur relatively early during treatment and often requires monitoring of sodium levels during therapy. While carbamazepine can also cause hyponatremia, it is more commonly seen with oxcarbazepine, making it the most likely side effect when comparing the two. Now, let's evaluate the incorrect options: A. Dermatological side effects: Both carbamazepine and oxcarbazepine can cause dermatological side effects, including rash and allergic reactions. However, carbamazepine is more commonly associated with severe dermatological side effects, including Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN), especially in individuals with certain genetic predispositions, such as those with the HLA-B*1502 allele. While oxcarbazepine can cause rashes as well, dermatological issues are more common with carbamazepine than with oxcarbazepine. B. Agranulocytosis: Both carbamazepine and oxcarbazepine can cause agranulocytosis (a severe decrease in white blood cell count), but it is more commonly observed with carbamazepine. The incidence of agranulocytosis is significantly higher with carbamazepine, which can result in life-threatening infections due to the lack of sufficient white blood cells. Oxcarbazepine is considered to have a lower risk of causing agranulocytosis compared to carbamazepine. D. Visual side effects: Visual side effects, such as blurred vision and diplopia (double vision), can be seen with both carbamazepine and oxcarbazepine, but they are more commonly associated with carbamazepine than oxcarbazepine. While both drugs can cause eye-related issues, they are not a distinguishing feature between the two, and visual side effects are not more commonly seen with oxcarbazepine.",
      "correct_choice_id": 237093,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19131451699004642/19131451699004642.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19131451699004642/19131451699004642.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81275,
      "choices": [
        {
          "id": 237095,
          "text": "Dermatological side effect"
        },
        {
          "id": 237096,
          "text": "Agranulocytosis"
        },
        {
          "id": 237097,
          "text": "Hyponatremia"
        },
        {
          "id": 237098,
          "text": "Visual side effects"
        }
      ],
      "text": "Which of the following side effects is more commonly seen with carbamazepine than with oxcarbazepine?",
      "unique_key": "Q5884394",
      "question_audio": null,
      "question_video": null,
      "map_id": 34971333,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Dermatological side effects. Carbamazepine is more commonly associated with dermatological side effects compared to oxcarbazepine. Notably, carbamazepine has a higher risk of causing serious dermatological reactions, such as rash, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). These severe skin reactions are particularly more common in patients with the HLA-B*1502 allele, often seen in people of Asian descent. Oxcarbazepine, while it can also cause mild rashes, is generally associated with a lower risk of serious dermatological reactions when compared to carbamazepine. Thus, dermatological side effects are more prevalent with carbamazepine. Now, let's evaluate the incorrect options: B. Agranulocytosis: Agranulocytosis (a dangerous decrease in white blood cell count) is a known but rare side effect of both carbamazepine and oxcarbazepine. However, carbamazepine is more commonly associated with this severe side effect than oxcarbazepine. This condition can lead to increased susceptibility to infections, and patients on carbamazepine require regular blood monitoring for this reason. So, agranulocytosis is more common with carbamazepine, making it incorrect for this question. C. Hyponatremia: Both carbamazepine and oxcarbazepine can cause hyponatremia (low sodium levels), but hyponatremia is more common with oxcarbazepine. Oxcarbazepine tends to increase the secretion of antidiuretic hormone (ADH), which can lead to fluid retention and dilutional hyponatremia. While carbamazepine can also cause hyponatremia, the incidence is lower compared to oxcarbazepine. Hence, this makes hyponatremia more common with oxcarbazepine, not carbamazepine. D. Visual side effects: Both carbamazepine and oxcarbazepine can cause visual side effects, such as blurred vision and diplopia (double vision), but these are not particularly more common with either medication. Visual side effects are not a distinguishing factor between the two drugs, and they tend to occur with both agents at a similar rate. Therefore, visual side effects are not the correct answer for this question.",
      "correct_choice_id": 237095,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42116321699004658/42116321699004658.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42116321699004658/42116321699004658.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}